Quarterlytics / Basic Materials / Other Precious Metals / Almirall

Almirall

alm · LSE Basic Materials
Claim this profile
Ticker alm
Exchange LSE
Sector Basic Materials
Industry Other Precious Metals
Employees 201-500
← All annual reports
FY2021 Annual Report · Almirall
Sign in to download
Loading PDF…
ALLIED MINDS PLC 

ANNUAL REPORT AND ACCOUNTS 
For the year ended 31 December 2021 

 
 
 
 
 
 
 
 
 
 
 
Page 
no. 
3 
4 

5 
5 
7 
9 
13 
15 
19 

26 
26 
28 
36 
46 
56 
81 

86 
86 
98 
102 
153 
156 
160 

Contents 

Overview 
Chairman’s Report  

Strategic Report 
Highlights 
Company Overview 
Portfolio Review and Developments 
Key Performance Indicators 
Financial Review 
Risk Management 

Management and Governance 

The Board 
Directors’ Report 
Corporate Governance Report 
Sustainability 
Directors’ Remuneration Report 
Audit Committee Report 

Financial Statements 

Independent Auditor’s Report 
Consolidated Financial Statements 
Notes to the Consolidated Financial Statements 
Company Balance Sheet  
Notes to the Financial Statements 
Company Information 

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overview 

Allied Minds plc (Allied Minds or the Group) is an IP commercialisation company primarily focused on early 
stage company development within the technology sector.   

It has historically invested in companies at an early stage, including seed investments to build companies 
based on a technical breakthrough or invention.  As such, investments have significant upside potential, 
but also carry significant risk inherent in the early stage model.  

The  Group  is  currently  comprised  of  six  portfolio  companies  based  upon  a  broad  range  of  underlying 
innovative technologies ranging from wireless connectivity to space-based imagery and analytics. 

The ability of the Group’s portfolio companies to raise funds and continue achieving important technical 
and commercial milestones while building upon key partnership relationships is a key strength.  The Group 
continues to progress as it works to execute on growing the value of its portfolio company interests for 
its shareholders. 

For some time, the Board has been reviewing the range of strategic options available to it in order to 
return value to shareholders. Following the successful first close of the Series D fundraising by Federated 
Wireless announced in February 2022, the Board subsequently announced in March 2022, its intention to 
undertake a formal review of the Company's strategic options (the “Strategic Review”) including, but not 
limited to, a sale of the Company itself, which the Board intends to conduct under the framework of a 
“Formal Sale Process" in accordance with Rules 2.4 and 2.6 of the Takeover Code. alternatively, to seek to 
distribute certain assets and any cash reserves directly back to shareholders through a re-structure. The 
Strategic Review is solely aimed at creating and/or realising shareholder value. 

Subject to conclusion of the  Strategic Review, the Board will continue to aim to monetise the Group’s 
ownership positions at the appropriate time, recognising the value and benefit in achieving well-timed 
risk-adjusted returns for the benefit of shareholders. Upon the event of successful monetisation events 
from the sale of portfolio companies or portfolio company interests, Allied Minds anticipates distributing 
the  net  proceeds  to  its  shareholders,  after  due  consideration  of  potential  follow-on  investment 
opportunities within the existing portfolio and working capital requirements.   

The  Board  aims  to  ensure  that  the  Group  is  being  managed  in  as  cost  efficient  manner  as  possible, 
regularly reviewing the on going costs associated with being a listed company. The Board notes that the 
costs of maintaining a premium listing on the London Stock Exchange are prohibitive for a company of 
Allied Minds’ current size and maintaining a public listing is expensive with more than 50 per cent of the 
Company’s annual budget devoted to meeting the requirements of being a listed company.  

That said, the Directors believe the Group’s cash balance is sufficient to continue to support Allied Minds' 
operations and portfolio companies in accordance with its current strategy.  

3 

 
 
 
 
Chairman’s Report 

This is my last Chairman’s letter to you having taken the decision to stand down from the Board  upon 
signing off these accounts.  

Following this decision and conscious of the recent board changes, there is a need to appoint additional 
directors  to  the  board of  the  Company. The Directors  are working  closely with  the  Company’s  largest 
shareholders to identify and recruit new directors to the board of the Company.  

Allied Minds has an unusual Board structure, having been comprised solely of Non-Executive Directors, 
with each portfolio company having its own Board of Directors.  The Non-Executive Directors of Allied 
Minds serve on the Boards or have observer status on each active portfolio company.  This has enabled 
us to work in a cost-efficient manner while utilising the skills of the Allied Minds directors. 

Over my time as Chairman I, and my Board colleagues, have reviewed the portfolio of investments we 
inherited and took the appropriate tough decisions to ensure we maximise those investments with the 
most perceived value and move them towards monetisation. 

As at the start of 2021, all the portfolio companies Allied Minds was invested in were essentially pre or at 
the  early  stages  of  generating  revenue,  and  a  number  of  them  faced  substantial  challenges.    These 
challenges  resulted  in  us  exiting  or  closing  our  investments  in  several  companies,  leaving  us  with  six 
companies which, in my and the Board’s view, have significant potential and merit support.  

This restructuring of the portfolio has been challenging. In several cases hopes and expectations of the 
value of our investments were out of line with reality and this has had a consequential impact on  the 
share  price.  However,  this  rebasing  of  the  value  of  the  investments,  and  providing  clarity  to  all 
shareholders, needed to take place, and we now have six investments which have potential. Of these our 
investment in Federated Wireless is the most valuable, as demonstrated by the recent Series D upround 
at a post-money valuation of $302 million.  

As part of the Board’s review of its strategic options, and its frustrations with the undervaluation of the 
Company on the stock market, and the costs of being a listed entity, the Board announced in March 2022 
that we were undertaking a formal strategic review and sale process. This review may lead to an offer for 
the Company, or a distribution of assets and cash to shareholders.  

It has been my pleasure to serve as your Chairman, and I wish my successor every success. 

Harry Rein 
Chairman 
14 June 2022 

4 

 
 
 
 
 
Highlights 

Investment & Financial Highlights 

  $68.5 million invested in portfolio companies, of which $61.8 million was raised from third-party 

investment. 

  Cash and cash equivalents at 31 December 2021: $9.7 million (FY20: $24.5 million), of which $9.0 

million is held within Allied Minds (FY20: $22.3 million). 

  Revenues of $1.5 million (2020: $0.5 million) mainly from non-recurring engineering (NRE) and 
service contracts within Bridgecomm, reflecting the early stage nature of our portfolio companies. 
  Share buyback programme launched in June 2021 to buy back up to $3.0 million of the Group's 

shares to redistribute excess capital for the benefit of shareholders. 

o  A total of 2,537,712 shares, to date, have been purchased at a cost of $0.7 million.  

Selected Portfolio Company Highlights 

  BridgeComm (consolidated subsidiary): 

o  Commenced sales of its Optical Inter-Satellite Link terminals - used in programs for space 

and ground applications with commercial and US Government customers. 

o  Launched Managed Optical Communication Array (MOCA) technology which allows for 
multi-domain  capabilities  to  share  large  volumes  of  data  significantly  faster  with 
increased security.  

o  Developed a proprietary, patent awarded set of technologies around point to multipoint 

optical communications using MOCA technology.   

o  Advanced one-to-many optical wireless communications (OWC) using MOCA technology 

to support Low Earth Orbit (LEO) constellations. 

o  Post  year  end,  Allied Minds  and  AE  Industrial  HorizonX  Venture  Fund  I,  LP  (HorizonX), 
jointly  contributed  an  aggregate  of  $0.8  million  of  convertible  bridge  financing  to 
BridgeComm,  each  contributing  $0.4  million.  The  bridge  financing  will  be  applied  to 
support the business to the completion of a new financing round. 

  Federated Wireless (equity accounted investment): 

o  Awarded multi-million-dollar contract from the US Department of Defense as part of its 

o 

5G Smart Warehouse Initiative.  
In November 2021, Allied Minds invested $4,283,000 in Federated as bridge financing, 
which is held at fair value of $4,500,000 at 31 December 2021. 

o  Post year end, Federated Wireless announced two Series D fundraises for a total of $72 

million, giving Federated Wireless a post money valuation of $302 million. 

o  Allied Minds’ bridge financing fully converted following the post year end completion of 
the Series D funding rounds. As a result, Allied Minds' fully‐diluted ownership of the issued 
share capital of Federated Wireless stands at 23.96%. 

o  Key  appointments  made  to  the  company’s  leadership  team  in  2021,  including  Chief 

Commercial Officer and Chief Financial Officer. 

o  Achieved 3.8x revenue growth in 2021 and expects continued momentum through 2022 

and beyond. 

5 

 
 
 
 
 
  OcuTerra (ordinary and preference share holding): 

o  Closed  $35  million  Series  B  funding  from  new  investors  and  as  part  of  the  raise  the 

company was deconsolidated from the group financial statements. 

o  Proceeds  will  be  used  to  fund  a  Phase  II  clinical  trial  of  its  OTT166  asset  in  diabetic 

retinopathy, as well as for other working capital needs. 

o  The  company  is  preparing  for  the  start  of  the  Phase  2  trial,  and  is  building  out  its 

managerial and clinical team. 

o  Now funded for the immediate future. 

  Orbital Sidekick (investment held at fair value): 

o  Closed  $16  million  Series  A  funding  led  by  Temasek  -  included  new  investors  Energy 
Innovation Capital and Syndicate 708 and existing investors Allied Minds and 11.2 Capital. 
o  Launched most powerful satellite yet, Aurora, to collect and analyse hyperspectral data, 

with a broad focus on sustainability.  

o  Expanded the team from 12 to 39, which is expected to reach 65 employees by the end 

of 2022. 

o  Expanding satellite operations within existing partnerships with Phillips 66 and iPIPE to 
leak  prevention  and  monitoring  for  the  energy  sector  -  full 

provide  better 
commercialisation anticipated during 2023. 

o  Signed a contract with one of the largest pipeline operators in North America  - Energy 
Transfer - to deliver recurring monitoring services from our satellites through 2023. 
o  Orbital has sufficient cash to fund the business until August 2022 and is in advanced talks 
with  potential  investment  firms  and  strategic  partner  groups  to  secure  the  required 
funding.  

  Touch Bistro (investment held at fair value) 

On  28  March  2022,  Allied  Minds  announced  that  it  had  completed  the  disposal  of  its 
residual shareholding in Touch Bistro for $5.5m CAD ($4.4m USD) in line with its strategy 
of  monetising  its  investment  portfolio.  Of  the  sale  proceeds,  $4.97m  CAD  has  been 
received and $0.53m CAD is to be held in escrow, with an initial release date in Q3 2022, 
subject to any then outstanding claims. 

Corporate Developments  

Post-period  end,  Allied Minds  announced  in March 2022  that  it  will  undertake  a  formal  review  of  the 
Company's  strategic  options  (the  “Strategic  Review”)  including,  but  are  not  limited  to,  a  sale  of  the 
Company itself, which the Board intends to conduct under the framework of a "Formal Sale Process" in 
accordance with Rules 2.4 and 2.6 of the Takeover Code, alternatively, to seek to distribute certain assets 
and any cash reserves directly back to shareholders through a re-structure. The rationale for the strategic 
review is detailed later in the strategic report on page 7. The Company also announced the resignation of 
Non-Executive Directors, Mark Lerdal and the forthcoming resignation of Harry Rein.  Harry Rein and Bruce 
Failing, the Senior Independent Director, and the Company's largest shareholders are working to ensure 
an orderly transition to any new Independent Directors. 

Company Overview 

6 

 
 
 
 
 
Overview 

Allied Minds is an IP commercialisation company primarily focused on early stage company development 
within the technology sector.   

We  have  historically  invested  in  companies  at  an  early  stage,  including  seed  investments  to  build 
companies based on a technical breakthrough or invention.  As such, our investments have significant 
upside potential, but also carry significant risk inherent in the early stage model.   

The  Group  is  currently  comprised  of  six  portfolio  companies  based  upon  a  broad  range  of  underlying 
innovative technologies ranging from wireless connectivity to space-based imagery and analytics.   

The Group remains focused to execute its plan to maximise the value of its portfolio company interests 
and deliver well-timed, risk-adjusted returns for its shareholders. 

Model  

As a manager of a technology-focused portfolio in which we hold significant ownership positions, we seek 
to provide hands-on support over the life of our companies to support their growth, focusing on enabling 
and  driving  commercialisation,  supporting  follow-on  investment  rounds,  and  positioning  for  superior 
monetisation opportunities.   

We seek to play an active role in developing the strategic direction of our portfolio companies and driving 
ongoing planning and assessment.  Our Non-Executive Directors serve on the boards of directors of our 
portfolio companies, working with them to develop and implement strategic, operating and funding plans.  
We  evaluate  on  an  on-going  basis  the  progress  and  potential  of  each  of  the  portfolio  company’s 
businesses,  and  make  strategic  and  funding  decisions  based  on  the  regular  review  of operational  and 
financial  performance  and  the  achievement  of  key  milestones.    Together  with  our  management,  the 
respective portfolio company boards of directors define the critical milestones, or inflection points, for 
each portfolio company and measure tangible progress towards commercialisation and the key factors 
for a successful monetisation event.   

 Where appropriate, we seek to include partners who validate the market opportunity and can provide 
support  and/or  commercial  commitments  to  accelerate,  expand  and/or  de-risk  the  path  to 
commercialisation. Co-investors in later rounds include financial, strategic and commercial partners.  

Strategy 

Allied  Minds  is  focused  on  supporting  its  existing  portfolio  companies  and  maximising  monetisation 
opportunities for portfolio company interests.  For some time, the Board has been reviewing the range of 
strategic options available to it in order to return value to shareholders. The Board resolved, in March 
2022, to undertake a formal review of the Company's strategic options (the “Strategic Review”) including, 
but not limited to, a sale of the Company itself, which the Board intends to conduct under the framework 
of a “Formal Sale Process" in accordance with Rules 2.4 and 2.6 of the Takeover Code, alternatively, to 
seek  to  distribute  certain  assets  and  any  cash  reserves  directly  back  to  shareholders  through  a  re-
structure. The Strategic Review is solely aimed at creating and/or realising shareholder value. 

Subject to conclusion of the  Strategic Review, the Board will continue to aim to monetise the Group’s 
ownership positions at the appropriate time, recognising the value and benefit in achieving well-timed 

7 

 
 
risk-adjusted returns for the benefit of shareholders. Upon the event of successful monetisation events 
from the sale of portfolio companies or portfolio company interests, Allied Minds anticipates distributing 
the  net  proceeds  to  its  shareholders,  after  due  consideration  of  potential  follow-on  investment 
opportunities within the existing portfolio and working capital requirements.   

The value of Allied Minds is dependent upon the value of our existing portfolio companies and our ability 
to translate that value into cash as effectively and efficiently as possible and to deliver that cash, net of 
our obligations and operating cash needs, to our shareholders.   

The  Board  aims  to  ensure  that  the  Group  is  being  managed  in  as  cost  efficient  manner  as  possible, 
regularly reviewing the on going costs associated with being a listed company. The Board notes that the 
costs of maintaining a premium listing on the London Stock Exchange are prohibitive for a company of 
Allied Minds’ current size and maintaining a public listing is expensive with more than 50 per cent of the 
Company’s annual budget devoted to meeting the requirements of being a listed company.  

Outlook 

There was substantial technical and commercial progress from within some portfolio companies during 
2021 and post period, including successful funding rounds, development milestones, contract wins and 
industry  partnerships.  The  milestones  achieved  demonstrate  examples  of  solving  difficult  technical 
problems,  developing  innovative  products  and  services  across  a  range  of  large  potential  markets, 
establishing important partnerships to develop technology and go to market channels, and the creation 
of shareholder value. 

The Board of Allied Minds continually assesses  its  portfolio of investments and with a member of the 
Board sitting on or leading the boards of all our material investments, the Board can ensure it is optimally 
placed  to  take  timely  decisions  based  on  up  to  date  information.  This  will  not  be  impacted  by  the 
departure  of  Harry  Rein  as  Chairman  and  a  process  is  currently  underway  to  ensure  the  appropriate 
number of non-executive directors serve on the board.   

This approach has ensured that decisive actions are taken, even if these are sometimes difficult such as 
the decision to liquidate Spin Memory, and sell Spark Insights. 

Although the remaining portfolio companies are mostly at a relatively early stage in their lifecycle, the 
Board is positive about their prospects upon exit if the portfolio companies continue to meet their planned 
technical and commercial goals. 

Portfolio Company Valuation  

Of the Company’s six active  portfolio companies, one  is currently majority owned and controlled, and 
therefore fully consolidated in the Company’s consolidated financial statements prepared in accordance 
with UK adopted International Accounting Standards.  

Of the remaining five portfolio companies, the Company holds a significant minority stake in three of these 
companies and small positions in both TouchBistro, Inc. (as a result of the stock-for-stock sale of TableUp, 
Inc.) and Concirrus (as a result of the stock-for-stock sale of Spark Insights, Inc.).  In each case, where Allied 
Minds  holds  a  significant  minority  stake,  it  is  able  to  exercise  significant  influence  over  the  portfolio 
company  by  virtue  of  its  large,  albeit  minority,  ownership  stake  in  the  portfolio  company  and  its 
representation on the board of directors. The investment in preferred stock in these portfolio companies 

8 

 
 
is  accounted  for  under  IFRS  9  and  is  classified  by  the  Company  as  an  investment  at  fair  value  in  the 
Company’s consolidated financial statements.   Due  to the equity-like  characteristics of  the Company’s 
common  stockholdings  in  Federated  Wireless,  this  investment  is  accounted  for  under  IAS  28  and  is 
classified by the Company as investments  in associates. Accordingly,  since  Allied Minds has significant 
influence  over  this  entity  through  the  voting  rights/potential  voting  rights  held,  it  gives  access  to  the 
returns associated with an ownership interest in this associate. For Ordinary stock holdings, where the 
group  does  not  have  significant  influence,  these  investments  are  held  at  fair  value  in  the  Company’s 
consolidated financial statements. 

Allied Minds provides qualitative and quantitative disclosure in relation to the commercial and financial 
progress  of  its  portfolio  companies,  and  directional  commentary  on  valuation.    In  addition,  where 
commercially possible, Allied Minds provides, for each portfolio company: (i) the date of the last equity 
funding round, (ii) the post-money valuation of such round, (iii) the named key co-investors in such round, 
and (iv) the Company’s issued and outstanding ownership, and fully-diluted ownership, of such portfolio 
company.   

This information is set forth in the Portfolio Review and Developments section below.  The ownership 
interests are as of 03 May 2022. The fully-diluted percentages take into account outstanding stock options 
granted to employees, directors and advisors, current stock options available for grant pursuant to the 
company’s stock option plan, and outstanding warrants to purchase common and preferred stock.  

The post-money valuations disclosed for each entity below do not represent IFRS 13 fair values but rather, 
are based on the pre-money valuation set by the investors in the latest financing round plus the total 
money raised in that round.   

There can be no guarantee that the aforementioned post-money valuations of the portfolio companies 
will be considered to be correct in light of the future performance of the various companies, or that the 
Company would be able to realise proceeds in the amount of such valuations, or at all, in the event of a 
sale by it of any of its portfolio companies or its ownership interest in such portfolio companies.   

Portfolio Review and Developments 

---------- 

1)  BridgeComm Inc. (BridgeComm) (consolidated subsidiary) 

BridgeComm  is  developing  high-speed  optical  wireless  communications  to  provide  fast,  secure, 
enterprise-grade  broadband  service  for  space,  terrestrial  and  5G  connectivity.    Interest  in  the  optical 
communications  market  is  growing  with  commercial  space  opportunities  and  government  programs 
looking for the unique characteristics of high speed and security.  

BridgeComm has developed a proprietary, patent awarded set of technologies around point to multipoint 
optical communications using Managed Optical Communication Array (MOCA) technology.  This means 
BrideComm  can  truly  complement  legacy  Radio  Frequency  (RF)  technology. 
  BrideComm  has 
demonstrated this capability to customers and is now developing terminals for specific applications. Key 
partners include Space Micro for production of point to multipoint terminals based on MOCA technology 
and Boeing that has supported BridgeComm and partnered on key applications. 

9 

 
 
 
The conflict in the Ukraine has highlighted the value of Bridgecomm’s point to multi point technology. 
BridgeComm’s  one-to-many  high-speed  optical  communications  technology  allows  for  dispersed 
communications which are difficult to detect and/or intercept.  Current battlefield communications tend 
to use a single point of distribution with the risk of a single point of failure.  BridgeComm’s one-to-many 
communications enables a mesh network, eliminating this point of failure. The goal is to install 1000’s of 
satellites  with  BridgeComm’s  non  mechanical  software  driven  optical  communications  system.   This 
would  allow  dispersed  battlefield  control  from  space.   In  addition  it  is  hoped  that  BridgeComm’s 
technology will provide the optical intersatellite communications capability of choice for all proliferated 
low earth orbit constellations. 

BridgeComm will require up to $5mm additional capital to deliver an existing contract with The Space 
Development Agency, the objective of which is to prove MOCA technology over longer distances. 

BridgeComm  is  currently  in  partnering  discussions  with  Aeroequity  Industrial  partners  to  provide 
additional funding and US government sourcing expertise.  In addition, for BridgeComm to succeed as a 
US  government  vendor,  it  will  need  to  be  a  US  based  company.   Because  AEI  brings  technical  and 
government knowledge, it is planed that Allied Minds will be a large minority shareholder post transaction 
which is expected to be a down round to the last valuation. 

Holdings and valuation: 

  Date of Last Funding Round: September 2018 
  Post-Money Valuation: $38.0 million 
  Co-Investors: Boeing HorizonX Ventures (venture arm of Boeing Company) 
  Allied Minds’ Issued and Outstanding Ownership: 81.15% 
  Allied Minds’ Fully-Diluted Ownership: 62.92% 

2)  Federated Wireless Inc. (Federated) (equity accounted investment) 

Founded in 2012, Federated is the market leader in Citizen Band Radio Service (CBRS) shared spectrum. 
Shared spectrum, also known as CBRS,  is an innovative technology that delivers the best attributes of 
traditional wireless and Wi-Fi, with lower fixed cost, higher quality, and greater efficiency and scale.  

As the first to market with a Spectrum Access System (“SAS”), Federated Wireless is the nationwide leader 
in enabling, commercializing, and driving adoption of shared spectrum. With more than 350 customers 
and  over  90,000  connected  devices  across the  United  States and  territories,  the  company  serves  a 
customer base spanning defense, government, manufacturing, telecommunications, utilities, real estate, 
and education, with a wide range of use cases ranging from network densification and mobile offload to 
private  wireless  and  industrial  IoT.  Noteworthy  customers  include  Charter,  Comcast,  Verizon,  the  US 
Department of Defense and Carnegie Mellon University.  

The  company  has  driven  several  significant  advancements  in  2021.  These  include  the  launch  of  the 
secondary CBRS spectrum market via its Spectrum Exchange; significant deployments of a dedicated CBRS 
network for IoT research at Fort Carson, CO, and another for modernization of the Marine Corps Logistics 
Command  warehouse  operations  in  Albany,  GA;  along  with  deployment  of  the  first  CBRS  networks  in 
Puerto Rico and the U.S Virgin Islands, delivering service to the region’s Wireless Internet Service Providers 
(WISPs) and Mobile Network Operators (MNOs). The last year has seen its customer and partner base 

10 

 
 
 
expand  rapidly  into  new verticals  and the  number of  active  CBRS  devices  grow  significantly.  As of  the 
publication of this report, the company has more than 350 customers, with more than 90,000 devices 
deployed, which together indicate strong momentum for the entire market segment.  

Accelerating private 5G wireless for enterprise 

Federated  Wireless  is  powering  innovation  in  how  networks  are  delivered  and  reshaping  wireless 
connectivity for cloud-enabled technologies. The company is focused on accelerating enterprise adoption 
of private wireless networking and delivering new capabilities for network edge innovation. Its goal is to 
simplify  and  automate  how  wireless  networks  are  purchased,  deployed,  provisioned,  and  managed, 
making it easier for organizations to customize their network to business requirements, and speed time 
to market with advancements in IoT, VR/AR, and other digital technologies. 

Critical to the Federated Wireless strategy is expanding its edge solutions, which it will achieve through 
collaboration  with  hyperscale  providers  that  have  been  growing  and  strengthening  over  the  past  two 
years, including AWS, Intel, HPE-Aruba, JMA, Cisco, and others. The company’s top priorities include: 

 

Investing in cloud-native tools to empower edge innovation, including automation, application 
analytics, and zero touch provisioning (ZTP); 

  Mobilizing  the  ecosystem  with  a  heightened  focus  on  relationship  management,  business 

development, and sales enablement; 

  Expanding product capabilities for sharing in 6 Ghz and promoting its adoption domestically and 

internationally; and, 

  Ramping up commercial capacity with increased investment in Sales, Marketing, and Customer 

Success. 

Investing in growth 

In  addition  to  significant  investments  in  product  development,  Federated  Wireless  made  key 
appointments to the company’s leadership team in 2021, including: 

 

Industry veteran Chris Swan joined as Chief Commercial Officer to focus on delivering the very 
significant  growth  opportunity  for  the  business  with  leadership  over  sales,  marketing,  and 
customer care.  

  Strategic operations and finance executive Loren Buck joins as Chief Financial Officer. 

Financially,  Federated  Wireless  saw  3.8x  revenue  growth  in  2021  and  expects  continued  momentum 
through 2022 and beyond. 

Subsequent to year end, Federated Wireless raised $72 million through a two stage Series D funding to 
fuel  growth  in  5G  private  wireless  and  other  strategic  focuses.  An  affiliate  of  Cerberus  Capital 
Management,  L.P.  led  the  round,  with  affiliates  of  Fortress  Investment  Group,  Giantleap  Capital,  and 
LightShed  Ventures  added  as  new  investors  with  existing  investors  Allied  Minds  and  GIC,  Singapore’s 
sovereign wealth fund, also participating.  

Holdings and valuation: 

11 

 
 
  Date of Last Funding Round: May 2022  
  Post-Money Valuation: $302 million 
  Co-Investors: Cerberus Capital Management LLP and GIC (Singapore’s sovereign wealth fund) 
  Allied Minds’ Fully-Diluted Ownership: 23.96% 

3)  OcuTerra Therapeutics, Inc. (ordinary and preference share holding) 

OcuTerra is a clinical stage ophthalmology company developing innovative small molecule drugs for non-
invasive  use  in  treating  ophthalmologic  diseases  that  are  currently  treated  in  the  early  stages  with  a 
“watch and wait” protocol.  The company has announced a Series B financing of $35m that will be used 
to fund a Phase 2 trial starting in Q3 2022 of its non-invasive eyedrops (OTT166) for use in early active 
management of Diabetic Retinopathy.  It will be  studied in the trial for the treatment  of moderate  to 
severe  non-proliferative  and  mild  proliferative  Diabetic  Retinopathy. Diabetic Retinopathy  is  a  disease 
that results in loss of vision for diabetic patients. 

Phase  1b  clinical  trials  of  OTT166  eye  drops  in  patients  with  diabetic  retinopathy  and  wet  AMD  have 
demonstrated safety, tolerability and clear clinical evidence of biological activity.  OTT166 is a novel small 
molecule  selective  integrin  inhibitor  that  has  been  engineered  to  have  the  required  physiochemical 
characteristics to be able to reach the retina , where the damage occurs, from eye drop application.  The 
current standard of care involves injections into the eye and/or laser treatment.  The OcuTerra drops are 
intended to be used earlier in the treatment of Retinopathy, potentially delaying or eliminating the need 
for intravitreal injections. If the Phase 2 trial is successful, the next step would be a Phase 3 trial involving 
more patients and if successful in meeting the clinical end points application to the FDA for approval.   

The  company  believes  that  it  is  well  positioned  to  transform  the  treatment  of  Diabetic  Retinopathy.  
Currently the company is preparing for the start of the Phase 2 trial, and is building out its managerial and 
clinical team. 

Allied Minds is a minority shareholder in OcuTerra and as such there is no current intention to invest any 
further capital in the company.  

Holdings and valuation: 

  Date of Last Funding Round: November 2021  
  Valuation: $51.3 million 
  Co-Investors: Various third parties 
  Allied Minds’ Issued and Outstanding Ownership: 17.06% 
  Allied Minds’ Fully-Diluted Ownership: 12.33% 

4)  Orbital Sidekick Inc. (Orbital) (investment held at fair value) 

Orbital  has  developed  a  proprietary  analytics  platform  based  upon  its  hyperspectral  technology  that 
allows it to take a proprietary “chemical fingerprint” from space.  Initially, Orbital is addressing the very 
current and large concerns about the environment by focusing on potential energy pipeline failures.  By 
employing its space-based technology, it is able  to detect  and identify natural gas, oil leaks and other 
failures much more rapidly than current monitoring techniques in a more cost effective way and the added 
benefit of helping to minimise environmental damage.  

12 

 
 
Orbital SideKick has grown significantly over the past 12 months, expanding the team from 12 to 39. The 
Company is expected to reach 65 employees by the end of 2022. Orbital has invested heavily in product 
development, engineering, and analytics, and is now growing the Sales & Marketing Team ahead of the 
launch  and  commissioning  of 6 satellite  GHOSt  constellation  beginning  in  Q3  of  2022.  The  Company’s 
technology demonstration mission - Aurora - successfully validated its hyperspectral sensor technology 
performance in a space environment and served as a dress rehearsal for the GHOSt constellation.  The 
company has  recently  signed a contract  with one  of the largest pipeline operators in North America  - 
Energy Transfer - to deliver recurring monitoring services from its satellites through 2023. The Company 
recently signed a significant  work program contract with In-Q-Tel, and expects  to expand  its  footprint 
within  the  defense  &  intelligence  community  in  2022  and  beyond.  The  Company  is  also  developing 
products for the mining and agriculture industries, along with fire fuel and carbon mapping capabilities.  

Orbital  has  sufficient  cash  to  fund  the  business  until  August  2022.  Orbital  is  in  advanced  talks  with 
potential investment firms and strategic partner groups to secure the required funding. The additional 
funding will allow the company to add its product to an additional six satellite launches.  

Holdings and valuation: 

  Date of Last Funding Round: April 2021 
  Post-Money Valuation: $46 million  
  Co-Investors: Temasek, Energy Innovation Capital and 11.2 Capital 
  Allied Minds’ Issued and Outstanding Ownership in respect of preference shares: 26.52%  
  Allied Minds’ Fully-Diluted Ownership: 24.11%  

5)  Concirrus (acquirer of Spark Insights Inc.) (common shares in Concirrus) 

On 1 November 2021, Allied Minds announced the disposal of portfolio company Spark Insights, Inc. to 
Concirrus, a private UK-based insurance technology company. The disposal is valued at $700,000 USD and 
was paid in Concirrus stock. 

6)  TouchBistro, Inc. (acquirer of TableUp, Inc.) (common shares in TouchBistro) 

On  28th  March  2022,  Allied  Minds  announces  that  it  had  completed  the  disposal  of  its  residual 
shareholding  in  Touch  Bistro  for  $5.5m  CAD  ($4.4m  USD)  in  line  with  its  strategy  of  monetising  its 
investment portfolio. Of the sale proceeds, $4.97m CAD has been received and $0.53m CAD is to be held 
in escrow, with an initial release date in Q3 2022, subject to any then outstanding claims. 

Key Performance Indicators  

In  2020,  the  Company  measured  its  performance  through  the  percentage  level  of  achievement  of 
management by objectives (MBOs). These objectives sought to link financial, operational, technical and 
other  performance  milestones  established  by  the  Board  directly  to  remuneration  and  KPIs.  In  2021, 
however,  MBOs  were  removed  following  changes  in  the  Company’s  management  structure  and  the  
absence of Executive Directors. 

The  following  Key  Performance  Indicators  (KPIs)  were  selected  to  measure  the  performance  of  the 
Company in 2021.  These objectives seek to link financial, operational, technical and other performance 

13 

 
 
 
milestones established by the Board directly to remuneration and KPIs, as further set out in the director 
compensation schemes previously disclosed to the market.  

1. 

Increase  Company  Non-Executive  Director  (NED)  engagement  at  each  portfolio  company.  We 
have continued to hold NED roles on the board of each of the significant portfolio investments.  
2.  Provide strategic, operational and financing support and assistance to the portfolio companies 
through representation on the board of each portfolio company. We have continued to provide 
this support to each of the portfolio companies throughout the period.   

3.  Critically  evaluate  and  monitor  portfolio  company  progress  with  objective  of  maximising 
shareholder return on investment (ROI). We have critically evaluated the performance and this 
has resulted in the investment portfolio changes in the period.  

4.  Manage HQ cash and expenses to maximise shareholder ROI, HQ expenses in the current year 

were $5.69m (2020: $7.11m). 

We  note  that  as  a  result  of  the  strategic  changes  announced  by  the  Board  on  15  January  2021,  the 
portfolio shall be managed by the Board, all of whom are Non-Executive Directors, on a go-forward basis.  
The Board places equal importance on each of the listed KPIs. 

14 

 
 
 
 
Financial Review  

During  2021,  $68.5  million  was  invested  into  existing  portfolio  companies.  This  included  $6.8  million 
invested by Allied Minds, with $61.7 million coming from third-party investment, to further accelerate the 
development of the Group’s existing companies.   

Consolidated Statement of Comprehensive Loss 

For the years ended 31 December 

Revenue 
Cost of revenue 
Selling, general and administrative expenses 
Research and development expenses 
Finance cost, net 
Other expense  
Other comprehensive loss 

 Total comprehensive loss 

 of which attributable to: 
 Equity holders of the parent  
 Non-controlling interests 

2021 
$ '000 

2020 
$ '000 

 1,544  
 (443) 
 (10,569) 
 (2,650) 
 (2,788) 
(1,338) 
(41) 
(16,285) 

 480  
 (210) 
 (10,497) 
 (4,712) 
 (1,786) 
(38,779) 
         (116) 
(55,620) 

 (15,575) 
 (710) 

(53,141) 
 (2,479) 

Revenue increased by $1.0 million, to $1.5 million in 2021 (2020: $0.5 million). This increase is primarily 
attributable to revenue from existing and new contracts in 2021 at BridgeComm. Cost of revenue at $0.4 
million  (2020:  $0.2  million)  was  lower  as  a  percentage  of  revenue,  when  compared  to  the  prior  year, 
mainly due to the nature of the revenue being delivered. 

Selling,  general  and  administrative  (SG&A)  expenses  increased  by $0.1  million, to  $10.6 million  (2020: 
$10.5  million).  This  increase  was mainly  due  to  additional  professional  fees  incurred  in  regards  to the 
latest financing at OcuTerra Therapeutics in the first half of 2021. 

Research and development (R&D) expenses decreased by $2.1 million, to $2.6 million (2020: $4.7 million). 
The decrease was primarily due to the deconsolidation of two subsidiaries in 2021. The remainder of the 
decrease reflects the net effect from R&D spend at the remaining subsidiaries. 

Net finance cost increased by $1.0 million in 2021 to $2.8 million (2020: $1.8 million). The increase in the 
net cost reflects the impact from the deconsolidation of OcuTerra in the first half of 2021 of $7.7 million 
and $0.1 million increase of a convertible note payable due to the fair value adjustment. This increase was 
offset by the $5.2 million decrease of the subsidiary preferred shares liability balance at BridgeComm as 
a result of IFRS 13 fair value accounting. Lastly, interest expense, net of interest income, was $0.2 million 
in 2021 (2020: $23 thousand).  

Other  expenses  decreased  to  $1.3  million  (2020:  $38.8  million)  reflecting  $14.2  million  of  gain  on 
deconsolidation of OcuTerra and Spark Insights, $0.4 million of gain from Paycheck Protection Program 
(PPP) loan forgiveness and $0.3 million of compensation from third parties for disposal of fixed assets, 
offset by $13.9 million loss on investments held at fair value as well as the company’s share of loss of $2.3 
million from its associates.     

15 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As a result of these factors, total comprehensive loss decreased by $39.3 million to $16.3 million (2020: 
$55.6 million). Total comprehensive loss attributed to the equity holders of the Group was $15.6 million 
(2020: loss of $53.1 million) and $0.7 million loss (2020: $2.5 million) was attributable to the owners of 
non-controlling interests. 

Consolidated Statement of Financial Position 

As of 31 December 

Non-current assets  
Current assets 

     Total assets  

Non-current liabilities 
Current liabilities 
Equity  

 Total liabilities and equity 

2021 
$ '000 

2020 
$ '000 

 35,229    
 20,672    
      55,901    

44,416 
 32,584  
77,000 

 213    
11,033    
 44,655    
55,901 

2,246 
16,468 
58,286 
77,000 

Significant  performance-impacting  events  and  business  developments  reflected  in  the  Company’s 
financial position at year end include:  

Non-current assets 

Property  and  equipment  decreased  by  $0.8  million  to  $0.8  million  (2020:  $1.6  million),  reflecting 
depreciation  expense  of  $0.5  million,  impairment  loss  of  $0.5  million  offset  by  $0.2  million  in  gain on 
disposal of fixed assets. 

Investments  at  fair  value  decreased  to  $33.9  million  (FY20:  41.6  million).  The  change  reflects  the 
recognition of a $5.7 million investment as a result of the deconsolidation of OcuTerra and $0.7 million 
investment as a result of the disposal of Spark Insights. The increase was offset, in part, by a loss of $14.1 
million of the fair value accounting for other investments held at fair value.  

Right-of-use assets decreased to $0.4 million (2020: $0.6 million) primarily related to depreciation of $0.3 
million offset by recognition of a new lease entered into by BridgeComm of $0.1 million in 2021.  

Current assets 

Cash and cash equivalents decreased by $14.8 million to $9.7 million (2020: $24.5 million). The decrease 
is mainly attributed to $9.1 million of net cash used in operations, $18.7 million cash used in investing 
activities, offset by $13.0 million cash provided by financing activities. 

Trade  and  other  receivables  decreased  by  $0.1  million  to  $5.9  million  (2020:  $5.8  million)  due  to  a 
cumulative  decrease  in  trade  receivables  and  prepaid  expenses  of  $0.1  million  as  a  result  of 
deconsolidation of OcuTerra in the first half of 2021. 

Other financial assets have increased by $2.8 million to $5.1 million (FY2020: $2.3 million) primarily due 
to the conversion of Orbital’s convertible note of $1.5 million into preferred shares upon the closing of 
the Series A funding offset by Allied Minds’ $4.3 million investment in Federated Wireless in the form of 

16 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SAFEs (simple agreements for equity). 

Current liabilities 

Subsidiary preferred shares decreased by $5.2 million to $1.3 million (2020: $6.5 million) primarily driven 
by $5.2 million in IFRS 9 fair value adjustment at BridgeComm for the year.  

Deferred  revenue  increased  by  $1.3  million  to  $4.9  million  (2020:  $3.6  million)  primarily  due  to  new 
revenue contracts recognised at BridgeComm in 2021. 

Loans decreased by $0.1 million (2020: $3.1 million) primarily due to forgiveness of PPP loans.  

Non-current liabilities 

Lease  liabilities  decreased  by  $1.0  million  to  $0.8  million  (2020:  $1.8  million)  primarily  due  to  lease 
payments offset by issuance of a new lease at BridgeComm in second half of 2021.  

Other non-current liabilities decreased by $1.4 million (2020: $1.4 million) primarily due to loan payments 
of convertible promissory notes at OcuTerra Therapeutics.  

Equity 

Net equity decreased by $13.6 million to $44.7 million (2020: $58.3 million) reflecting the combination of 
comprehensive loss for the period of $16.3 million, repurchase of ordinary shares of $0.7 million offset by 
the effect of deconsolidation of OcuTerra and Spark Insights of $3.2 million and $0.2 million charge due 
to equity-settled share based payments.  

Consolidated Statement of Cash Flows 

For the years ended 31 December 

Net cash outflow from operating activities 
Net cash outflow from investing activities 
Net cash inflow/(outflow) from financing activities 

 Net decrease in cash and cash equivalents 
 Cash and cash equivalents in the beginning of the year 
 Cash and cash equivalents at the end of the year 

2021 
$ '000 

2020 
$ '000 

 (9,060) 
 (18,749) 

 13,030    

 (14,779) 

 24,489    
9,710 

 (17,057) 
 (11,341) 
 (37,684) 
 (66,082) 
 90,571  
 24,489  

The Group’s net cash outflow from operating activities of $9.1 million in 2021 (2020: $17.1 million) was 
primarily due to the losses for the year of $16.3 million offset by  the  net  effect  from  movement 
in 
working capital of $1.7 million, other finance charges of $2.6 million, the adjustment for non-cash items 
such as depreciation, amortisation, impairments, share of net loss of associate, gain on deconsolidation, 
loss on investments held at fair value and share-based payment expenses of $2.9 million. 

The Group had a net cash outflow from investing activities of $18.7 million in 2021 (2020: $11.3 million). 
This outflow was predominately related to the deconsolidation of OcuTerra and Spark Insights totaling 
$13.3 million, the $0.9 million investment made in the Orbital Series A funding and $4.3 million investment 
made in Federated in the form of a SAFE. 

17 

 
 
 
 
 
 
 
 
 
 
 
 
 
The Group’s net cash inflow provided by financing activities of $13.0 million in 2021 (FY20: $37.7 million) 
reflects, in part, proceeds from issuance of preferred shares in subsidiaries of $14.6 million and the receipt 
of $0.2 million of PPP loans. The increase was offset by $1.1 million in lease payments and $0.7 million 
payments to repurchase the company’s own shares. 

The Group’s strategy is to maintain healthy, highly liquid cash balances that cover its operating expenses 
as a publicly listed entity and are readily available for small, follow-on investments in portfolio companies 
in a manner consistent with the Board’s strategy for the Company and Group. To further minimise its 
exposure  to  risks  the  Group  does  not  maintain  any  material  borrowings  or  cash  balances  in  foreign 
currency.  

The Directors have further considered the on-going viability of the Company for the next three years, as 
required pursuant to the 2018 version of the UK Corporate Governance Code, in the Management and 
Governance section of the Annual Report and Accounts at pages 26 to 27. 

18 

 
 
 
 
 
 
 
 
 
Risk Management  

The execution of the Group’s strategy is subject to a number of risks and uncertainties.  The Board has 
adopted  a  system  of  continuous  review  in  which  it  regularly  consults  with  management  to  identify 
principal and emerging risks facing the Group and to assess and determine how to address and mitigate 
against such risks in a manner consistent with the Company’s risk appetite to achieve its strategic goals.  
Throughout the year, the Board considers and reviews both risks arising from the internal operations of 
the Group, and those arising from the business environment in which it operates.  It is possible that one 
or more of these identified risks could impact the Group in a similar timeframe which may compound 
their effects. 

With our focus on early stage company  development, commercialisation and monetisation, the Group 
inherently  faces  significant  risks  and  challenges.    The  overall  aim  of  the  risk  management  policy  is  to 
achieve an effective balance of risk and reward, although ultimately, no strategy can provide an absolute 
assurance against loss. 

The  Board  has  carried  out  a  robust  assessment  of  the  principal  and  emerging  risks  facing  the  Group, 
including those that would threaten its business model, future performance, solvency and/or liquidity.  
The major risks and uncertainties identified by the Board are set out below, along with the consequences 
and mitigation strategy of each risk. 

1.  

The science and technology being developed or commercialised by the Group’s businesses may 
fail and/or the Group’s businesses may not be able to develop their innovations and intellectual 
property into commercially viable products or technologies.  There is also a risk that some of the 
portfolio  companies  may  fail  or  not  succeed  as  anticipated,  whether  as  a  result  of  technical, 
product, market, fund-raising or other risks, resulting in an impairment of the Group’s value. 

Impact: The failure of any of the Group’s portfolio companies would impact the Group’s value.  A failure 
of one of the major portfolio companies could also impact the Group’s reputation as a builder of high 
value businesses and possibly make additional fund raising at the Group or portfolio company level more 
difficult. 

Mitigation: 

  Before making any follow-on investment in the current portfolio, extensive due diligence is carried 
out  by  the  Group  which  covers  all  the  major  business  risks  including  market  size,  strategy, 
adoption  and  intellectual  property.    Where  appropriate,  we  seek  validation  through  co-
investment by other strategic and/or financial parties. 

  A  disciplined  approach  to  capital  allocation  is  pursued  whereby  we  closely  monitor  milestone 
developments before  committing additional capital.  Should a project  fail to achieve  sufficient 
progress or is unable to attract other co-investors, we may terminate the investment. 

  Dedicated  leadership  with  deep  industry  or  sector  knowledge,  and  relevant  technical  and/or 
leadership experience, is recruited to management positions, and the Group ensures that each 
portfolio  company  has  independent  directors  and/or  other  advisors,  as  appropriate  for  the 
relevant stage of development. 

19 

 
 
 

Each portfolio company holds board of director meetings at least  quarterly, with participation 
from  the  Group’s  Directors,  management  and/or 
investment  team,  along  with  senior 
management  and  independent  directors  and/or  advisors,  as  appropriate,  of  such  portfolio 
company. 

  Within  the  Group there  is  meaningful  operating  and investment  expertise  that provide  direct, 
hands-on  and  strategic,  operating  and  fund-raising  support  to  its  portfolio  companies,  as 
appropriate. 

 

The Group actively uses third party advisors and consultants, specific to the particular domain in 
which a portfolio company operates, to assist on market strategy and direction.  

2.  

The  portfolio  companies  expect  to  incur  substantial  expenditure  in  further  research  and 
development, product development, sales and marketing and other operational activities of its 
businesses.  There is no guarantee that the Group or any of its individual portfolio companies will 
become profitable prior to the achievement of a portfolio company sale or other liquidity event, 
and, even if the Group or any of its individual portfolio companies does become profitable, such 
profitability may not be sustainable.  The Group may not be able to attract other co-investors, or 
monetise  its  ownership  interests  in  portfolio  companies,  during  any  specific  time  frame  or 
otherwise on desirable terms, if at all.  

Impact: Allied Minds’ objective is to generate returns for its shareholders through early stage company 
development  within  the  technology  sector.    Such  value  is  expected  to  be  delivered  through  the 
commercialisation and monetisation of these businesses via a sale or other liquidity event for each.  The 
timing and size of these potential inflows is uncertain and, should liquidity events not be forthcoming, or 
in the event that they are achieved at values significantly less than the amount of capital invested, then it 
would be difficult to sustain the current levels of investment in the other portfolio companies.  This would 
lead  to  reduced  participation  in  funding  rounds,  which  will  result  in  a  lower  ownership  position,  or 
potentially impact the ability of a company to raise additional funds.   

Mitigation: 

  The  Group  retains  sufficient  cash  balances  in  order  to  support  its  cash  flow  requirements, 
including Allied Minds’ investment requirements for each portfolio company and for corporate 
resources. 

  The  Group  has  close  relationships  with  a  wide  group  of  investors,  including  within  its  current 
shareholder base, and continues to identify and develop strategic and financial relationships for 
co-investing in the Group’s portfolio companies. 

  Non-Executive Directors seek to build and maintain strategic and financial relationships for the 
Group,  and  each  portfolio  company  continually  seeks  to  engage  in  strategic  and  financial 
relationships relevant to their respective markets and to maintain current information on, and 
awareness of, potential fund-raising and monetisation strategies. 

3.  

A significant portion of the Group’s intellectual property relates to technologies which originated 
in the course of research conducted in, and initially funded by, US universities or other federally-
funded research institutions.  Although the Group has been granted exclusive licenses to use this 

20 

 
 
intellectual  property,  there  are  certain  limitations  inherent  in  these  licenses,  for  example  as 
required by the Bayh-Dole Act of 1980. 

Impact: There are certain circumstances where the US government has rights to utilise the underlying 
intellectual property without any economic benefit flowing back to the Group.  In the event that this were 
to happen, this could impact the financial return to the Group on its investment in the applicable portfolio 
companies. 

Mitigation: 

  To the Board’s knowledge, while these so called “march in” rights exist, the US government has 

never had cause to use them. 

  The Group seeks to develop dual use capabilities for the technology it licenses and generally tends 

to avoid use cases directly applicable to government use. 

  This risk is also mitigated through employing experienced technology transfer experts supported 

by our legal team to assess risks that may arise out of this eventuality. 

4.  

Certain of the portfolio companies currently have in place cooperative research and development 
agreements  with  certain  US  Department  of  Defense  laboratories  and  other  federally  funded 
government institutions.  Certain regulatory measures apply to these agreements which restrict 
the export of information and material that may be used for military or intelligence applications 
by  a  non-US  person.    Compliance  with  these  regulatory  measures  may  be  complex  and  limit 
commercial alternatives. 

Impact:  If  certain  portfolio  companies  were  to  breach  restrictions  on  the  use  of  certain  licensed 
technologies,  particularly  those  derived  from  federally  funded  research  facilities,  this  could  materially 
impact upon the Group’s ability to license additional intellectual property from these establishments.  In 
certain circumstances, it may also lead to the termination of existing licenses.  In the event that this were 
to  happen,  this  could  materially  affect  a  number  of  the  Group’s  businesses,  potentially  harm  the 
reputation and standing of the Group and cause the termination of certain important relationships with 
federally funded research institutions. 

Mitigation: 

  Prior  to  licensing  any  technology  under  these  agreements,  the  Group’s  management  seeks  to 
identify the commercial and other alternatives available for products and services associated with 
such  technology  and  innovations,  and  to  ensure  that  there  are  sufficient  markets  available  to 
justify the capital investment.  

  Prior to the commercialisation process, the Group’s management seeks to obtain all the necessary 
clearances from applicable regulatory bodies to ensure that the export of products based upon 
the licensed IP is strictly in accordance with government guidelines. 

 

The Group, including certain of the portfolio companies, employs a number of individuals with 
experience in working with various government agencies. 

21 

 
 
 

Senior management is fully cognisant of the regulations and sensitivities in relation to this issue, 
in  particular  with  International  Traffic  in  Arms  Regulations  (ITAR)  which  regulate  the  use  of 
technologies for export, and has numerous mitigating actions available should issues arise. 

5.  

The Group operates in complex and specialised business domains and requires highly qualified 
and experienced management to implement its strategy successfully.  All of the operations of the 
Group  are  located  in  the  United  States,  which  is  a  highly  competitive  employment  market.  
Furthermore, given the relatively small size of the senior management at the corporate level, the 
Group  is  reliant  on  a  small  number  of  key  individuals.  As  announced  on  31  March  2022  and 
updated on 31 May 2021, the Chairman of the Company has announced his intention to resign 
from the board of directors following the publication of these annual report and accounts for the 
year ended 31 December 2021. The Company has an urgent need to appoint new directors to the 
board in order to ensure effective management to implement the execution of its strategy. 

Impact: There is a risk that the Group may lose key personnel, or fail to attract or retain new personnel.  
The loss of key personnel may negatively affect the Group’s competitive advantage. The Company also 
needs to identify and appoint new non-executive directors to the board of the Company with sufficient 
experience to execute the Company’s strategy.  

Mitigation: 

  The Company is working with its largest shareholders to identify and appoint new non-executive 

directors to the board of directors of the Company.  

  Senior  management  continually  monitor  and  assess  compensation  levels  to  ensure  the  Group 

remains competitive in the recruitment market. 

6.  

A large proportion of the overall value of the Group’s businesses may be concentrated in a small 
proportion of the Group’s businesses.  If one or more of the intellectual property rights relevant 
to a valuable business were terminated, this would have a material adverse impact on the overall 
value of the Group’s businesses. 

Impact: The termination of critical IP licenses would materially impact the value of the portfolio company 
and have a consequent effect on the value of the overall Group. 

Mitigation: 

 

In  each  portfolio  company,  the  management  is  specifically  directed  to  pursue  a  policy  of 
generating and patenting additional intellectual property to both provide additional protection 
and create direct IP ownership for the company. 

  Where  possible,  the  Group  seeks  to  negotiate  intellectual  property  ownership  rights  in  any 
research and development agreement it enters into with a network partner, such that the Group 
becomes a part owner of the underlying IP. 

7.  

The US Investment Company Act of 1940 regulates companies which are engaged primarily in the 
business of investing, reinvesting, owning, holding or trading in securities.  Securities issued by 
companies  other  than  consolidated  partner  companies  are  generally  considered  ‘‘investment 
securities’’ for purposes of the Investment Company Act, unless other circumstances exist which 

22 

 
 
actively  involve  the  company  holding  such  interests  in  the  management  of  the  underlying 
company. 

Impact:    If  the  Company  is  deemed  to  be  an  ‘‘investment  company’’  subject  to  regulation  under  the 
Investment Company Act, applicable restrictions could make it impractical for the Group to continue its 
business as contemplated and could have a material adverse effect on its business.  If anything were to 
happen  which  would  cause  the  Company  to  be  deemed  to  be  an  investment  company  under  the 
Investment Company Act, requirements imposed by the Investment Company Act, including limitations 
on capital structure, ability to transact business with portfolio companies and ability to compensate key 
employees, could make it impractical for it to continue its business as currently conducted.    

Mitigation: 

  The Company intends to monitor and conduct its operations so that it will not be deemed to be 

an investment company under the Investment Company Act. 

  The  Company  seeks  to  build  value  through  its  current  portfolio  companies;  it  is  not  engaged 
primarily  in  the  business  of  investing,  reinvesting,  owning,  holding or  trading  in  securities  and 
does not own or propose to acquire investment securities above prescribed thresholds under the 
Investment Company Act. 

  Currently  the  Company  holds  more  than  50%  of  the  voting  securities  in  one  of  its  portfolio 
companies,  and  more  than  20%  of  all  of  its  other  portfolio  companies  (except  TouchBistro, 
OcuTerra  and  Concirrus),  and  intends  to  continue  to  try  to  maintain  significant  influence  in 
portfolio companies.  

  The  Company  seeks  to  maintain  significant  influence  in  portfolio  companies  through  a 

combination of the following:  

o  Rights to elect representatives to the board of directors, with ability to exercise influence over 
the  portfolio  company’s  business  strategy,  operating  plans,  budgets  and  key  corporate 
decisions; 

o  Legal  rights,  such  as  access  to  information  (books  and  records)  and  financial  statements, 
liquidation preferences, registrations rights, rights of first refusal, pre-emptive rights and co-
sale rights; and 

o  Protective provisions, such as rights to block certain portfolio company actions. 

8.  

As a result of the Group’s strategy, the Group’s overall success is dependent on a limited, finite 
portfolio of businesses.  If one or more of such businesses were to fail, this would have a material 
adverse impact on the overall value of the Group’s businesses and the Group’s ability to return 
money to shareholders.   

Impact: The failure of one or more remaining Group businesses would materially impact the overall value 
of the Group’s portfolio and have a consequent effect on the returns available to shareholders. 

23 

 
 
Mitigation: 

  The Board is committed to engaging and working closely with the remaining portfolio companies 

to provide guidance and advice as they navigate funding, operational, and other needs.  

  The  Board  continues  to  monitor  performance,  progress,  and  development  of  each  portfolio 
company  to  critically  assess  the  return  prospects  of  the  remaining  portfolio  and  make 
adjustments as necessary. 

9. 

Given its current cash and financial position, the Group expects to remain operational through 
the  next  three  years.    However,  if  the  Group  is  unable  to  generate  sufficient  revenue, 
appropriately  manage  expenses,  attract  co-investors  to  participate  in  follow-on  portfolio 
company financings, or generate a sale or other liquidity event for any of its existing portfolio 
companies  or  portfolio  company  interests  prior  to  the  end  of  such  period,  then  the  Group’s 
business,  financial  condition,  results  of  operations,  prospects  and  future  viability  could  be 
adversely affected. 

Impact:  Lack of capital could restrict the Group’s ability to further fund, develop and commercialise its 
existing businesses.  In turn, this could ultimately lead to failure of individual portfolio companies and loss 
of investment as well as failure of the Group as a whole.    

Mitigation: 

  The Board and Senior management continually seek to build and maintain close relationships with 
its shareholder base and other strategic partners at the Group level, and each portfolio company 
continually seeks to engage in strategic relationships relevant to their respective markets and to 
maintain  current  information  on  and  awareness  of  potential  fund-raising  and  monetisation 
strategies. 

  The  Company  strives  to  maintain  majority  ownership  and/or  primary  control  over  all  of  the 
portfolio  companies  and/or  portfolio  company  board  representation,  so  that  it  can  seek  to 
influence optimal capital allocation, use of cash, and fund-raising strategy.   

  The Company has built a valuable portfolio of companies since its inception. 

  The Company continuously and critically reviews the progress of its portfolio companies against 
pre-set milestones to ensure its financial capital and human resource is properly allocated to the 
more  promising  areas  of  its  portfolio  to  help  strengthen  and  accelerate  the  Group’s  path  to 
monetisation. 

  The Company recognises the  need to identify and appoint  new non-executive directors to the 
board of the  Company with  sufficient  experience  to execute  its  strategy.  It  is working  with  its 
largest shareholders to identify and appoint new non-executive directors to the board of directors 
of the Company. 

COVID-19 

As  Allied  Minds  navigates  the  continued  consequences  of  the  coronavirus  pandemic,  we  continue  to 
closely monitor, assess, and respond to the impacts of the pandemic. The Group took several actions to 

24 

 
 
enable Allied Minds and its portfolio companies to continue operating safely and effectively, including 
implementing remote working environments, using virtual meeting platforms, and reducing travel. 

While the consequences of the coronavirus pandemic have had varying degrees of commercial impact 
across the portfolio in the past year, the actions and mitigation put in place by the Group enabled day-to-
day operations to continue effectively across the portfolio.  Allied Minds remains in close communication 
with all customers, suppliers and partners to collaborate on how to best support each other's needs in 
the post-pandemic environment.  

Ukraine 

The Board has considered the potential impact on the Group of the current situation in Ukraine. The Group 
has no operations in Russia, Ukraine or Belarus and, as such, does not expect and direct, material impact 
on its business. Any possible impact to the Group would likely manifest itself in inflationary pressure, and 
deterioration in global economic performance and confidence. These impacts are being monitored closely 
by the Board.  

Corporate and Social Responsibility 

Details on the Group’s policies, activities and aims with regard to its corporate and social responsibilities, 
including diversity, are included in the Sustainability section on pages 53 to 56 and are incorporated into 
this Strategic Report by reference. 

This Strategic Report has been approved by the Board of Directors.  

ON BEHALF OF THE BOARD 

Harry Rein  
Chairman  
14 June 2022

25 

 
 
 
 
 
 
 
 
 
 
MANAGEMENT AND GOVERNANCE 

The Board 

Non-Executive Directors 

Harry Rein – Non-Executive Chairman (stepping down from the Board upon publication of these accounts) 

Harry joined Allied Minds as an independent Non-Executive Director in November 2017, and has served as the Non-
Executive Chairman since March 2020. 

Harry  Rein  has  over  50  years  business  experience.  Starting  his  career  in  manufacturing  and  strategic  consulting 
positions before joining General Electric Company in 1978 and directed several of GE’s lighting businesses as general 
manager before joining the GE’s venture capital subsidiary as President and CEO. 

Harry then led the spin out of GE’s Venture business in 1987 which became the foundation of Canaan Venture Partners, 
where he was founder and managing partner raising $1.65bn and investing into venture capital opportunities. Harry 
retired from Canaan in 2002. Canaan still thrives today, and at this time the firm has raised 12 Funds for an excess of 
$6.0bn. 

At the time of retiring from Canaan, Harry became general partner of Foundation Medical Partners (“FMP”), a venture 
capital firm focused on early-stage healthcare venture capital companies. FMP started life as a small affiliated venture 
fund of The Cleveland Clinic Foundation. Harry was instrumental in the conception and creation of the firm.  Harry 
stepped back from his role at FMP in 2012. The firm continues to operate successfully out of Boston under the name 
of Flare Capital. 

Harry  has  served  on  the  board  of  directors  of  over  20  public  and  private  entrepreneurial  companies,  including: 
Anadigics (NASDAQ: ANAD), Cell Pathways, OraPharma (acquired by Johnson & Johnson), National MD (acquired by 
GE),  OmniSonics,  GenVec  (NASDAQ:  GNVC),  CardioNet  (NASDAQ:  BEAT)  and  Spine  Wave,  and  was  an  investor  in 
Praecis Pharmaceuticals (NASDAQ: PRCS). 

In addition to serving as Chairman of the Board of Allied Minds,  Harry  is also chairman of the board of Federated 
Wireless, and also serves on the board of DeliverCareRx. 

Harry Rein attended Emory University and Oglethorpe College (1968) and holds an M.B.A. from the Darden School at 
the University of Virginia (1973). 

Bruce Failing – Senior Independent Director  

Bruce joined Allied Minds as the Senior Independent Director in March 2020.  Bruce has over 40 years of management 
and  investment  experience  in  the  areas  of  media  and  consumer  products,  applied  technology  and  logistics 
management.  He  founded  and  currently  is  the  General  Partner  of  Alerion  Partners  and  serves  on  the  Boards  of 
Directors of Grand Brands, Enviroscent and DeliverCareRX.  Previously, he was CEO of Productivity Solutions, Electronic 
Retailing  Systems  and  Actmedia,  and  Executive  Chairman  of  ScentAir  Technologies  and  Lamaze  Publishing  &  the 
Newborn Channel. Bruce attended Tufts University (1971) and holds an MBA from Harvard Business School (1973).  
Bruce serves on each of the Audit, Nomination and Remuneration (Chair) Committees. 

26 

 
 
 
 
 
 
 
 
 
   
Mark Lerdal - Independent Non-Executive Director (resigned effective from 10 March 2022) 

Mark joined Allied Minds as an independent Non-Executive Director in December 2019.  Mark brings more than 30 
years of  executive  leadership  to  his  role  at  Allied Minds,  as  well  as  numerous executive  and  non-executive  board 
directorships at public and private companies.  Mark currently serves as the executive chairman of Leaf Clean Energy 
Company.  Previously,  Mark  has  served  as  managing  director  of  MP2  Capital,  LLC,  president  of  Hydrogen  Energy 
California, a developer of a carbon capture and sequestration facility, and a managing director at KKR Finance in its 
debt securities division.  Mark served on the Boards of Directors of Trading Emissions plc (LSE: TRE) until January 2019, 
TerraForm Global Inc. (NASDAQ: GLBL) until December 2017, and TerraForm Power (NASDAQ: TERP) until November 
2015.  Mark  also  serves  on  a  number  of  private  company  boards,  including  Empower  Energies,  Southern  Current, 
Cotton  Plains  Holding  III  and  Canadian  Breaks.  Mark  attended  Stanford  University  (1981)  and  holds  a  JD  from 
Northwestern University Pritzker School of Law (1984). Mark served on each of the Audit (Chair), Nomination and 
Remuneration Committees. 

Table of Board Attendance 

The table below summarises the attendance of the Directors at the scheduled meetings held during the year: 

Director 
Harry Rein (1) 
Mark Lerdal (2) 
Bruce Failing 
--------------- 

Meetings Attended 

Audit 
Committee 
1 of 1 
1 of 1 
1 of 1 

Nomination 
Committee 
1 of 1 
1 of 1 
1 of 1 

Remuneration 
Committee 
1 of 1 
1 of 1 
1 of 1 

Board 
 4 of 4 
3 of 4 
4 of 4 

1  Mr. Rein resigned from the Board effective as of the date of these accounts.  
2  Mr. Lerdal resigned from the Board effective as of 10 March 2022. 

27 

 
 
 
 
 
 
 
 
Directors’ Report 

The  Directors  present  their  report  together  with  the  audited  financial  statements  for  Allied  Minds  plc  and  its 
subsidiaries for the year ended 31 December 2021.  The Company was incorporated on 15 April 2014 under the UK 
Companies Act 2006 (Companies Act). 

Directors 

The  Directors of  the  Company  as  at  31  December  2021  were  those  listed  on  pages  26  to  27  and these  pages  are 
incorporated  into  this  Directors’  Report  by  reference.    During  the  year,  Joseph  Pignato  resigned  as  an  Executive 
Director on 14 January 2021. Post-period end, Mark Lerdal resigned as a Non-Executive Director on 10 March 2022 
and Harry Rein is due to step down from the Board upon publication of these accounts.  

The Directors are conscious of the recent board changes and the need to appoint additional directors to the board of 
the Company. The Directors are working closely with the Company’s largest shareholders to identify and recruit new 
directors to the board of the Company. 

The Directors’ interests in the share capital of the Company are as shown in the Directors’ Remuneration Report on 
pages 56 to 59.  None of the Directors were materially interested in any significant contract to which the Company or 
any of its portfolio companies were party during the year. 

Corporate Governance 

Information  that  fulfils  the  requirements  of  the  corporate  governance  statement  can  be  found  in  the  Corporate 
Governance Report on pages 36 to 45, the Directors Remuneration Report on pages 56 to 59, and the Audit Committee 
Report on pages 81 to 85, and is incorporated into this Report of the Directors by reference. 

Directors’ Compensation for Loss of Office and Payments to Past Directors 

During the year, Joe Pignato, was paid a severance package following his resignation as a Director of the Company on 
14 January 2021 and the details of this package are set out on page 70 of the Directors’ Report below. Save for the 
severance package for Joe Pignato following his resignation as a Director of the Company on 14 January 2021 and save 
for  payments  to  past  directors  and  loss  of  office  payments  previously  disclosed  in  our  2019  Annual  Report  and 
Accounts, no payments to past directors were made during the last financial year. 

Employees 

The Group’s policies in relation to employees are disclosed on pages 54 to 55, and these pages are incorporated into 
this Directors’ Report by reference. 

Results and Dividends 

During the period, the Group generated a net comprehensive loss after taxation for the year ended 31 December 
2021 of $16.3 million (2020: $55.6 million).  The Directors do not recommend the payment of an ordinary dividend 
for 2021 (2020: nil).   

Strategic Report 

The Group’s Strategic Report can be found on pages 3 to 69, and includes information as to the Group’s activities in 
the  field  of  research  and  development,  and  as  to  the  likely  future  development  of  the  Group.    Financial  key 
performance indicators can be found on pages 13-14.  

28 

 
 
The  Strategic  Report  contains  forward-looking  statements  with  respect  to  the  business  of  Allied  Minds.    These 
statements reflect the Board’s current view, are subject to a number of material known and unknown events, risks 
and uncertainties, and could change in the future.  Factors that could cause or contribute to such changes include, but 
are not limited to, anticipated changes to senior management of the Company, general economic climate and trading 
conditions, as well as specific factors relating to the financial or commercial prospects or performance of the Group’s 
individual portfolio companies, and the ability to consummate expected fundraising and other transactions. 

Strategic review  

Allied Minds is focused on supporting its existing portfolio companies and maximising monetisation opportunities for 
portfolio company interests. For some time, the Board has been reviewing the range of strategic options available to 
it  in  order  to  return  value  to  shareholders  and  following  the  successful  first  close  of  the  Series  D  fundraising  by 
Federated Wireless announced in February 2022,  thanks he Board resolved, in March 2022, to undertake a formal 
review of the Company's strategic options (the “Strategic Review”) including, but not limited to, a sale of the Company 
itself, which the Board intends to conduct under the framework of a “Formal Sale Process" in accordance with Rules 
2.4 and 2.6 of the Takeover Code, alternatively, to seek to distribute certain assets and any cash reserves directly back 
to shareholders through a re-structure. The Strategic Review is solely aimed at creating and/or realising shareholder 
value. 

Subject  to conclusion  of  the  Strategic  Review,  the  Board  will  continue  to  aim  to monetise the  Group’s  ownership 
positions at the appropriate time, recognising the value and benefit in achieving well-timed risk-adjusted returns for 
the benefit of shareholders. Upon the event of successful monetisation events from the sale of portfolio companies 
or portfolio company interests, Allied Minds anticipates distributing the net proceeds to its shareholders, after due 
consideration  of  potential  follow-on  investment  opportunities  within  the  existing  portfolio  and  working  capital 
requirements.   

The Board aims to ensure that the Group is being managed in as cost efficient manner as possible, regularly reviewing 
the on going costs associated with being a listed company. The Board notes that the costs of maintaining a premium 
listing on the London Stock Exchange are prohibitive for a company of Allied Minds’ current size and  maintaining a 
public  listing  is  expensive  with  more  than  50  per  cent  of  the  Company’s  annual  budget  devoted  to  meeting  the 
requirements of being a listed company.  

Principal and Emerging Risks and Uncertainties and Financial Instruments 

The Group, through its operations, is exposed to a number of risks.  The Group’s risk management objectives and 
policies are described on pages 19 to 25 and in the Corporate Governance Report on 36 to 45.  Further information on 
the Group’s financial risk management objectives and policies, including those in relation to credit risk, liquidity risk 
and market risk, is provided in note 21 to the consolidated financial statements, along with further information on the 
Group’s use of financial instruments.  The pages referenced in this paragraph are incorporated into this Directors’ 
Report by reference. 

Significant Agreements 

The Group has not entered into any significant agreements which may be impacted by a change of control following a 
takeover bid.  

29 

 
 
 
 
Share Capital 

Details of the structure of the Company’s share capital and the rights attaching to the Company’s shares are set out in 
note 14 to the consolidated financial statements.  Other than the minimum share ownership policy adopted by the 
Board in April 2016 with respect to Executive Directors, there are no specific restrictions on the holding of securities 
or  on  the  transfer  of  shares,  which  are  both  governed  by  the  general  provisions  of  the  Company’s  Articles  of 
Association (Articles) and prevailing legislation.  None of the ordinary shares carry any special rights with regard to 
control of the Company and there are no restrictions on voting rights.  

At the last Annual General Meeting of the Company held on  12 May 2021 (2021 AGM), authority was given to the 
Directors,  pursuant  to  the  relevant  provisions  of  the  Companies  Act,  to  allot  unissued  relevant  securities  in  the 
Company up to a maximum amount equivalent to approximately two thirds of the issued ordinary share capital on  2 
April 2021 at any time up to the earlier of the conclusion of the next Annual General Meeting (AGM) of the Company 
and 31 May 2022.  In addition, at the 2021 AGM, the Directors were also given authority, effective for the same period 
as the aforementioned authority, to allot relevant securities in the Company up to a maximum of approximately one-
third of the total ordinary share  capital in issue on  2 April 2021  in connection with an offer by way of a fully pre-
emptive rights issue.  The Company did not allot any shares under these authorities during the past year.  The Directors 
do not intend to issue any new ordinary shares over the coming year and do not propose to renew these authorities 
at the Company’s next AGM. 

Under the Companies Act, the Company has the power to purchase its own shares in accordance with Part 18, Chapter 
5 of the Companies Act.  At the 2021 AGM, a special resolution was passed which granted the Directors authority to 
make market purchases of the Company’s shares pursuant to these provisions of the Companies Act up to a maximum 
of approximately 10% of the Company’s issued share capital on  2nd April 2021 provided that the authority granted set 
a minimum and maximum price at which purchases can be made and is exercisable at any time up to the earlier of the 
conclusion of the next AGM and 31 May 2022.   

On 23 June 2021, the Company announced the launch of a share buyback programme to buy back up to $3.0 million 
of the Company’s shares to run until 15 October 2021 or, if earlier, the date of the announcement of the Group’s 
interim results for the six months ending 30 June 2021. Pursuant to the share buyback  programme, the Company 
bought back a total of 2,537,712 shares at a cost of $0.7 million.  

The Directors will seek to renew the authority within similar parameters and for a similar period at the next AGM, 
expected to be held on 27 July 2022.  

Articles of Association 

The Company’s Articles may be amended by a special resolution of the shareholders. 

Substantial Shareholders 

As at 31 December 2021, the Company had been advised of the following notifiable interests in the Company’s voting 
rights under DTR 5.  Other than as shown, so far as the Company (and its directors) are aware, no other person holds 
or is beneficially interested in a disclosable interest in the Company. 

30 

 
 
 
 
Shareholder 
Crystal Amber Fund Limited 
Invesco 
GIC 
Mr Mark Pritchard 
Hargreaves Lansdown Asset Mgt 
Invesco (OppenheimerFunds) 
Janus Henderson Investors 
Partners Group 
Castellain Capital 

Number of Shares 
43,378,770 
39,537,697 
19,382,360 
19,382,360 
11,466,271 
10,170,033 
9,250,000 
7,721,846 
7,349,772 

Percentage 
18.10% 
16.50% 
8.09% 
5.53% 
4.78% 
4.24% 
3.86% 
3.22% 
3.07% 

Between the year end and 31 May 2022 (the latest practicable date prior to publication), Metage Capital has accrued 
a notifiable interest of 3.63% and Charles Stanley has accrued a notifiable interest of 3.55% in the voting rights of Allied 
Minds.     

Research and Development 

Details of the Group’s research and development activities are included in the Portfolio Review and Developments 
section on pages 9 to 13.  

Stakeholder Engagement 

Details  of  the  Group’s  engagement  with  key  stakeholders,  including  suppliers,  customer  and  other  business 
relationships are included in the Stakeholder Engagement section on pages 50 to 55.  

Political and Charitable Donations 

The Group did not make any political or charitable donations in 2020 or 2021. 

Corporate and Social Responsibility 

Details on the Group’s policies, activities and aims with regard to its corporate and social responsibilities are included 
in the Sustainability section on pages 46 to 50, and are incorporated into this Directors’ Report by reference. 

Greenhouse Gas Emissions 

Details on the  greenhouse gas emissions associated with the Group’s operations are included in the  Sustainability 
section on pages 46 to 50.  

Directors’ Indemnity and Liability Insurance 

During the year, the Company has maintained liability insurance in respect of its directors who held office during the 
period.    Subject  to  the  provisions  of  the  Companies  Act,  the  Articles  provide  that  every  director  is  entitled  to  be 
indemnified out of the funds of the Company against any liabilities incurred in the execution or discharge of his or her 
powers or duties. 

Issuance of Equity by Major Subsidiary Undertaking 

None of the Company’s major subsidiary undertakings (as defined in the Listing Rules) issued equity in 2021.  

31 

 
 
 
 
Requirements of the Listing Rules 

The following table provides references to where the information required by Listing Rule 9.8.4R is disclosed: 

Section 
1 
2 
4 

5 
6 
7 

8 

9 
10 
11 
12 
13 
14 
15 

Listing Rule requirement 
Interest capitalised 
Publication of unaudited financial information 
Details of long-term incentive schemes for an 
individual director 
Waiver of emoluments by a director 
Waiver of future emoluments by a director 
Non pre-emptive issues of equity for cash 

Location 
Not applicable 
Not applicable 
Not applicable 

Not applicable 
Not applicable 
Notes to the Consolidated 
Financial Statements, Note 15 
Not applicable  

Non pre-emptive issues of equity for cash by any major 
subsidiary undertaking 
Parent participation in a placing by a listed subsidiary 
Not applicable 
Not applicable 
Contract of significance with director 
Contract of significance with a controlling shareholder  Not applicable 
Not applicable 
Provision of services by a controlling shareholder 
Not applicable 
Shareholder waivers of dividends 
Not applicable 
Shareholder waivers of future dividends 
Not applicable 
Relationship agreements with the controlling 
shareholder 

Viability Statement 

While the financial statements and accounts have been prepared on a going concern basis, provision 31 of the 2018 
version of the UK Corporate Governance Code (Code) requires the Directors to make a statement in the Annual Report 
with regard to the viability of the Group, including explaining how they have assessed the prospects of the Group, the 
period  of  time  for  which  they  have  made  the  assessment,  and  why  they  consider  that  period  to  be  appropriate.  
Accordingly, the Directors conducted this assessment over a three year period, taking into account the Group’s current 
position  and  capital  allocation  strategy.  This  considered  sensitivities  around  the  Company’s  operating  costs, 
particularly as a premium listed company on the London Stock Exchange, and the future capital requirements of its 
portfolio companies. As stated in the Company Overview on pages 7 to 9, the Directors remain focused on supporting 
our six existing portfolio companies and maximising monetisation opportunities for portfolio company interests, and 
not to deploy any capital into new portfolio companies.  This  approach reflects the continuation of the Company’s 
existing strategy and, taken together with significant reductions of its central costs, allows the Company to remain 
viable for the next three years.  This strategy, pursued to its conclusion, would see the Group’s existing assets continue 
to  be managed  and  eventually  monetised, with  no new  investments  being  taken on  and  with  a view  to  returning 
surplus proceeds to shareholders. As described in the Directors’ report on pages 28 to 35 above, the Directors have 
also initiated a Strategic Review aimed at a Formal Sale Process in accordance with Rules 2.4 and 2.6 of the Takeover 
Code, alternatively, to seek to distribute certain assets and any cash reserves directly back to shareholders through a 
re-structure. While this review may affect the Directors’ assessment of viability, at the date of this report, the Directors 
still expect the Company to remain viable over the three year viability period.   

Consequently,  in  terms  of  reporting  on  the  viability  of  the  Group  as  required  under  the  Code,  the  Directors  have 
prepared projections running out three years as, in their view, this remains an appropriate period, notwithstanding 
the eventual conclusion to the strategy and Strategic Review as outlined above. 

32 

 
 
 
The Directors are conscious of the recent board changes and the  need to appoint additional directors to the board of 
the Company. The Directors are working closely with the Company’s largest shareholders to identify and recruit new 
directors to the board of the Company.  

The Directors also carried out  a robust  assessment of the principal and emerging risks facing the Group, including 
those that would threaten its business model, future performance, solvency or liquidity, and the other principal and 
emerging risks detailed in the Strategic Report.  The three-year period includes the assumption that further funding is 
not required by the Group in the form of proceeds from either the sale of individual portfolio companies, the sale of 
certain portfolio company interests in secondary market transactions, or a combination thereof.  The Directors believe 
that a three-year assessment is most appropriate as it aligns with the Group’s normal and well-established budgeting 
process.  In making their assessment, the Directors considered a wide range of information, including present and 
future economic conditions, future projections of profitability, cash flows and capital requirements, and the potential 
sale of certain portfolio company interests in secondary market transactions.  

The Group’s annual budgeting process builds into a robust three-year plan, which is the period the Directors consider 
as an appropriate period to be covered by the viability statement.  This plan forms the basis for strategic decisions 
across the Group.  The consolidated plan is reviewed and approved annually by the Directors at the beginning of the 
year. Progress against the original plan is reviewed quarterly by the Directors, and adjustments to the plan can be 
made if needed to address new risks or to take advantage of new opportunities.   

In  summary,  the  Directors  have  assessed  the  viability  of  the  Group  over  the  three  year  period.    As  part  of  this 
assessment  they  intend  to  continue  to  take  proactive  steps   to manage  cash  expenses,  consider  capital  allocation 
decisions,  careful control over  how working capital requirements are met, and careful budgeting by the Group for 
such period.  The Directors recognise the pressing need for the appointment of additional board members to support 
the future management of the Company, but do not consider this position to impact the viability of the Company. 
Based on this assessment, the  Directors have  a reasonable expectation that  the  Group will be  able to continue  in 
operation and meet its liabilities as they fall due over the three-year period. 

Disclosure of Information to Auditor 

Each of the persons who is a Director at the date of approval of this Annual Report confirms that: 

 

 

so  far  as  the  Director  is  aware,  there  is  no  relevant  audit  information  of  which  the  Company’s  auditor  is 
unaware; and 

the Director has taken all steps that he or she ought to have taken as a Director in order to make himself or 
herself aware of any relevant audit information and to establish that the Company’s auditor is aware of that 
information. 

This confirmation is given and should be interpreted in accordance with the provisions of Section 418 of the Companies 
Act. 

Annual General Meeting 

The Annual General Meeting (AGM) will be held at 14:00 EDT on 27 July 2022 at Allied Minds’ headquarters located at 
374 Congress Street, Suite 308, Boston, Massachusetts 02210, USA.  The Notice of AGM circulated with this Report 
and Accounts contains a full explanation of the business to be conducted at that meeting.   

33 

 
 
 
 
Auditors 

In accordance with Section 489 of the Companies Act 2006, a resolution for the appointment of BDO LLP as auditor of 
the Company is to be proposed at the forthcoming AGM. 

Directors’ Responsibilities Statement 

The  Directors  are  responsible  for  preparing  the  annual  report  and  the  financial  statements  in  accordance  with 
applicable law and regulations. 

Company  law  requires  the  directors  to  prepare  financial  statements  for  each  financial  year.    Under  that  law  the 
directors are required to prepare the group financial statements, in accordance with applicable law and UK adopted 
internation accounting standards. 

Under company law the directors must not approve the financial statements unless they are satisfied that they give a 
true and fair view of the state of affairs of the group and company and of their profit or loss for that period. 

In preparing these financial statements, the Directors are required to: 

 

select suitable accounting policies and apply them consistently; 

  make judgements and estimates that are reasonable and prudent; 

  provide  additional  disclosures  when  compliance  with  the  specific  requirements  in  IFRSs  are  insufficient  to 
enable users to understand the impact of particular transactions, other events and conditions on the entity’s 
financial position and financial performance;  

  prepare the financial statements on the going concern basis unless it is inappropriate to presume the group 

will continue in business; and   

  prepare  a  director’s  report,  a  strategic  report  and  director’s  remuneration  report  which  comply  with  the 

requirements of the Companies Act 2006. 

The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the 
parent company’s transactions and disclose with reasonable accuracy at any time the financial position of the parent 
company and enable them to ensure that its financial statements comply with the Companies Act 2006.  The Directors 
are responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention 
and detection of fraud and other irregularities. The Directors are responsible for ensuring that the annual report and 
accounts,  taken  as  a  whole,  are  fair,  balanced,  and  understandable  and  provides  the  information  necessary  for 
shareholders to assess the group’s performance, business model and strategy. 

The Directors are responsible for ensuring the annual report and the financial statements are made available on a 
website. Financial statements are published on the company’s website in accordance with legislation in the United 
Kingdom  governing  the  preparation  and  dissemination of  financial statements,  which may vary  from  legislation  in 

34 

 
 
other jurisdictions. The maintenance and integrity of the company’s website is the responsibility of the Directors. The 
Directors’ responsibility also extends to the ongoing integrity of the financial statements contained therein.  

Directors responsibilities pursuant to DTR4 

The Directors confirm to the best of their knowledge: 

•  

the consolidated and Parent Company financial statements, prepared in accordance with the relevant financial 
reporting  framework,  give  a  true  and  fair  view  of  the  assets,  liabilities,  financial  position  and  loss  of  the 
Company and the undertakings included in the consolidation taken as a whole; and 

•   The annual report includes a fair review of the development and performance of the business and the financial 
position  of  the  group  and  the  parent  company,  together  with  a  description  of  the  principal  risks  and 
uncertainties that they face. 

We consider the Annual Report and Accounts, taken as a whole, are fair, balanced and understandable and provides 
the information necessary for shareholders to assess the Group’s position, performance, business model and strategy. 

ON BEHALF OF THE BOARD 

Harry Rein  
Chairman  
14 June 2022 

35 

 
 
 
 
 
 
 
 
 
 
 
Corporate Governance Report 

Compliance with the UK Corporate Governance Code 

The Directors are committed to a high standard of corporate governance and have prepared this Annual Report with 
reference to the 2018 UK Corporate Governance Code (Code) which was published by the Financial Reporting Council 
(FRC) in July 2018.  The Code is available at the FRC website at www.frc.org.uk.  During the year ended 31 December 
2021, the Directors consider that the Company has been in compliance with the provisions set out in the Code with 
the following exceptions: 

  Contrary to Principle G of the Code, the Board solely comprises Non-Executive Directors, given the strategic shift 

of the Group and the stated objective of the Group for the next two to three years. 

  Contrary to provision 34 of the Code, certain Non-Executive Directors hold restricted stock units (RSUs) that vest 
over time.  These RSUs were granted to the Non-Executive Directors in 2016, 2017, 2018, 2019, 2020 and 2021 
and  do  not  have  performance  conditions.    After  careful  consideration,  given  that  the  level  of  the  awards  are 
limited, do not have performance-based vesting, and effectively operate like cash remuneration, the Board does 
not believe that ownership of these RSUs impacts the independence of the Non-Executive Directors.   

  Contrary to provision 24 of the Code, the Chairman, Harry Rein, was a member of the Audit Committee in 2021.  
The Board believes that Mr. Rein’s professional background and experience made him a valuable member of the 
Audit Committee and that his membership was in the best interests of our shareholders. Further, this appointment 
was  made  in  good  faith  to  conserve  Company  cash  resources  rather  than  potentially  seeking  to  appoint  an 
additional Non-Exective Director.  

  Contrary to provision 20, an external search consultancy was not used to identify and recruit Mr. Failing as a Non-
Executive Director.  Mr. Failing was proposed as a director candidate by a Non-Executive Director on the Board.  
After  careful  consideration  of  Mr.  Failing’s  qualifications  and  upon  recommendation  by  the  Nomination 
Committee, Mr.  Failing  was appointed to the Board on 10 March 2020 and his appointment was approved by 
shareholders at the AGMs held in June 2020 and May 2021.  

  Effective as of 14 January 2021, the Company no longer employs a chief executive officer.  Given the strategic shift 
of the Group, the Company’s Board and management determined that the most effective and efficient path to 
execute upon such strategy is to eliminate the chief executive officer role and to have direct participation by the 
Board on the boards of the portfolio companies.  This is contrary to provision 9 of the Code.  

  Contrary  to  provision  21  of  the  Code,  the  Board  does  not  intend  to  engage  in  an  externally  facilitated  board 
evaluation every three years. The Board is of the view that this would be contrary to the Company’s objective to 
effectively manage costs. 

Further explanation as to how the principles and provisions set out in the Code have been applied by the Company is 
provided  in  the  following  statements,  the  Directors’  Remuneration  Report,  the  Audit  Committee  Report  and  the 
Strategic Report. 

The Board 

Role and Responsibilities of the Board 

The  Board  is  responsible  to  shareholders  for  the  overall  management  of  the  Group  as  a  whole,  providing 
entrepreneurial leadership within a framework of controls for assessing and managing risk; defining, challenging and 
interrogating the Group’s strategic aim, direction and culture; maintaining the policy and decision-making framework 
in which such strategic aims are implemented; ensuring that the necessary financial and human resources are in place 
to  meet  strategic  aims;  monitoring  performance  against  key  financial  and  non-financial  indicators;  succession 
36 

 
 
planning;  overseeing  the  system  of  risk  management;  setting  values  and  standards  in  governance  matters;  and 
monitoring policies and performance on corporate social responsibility.  The Directors are also responsible for ensuring 
that obligations to shareholders and other stakeholders are understood and met,  and a satisfactory dialogue with 
shareholders  is  maintained.    All  Directors  are  equally  accountable  to  the  Company’s  shareholders  for  the  proper 
stewardship of its affairs and the long-term success of the Group. 

The  responsibility  of  the  Directors  is  collective.    The  Directors  are  responsible  for  constructively  developing  and 
challenging proposals on strategy, scrutinising the performance of management of portfolio companies, determining 
levels  of  remuneration  and  for  succession  planning  for  the  senior  management  of  the  company  and  portfolio 
companies.  The Non-Executive Directors must also satisfy themselves on the integrity of financial information and 
that financial controls and systems of risk management are robust. 

The Board reviews strategic  issues on a regular basis and exercises control over the performance of the Group by 
agreeing on budgetary targets and monitoring performance against those targets.  The Board has overall responsibility 
for the Group’s system of internal controls and risk management, as described on pages 50 to 52.  Any decisions made 
by the Board on policies and strategy to be adopted by the Group or changes to current policies and strategy are made 
following presentations by the Directors or senior management at the Company and a detailed process of review and 
challenge by the Board.  Once made, the Directors are fully empowered to implement those decisions. 

Except for a formal schedule of matters which are reserved for decision and approval by the Board, the Board has 
delegated the day-to-day management of the Group to the  Chairman who is supported by members of the senior 
management team.  The schedule of matters reserved for Board decision and approval are those significant to the 
Group as a whole due to their strategic, financial or reputational implications. 

This schedule is reviewed and updated regularly and currently includes those matters set forth below: 

•   Approval and monitoring of the Group’s strategic aims and objectives, and approval of the annual operating 

budget. 

•   Strategic acquisitions by the Group. 

•   Major disposals of the Group’s assets or subsidiaries. 

•   Changes to the Group’s capital structure, the issue of any securities and material borrowing of the Group. 

•   Approval of the annual report and half-year results statement, accounting policies and practices or any matter 

having a material impact on future financial performance of the Group. 

•   Ensuring a sound system of internal control and risk management. 

•   Approval of all circulars, prospectuses and other documents issued to shareholders governed by the FCA’s 
Listing Rules, Disclosure Guidance and Transparency Rules or the City Code on Takeovers and Mergers. 

•   Approving Board appointments and removals, and approving policies relating to Directors’ remuneration. 

•   Approval of terms of reference and membership of Board Committees. 

•   Considering and, where appropriate, approving Directors’ conflicts of interest. 

•   Approval, subject to shareholder approval, of the appointment and remuneration of the auditors. 

•   Major changes in employee share schemes. 

37 

 
 
•  

Insurance and litigation. 

The  schedule of matters  reserved  to  the  Board  is  available  on  request  from  the  Company  Secretary or within  the 
Investors section of the Group’s website at www.alliedminds.com. 

The Board delegates specific responsibilities to certain Committees that assist the Board in carrying out its functions 
and ensure independent oversight of internal control and risk management.  The three principal Board Committees 
(Audit, Nomination and Remuneration) play an essential role in supporting the Board in fulfilling its responsibilities 
and  ensuring  that  the  highest  standards  of  corporate  governance  are  maintained  throughout  the  Group.    Each 
Committee has its own terms of reference which set out the specific matters for which delegated authority has been 
given by the Board.  The initial terms of reference for each of the Committees, which are fully compliant with the 
provisions  of  the  Code  and  which  reflect  both  best  practice  and  the  recommendations  arising  from  the  external 
evaluation process undergone by the Board and its Committees in connection with the Company’s IPO, were adopted 
by the Board during 2014.  These were reviewed in in 2021 and will be reviewed annually on an ongoing basis and 
updated where necessary.  All of these are available on request from the Company Secretary or within the Investors 
section of the Group’s website at www.alliedminds.com. 

Board Size and Composition 

As  at  31  December  2021,  there  were  three    Directors  on  the  Board:  the  Non-Executive  Chairman,    and  two  Non-
Executive Directors.  During the year, Joseph Pignato resigned as an Executive Director on 14 January 2021. Post-period 
end, Mark Lerdal resigned as a Non-Executive Director on 10 March 2021. On 31 March 2022 , the Company announced 
that Harry Rein, informed the Board that he did not intend to stand for re-election at this year's AGM. As announced 
on 31 May 2022,  Harry  Rein will leave  the  Board  on the  day  following the  publication of these  annual report and 
accounts for the year ended 31 December 2021. 

The Directors recognise the pressing need for the appointment of additional board members to support the future 
management of the Company, but do not consider this position to impact the viability of the Company.  

The biographies of all of the Directors are provided on pages 26 to 27.   

The Company’s policy relating to the terms of appointment and the remuneration of both Executive and Non-Executive 
Directors is detailed in the Directors’ Remuneration Report on pages 56 to 80.  

The size and composition of the Board is regularly reviewed by the Board, and in particular the Nomination Committee, 
to ensure there is an appropriate and diverse mix of skills and experience on the Board. 

The  Company’s  Articles  allow  appointment  of  Directors  by  ordinary  resolution  and  require  all  Directors  to  submit 
themselves for re-election by the shareholders at the Company’s AGM following their first appointment and thereafter 
at each AGM in respect of which they have held office for the two preceding AGMs and did not retire at either of them.  
In addition, each director who has held office with the Company for a continuous period of nine years or more must 
retire and offer themselves up for re-election at every AGM. The Directors have carefully considered the composition 
of the board of directors following the resignation of Mark Lerdal on 10 March 2022 and the forthcoming departure 
of  Harry  Rein  from  the  board.  This  position  means  that,  unless  additional  board  members  are  appointed  in  the 
meantime, Bruce Failing will become the sole Director of the Company. A process is currently underway to restore the 
appropriate number of non-executive directors to the board. Nevertheless, given this position, and after consultation 
with  the  Company’s  largest  shareholders,  the  Directors  have  concluded  that  Bruce  Failing  shall  not  stand  for  re-
election at this year’s AGM  in order to avoid a situation where the Company could potentially have not Directors if 
Bruce Failing were not re-elected.   

38 

 
 
Diversity 

The Board is committed to a culture that attracts and retains talented people to deliver outstanding performance and 
further enhance the success of the Company.  In that culture, diversity across a range of criteria is valued, primarily in 
relation to skills, knowledge and experience and also in other criteria such as gender and ethnicity.  The Company will 
give careful consideration to issues of overall Board balance and diversity in making new appointments to the Board.  
In identifying suitable candidates, the Nomination Committee will seek candidates from a range of backgrounds, with 
the final decision being based on merit against objective criteria.  In addition, the terms of reference of the Nomination 
Committee  include  a  requirement  for  the  Committee  to  consider  diversity,  including  gender,  age,  professional 
background, and ethnicity, in evaluating the composition of the Board and in identifying suitable candidates for Board 
appointments.    A  breakdown  of  employee  gender  showing  the  percentage  of  persons  who  were  Directors  of  the 
Company and senior managers during the period covered by this Annual Report can be found on page 55. 

Non-Executive Directors 

The Non-Executive Directors provide a wide range of skills and experience to the Group.  They bring their own senior 
level  of  experience  in each  of their  respective  fields,  robust  opinions  and  an  independent  judgement  on  issues  of 
strategy,  performance,  risk  and  people.    They  are  well-placed  to  constructively  challenge  and  scrutinise  the 
performance of management at Board and Committee meetings.  The Code sets out the circumstances that should be 
relevant to the Board in determining whether each Non-Executive Director is independent.  The Board considers Non-
Executive Director independence on an annual basis as part of each Non-Executive Director’s performance evaluation.  
Having undertaken this review and with due regard to provision 10 of the Code, the Board has concluded this year 
that all of the Non-Executive Directors are considered by the Board to be independent of management and free of any 
relationship or  circumstance  which  could  materially  influence  or  interfere with,  or  affect,  or  appear  to  affect,  the 
exercise of their independent judgement. 

Non-Executive  Directors  are  required  to  obtain  the  approval  of  the  Chairman  before  taking  on  any  further 
appointments and the Chairman and any Executive Directors require the approval of the Board before adding to their 
commitments.  In all cases, the Directors must ensure that their external appointments do not involve excessive time 
commitment or cause a conflict of interest. 

The Role of Chairman  

On 31 March Harry Rein informed the Board that he does not intend to stand for re-election at this year’s AGM. On 
31 May 2021, it was announced that Harry Rein would step down from the board of directors with effect from the day 
following the publication of these annual report and accounts for the year ended 31 December 2021. 

Until  that  date,  Harry  Rein  has  been  working  closely  with  Bruce  Failing,  the  Senior  Independent  Director  and  the 
Company's largest shareholders to ensure an orderly transition to any new Independent Directors. 

The  Chairman  is  responsible  for  the  leadership  and  conduct  of  the  Board,  the  conduct  of  the  Group’s  affairs  and 
strategy and for ensuring effective communication with shareholders.  The Chairman facilitates the full and effective 
contribution of Non-Executive Directors at Board and Committee meetings, ensures that they are kept well informed 
and ensures a constructive relationship between the Non-Executive Directors.  The Chairman also ensures that the 
Board Committees carry out their duties, including reporting back to the Board either orally or in writing following 
their meetings at the next Board meeting.  The Chairman was deemed to be independent of management upon his 
appointment to the role. 

Senior Independent Director 

39 

 
 
Bruce Failing is the current Senior Independent Director, succeeding Harry Rein upon his assumption of the Chairman 
role.  A key responsibility of the Senior Independent Director is to be available to shareholders in the event that they 
may  feel  it  inappropriate  to  relay  views  through  the  Chairman  or  Executive  Directors.    In  addition,  the  Senior 
Independent Director serves as an intermediary between the rest of the Board and the Chairman where necessary 
and takes the lead when the Non-Executive Directors assess the Chairman’s performance and when the appointment 
of a new Chairman is considered.  Further, the Senior Independent Director will lead the Board in its deliberations on 
any matters on which the Chairman is conflicted. 

Given the resignation of Mark Lerdal on 10 March 2022 and the planned retirement of Harry Rein  upon publication 
of  these  accounts,  the  Directors  recognise  the  urgent  need  for  the  appointment  of  additional  board  members  to 
support the future management of the Company.  Unless additional board members are appointed in the meantime, 
Bruce  Failing  will  become  the  sole  Director  of  the  Company  .  Given  this  position,  and  after  consultation  with  the 
Company’s largest shareholders, the Directors have concluded that Bruce Failing shall not stand for re-election at this 
year’s AGM  in order to avoid a situation where the Company could potentially have not Directors if Bruce Failing were 
not re-elected.   

After consultation with the Company’s largest shareholders, it is intended that Bruce Failing shall serve as Chairman 
of the Company pending appointment of additional board members.  

Board Support 

The Company Secretary is responsible to the Board for ensuring Board procedures are followed, applicable rules and 
regulations are complied with and that the Board is advised on governance matters and relevant regulatory matters.  
All  Directors  have  access  to  the  impartial  advice  and  services  of  the  Company Secretary.    There  is  also  an  agreed 
procedure for directors to take independent professional advice at the Company’s expense.  In accordance with the 
Company’s Articles  and a contractual Deed of Indemnity,  Directors  have been granted an indemnity issued by the 
Company to the extent permitted by law in respect of liabilities incurred to third parties as a result of their office.  The 
indemnity  would  not  provide  any  coverage  where  a  director  is  proved  to  have  acted  fraudulently  or  with  willful 
misconduct.   The  Company has also arranged appropriate  insurance coverage in respect of legal action against  its 
directors and officers. 

Board Meetings and Decisions 

The Board meets regularly during the year, as well as when required by business needs.  The Board had  four scheduled 
Board meetings in 2021.  During their term of service, each of the Directors were present at the meetings during the 
year as set out in the table on page 27.   

The  schedule  of  Board  and  Committee  meetings  each  year  is,  so  far  as  is  possible,  determined  before  the 
commencement of that year and all Directors or, if appropriate, all Committee members are expected to attend each 
meeting.    Supplementary  meetings  of  the  Board  and/or  the  Committees  are  held  as  and  when  necessary.    Each 
member of the Board receives detailed Board packs, including an agenda based upon the schedule of matters reserved 
for its approval, appropriate reports and briefing papers in advance of each scheduled meeting.  If a director is unable 
to attend a meeting due to exceptional circumstances, he or she will still receive the supporting papers and is expected 
to  discuss  any matters  he or  she  wishes  to  raise with  the  Chairman  in  advance  of  the  meeting.    The  Board,  Chief 
Financial Officer and Company Secretary work together to ensure that the Directors receive relevant information to 
enable them to discharge their duties and that such information is accurate, timely and clear.  This information includes 
quarterly management accounts containing analysis of performance against budget and other forecasts.  Additional 
information is provided as appropriate or if requested.  At each meeting, the Board receives information, reports and 

40 

 
 
presentations from members of senior management as required.  This ensures that all Directors are aware of, and are 
in a position to monitor effectively, the overall performance of the Group, its development and implementation of 
strategy and its management of risk. 

Any matter requiring a decision by the Board is supported by a paper analysing the relevant aspects of the proposal 
including costs, benefits, potential risks involved and proposed executive management action and recommendations. 

The Board meetings give members of the Company’s senior management team, as well as the senior managers of the 
portfolio companies, the opportunity to formally present to the Board.   This assists the  Board in gaining a deeper 
understanding of the breadth, stage of development and diversity of the Group’s portfolio companies.    

Directors’ Conflicts of Interest 

Each director has a statutory duty under the Companies Act to avoid a situation in which he or she has or can have a 
direct or indirect interest that conflicts or may potentially conflict with the interests of the Company.  This duty is in 
addition  to  the  continuing  duty  that  a  director  owes  to  the  Company  to  disclose  to  the  Board  any  transaction  or 
arrangement under consideration by the Company in which he or she is interested.  The Company’s Articles permit 
the Board to authorise conflicts or potential conflicts of interest.  The Board has established procedures for managing 
and, where appropriate, authorising any such conflicts or potential conflicts of interest.  It is a recurring agenda item 
at all Board meetings and this gives the directors the opportunity to raise at the beginning of every Board meeting, 
any actual or potential conflict of interests that they may have on the matters to be discussed, or to update the Board 
on any change to a previous conflict of interest already declared.  In deciding whether to authorise any conflict, the 
directors must have regard to their general duties under the Companies Act and their overriding obligation to act in a 
way they consider, in good faith, will be most likely to promote the Company’s success.  In addition, the directors are 
able to impose limits or conditions when giving authorisation to a conflict or potential conflict of interest if they think 
this is appropriate.  The authorisation of any conflict matter, and the terms of any authorisation, may be reviewed by 
the  Board  at  any  time.    The  Board  believes  that  the  procedures  established  to  deal  with  conflicts  of  interest  are 
operating effectively. 

Induction, Awareness and Development 

A comprehensive induction process is in place for new directors.  The programme is tailored to the needs of each 
individual director and agreed with him or her so that he or she can gain a better understanding of the Group and its 
businesses.  This will generally include an overview of the Group and its businesses, structure, functions and strategic 
aims; site visits to the Group’s head office in Boston, Massachusetts, USA; and, upon request, site visits to a number 
of the Group’s portfolio companies, which will include meeting with such companies’ management and a presentation 
from them on their businesses.  In addition, the Company facilitates sessions as appropriate with the Group’s advisers, 
in  particular  its  corporate  broker,  Numis  Securities  Limited,  as  well  as  with  appropriate  governance  specialists,  to 
ensure that any new directors are fully aware of and understand their responsibilities and obligations as a director of 
a listed company and of the governance framework within which they must operate.  A new director may also seek to 
meet major shareholders. 

In order to ensure that the Directors continue to further their understanding of the issues facing the Group, the Board 
may also receive presentations at Board meetings by relevant members of the Group’s or portfolio company staff.  In 
addition, other members of senior management present to the Board to enhance the Board’s awareness of how the 
Group operates on a day-to-day basis and how such functions operate so as to assist in the execution of the Group’s 
strategy of maximising total returns to all shareholders through monetisation of its existing portfolio. 

41 

 
 
As a further aspect of their ongoing development, each Director also receives feedback on his or her performance 
following the Board’s performance evaluation in each year and, through the Company Secretary, access is facilitated 
to  relevant  training  and  development  opportunities  including  those  relevant  to  the  Non-Executive  Directors’ 
membership on the Board’s Committees. 

Board Effectiveness and Performance Evaluation 

A performance evaluation of the Board and its Committees is carried out annually to ensure that they continue to be 
effective and that each of the Directors demonstrates commitment to his or her respective role and has sufficient time 
to meet his or her commitment to the Company.  The Board conducts an internally facilitated Board evaluation led by 
the Chairman, assisted by the Company Secretary, and covering the effectiveness of the Board as a whole, its individual 
Directors and its Committees.  This review includes each of the Board and Committee members completing a detailed 
questionnaire.  A summary of the results of the questionnaire and review, together with the Chairman and Company 
Secretary’s observations and recommendations, are prepared and shared with members of the Board.   The  Board 
engages in a discussion of these results, provides feedback on the observations and recommendations, and develops 
a list of proposed improvements and actions, as deemed necessary.  In addition to the aforementioned annual reviews, 
the performance of the Executive Director is reviewed by the Board on an ongoing basis, as deemed necessary. 

During the 2021 financial year, the Board assessed its own effectiveness through an internal Board evaluation process.  
This  process  was  based  on:  a  review  of  documentation  including  Board  and  Committee  terms  of  reference,  the 
completion of a survey to Directors comprising quantitative and qualitative questions; and discussions with all Board 
members and a number of stakeholders who regularly interact with the Board, including the Company Secretary.  

The results were analysed by the Chairman and the Company Secretary, and a detailed discussion was facilitated with 
the Board to outline the observations and recommendations.  Overall it was concluded that the Board continues to 
work effectively.  The changes to the Board composition in recent years have resulted in a well-balanced Board with a 
range  of  skills  and  experience.  Following  the  resignation  of  Mark  Lerdal  on  10  March  2022  and  the  forthcoming 
retirement of Harry Rein, the Company is currently undertaking a recruitment process with the intention to restore 
the appropriate number of non-executive directors to the Board. As such, the size of the Board will continue to be 
appropriate given the Group’s current position and capital allocation strategy to focus exclusively on supporting our 
six existing portfolio companies and maximising monetisation opportunities for portfolio company interests, and not 
to  deploy  any  capital  into  new  portfolio  companies.    The  Board  did  not  recommend  any  changes  it  considered 
necessary. 

Committees of the Board 

The composition of the three Committees of the Board and the attendance of the members throughout the year is set 
out in the table on page 27.  The terms of reference of each Committee are available on request from the Company 
Secretary or within the Investors section of the Group’s website at www.alliedminds.com. 

Remuneration and Audit Committees 

Separate reports on the role, composition, responsibilities and operation of the Remuneration Committee and the 
Audit Committee are set out on pages 56 to 59, and pages 81 to 85, respectively, and are incorporated by reference 
into this Corporate Governance Report. 

Nomination Committee 

The Nomination Committee leads the process for Board appointments, re-election and succession of directors and the 

42 

 
 
Chairman.  Its key objective is to ensure that the Board is comprised of individuals with the necessary skills, knowledge 
and experience to ensure that it is effective in discharging its duties.  It is responsible for making recommendations to 
the Board and its Committees concerning the composition and skills of the Board including any changes considered 
necessary  in  the  identification  and  nomination  of  new  directors,  the  reappointment  of  existing  directors  and  the 
appointment of members to the Board’s Committees.  It also assesses the roles of the existing directors in office to 
ensure there continues to be a balanced Board in terms of skills, knowledge, experience and diversity.  In addition, the 
Nomination Committee reviews the senior leadership needs of the Group to enable it to compete effectively in the 
marketplace.    The  Nomination  Committee  also  advises  the  Board  on  succession  planning  for  Executive  Director 
appointments, although the Board itself is responsible for succession generally.  

The Committee was chaired by Harry Rein and its other members as at 31 December 2021 were Bruce Failing and 
Mark Lerdal, being a majority of independent Non-Executive Directors as prescribed by the Code.  The Nomination 
Committee meets as and when required or as requested by the Board.  The Nomination Committee met once during 
2021 to review the structure, size and composition of the Board, following which it discussed the conclusions with the 
Chairman.  Messrs. Rein, Failing, and Lerdal, were present at all meetings during the year, as applicable. 

Before selecting new appointees to the Board, the Nomination Committee shall consider the balance, skill, knowledge, 
independence,  diversity  (including  gender)  and  experience  on  the  Board  to  ensure  that  a  suitable  balance  is 
maintained.  The Committee shall adopt a formal, rigorous and transparent procedure for the appointment of new 
directors to the Board.  Consideration shall always be given as to whether identified candidates have sufficient time 
available to devote to the role.  When searching for appropriate candidates, the Committee shall give consideration 
to using an external search company, but may also consider candidates who are proposed by existing Board members 
or employees of the Group.  When the Committee has found a suitable candidate, the Chairman of the Committee 
will make a proposal to the whole Board.  The appointment of a candidate is the responsibility of the whole Board 
following  recommendation  from  the  Committee.    The  Committee  did  not  use  the  services  of  an  external  search 
company in 2021. 

The Committee and the full Board fulfilled its duties in 2021.  

Internal control 

The  Board  fully  recognises  the  importance  of  the  guidance  contained  in  Guidance  on  Risk  Management,  Internal 
Control  and  Related  Financial  and  Business  Reporting  (FRC).    The  Group’s  internal  controls  and  risk  management 
systems,  which  are  Group  wide,  were  in  place  during  the  whole  of  2021,  were  reviewed  by  the  Board  and  Audit 
Committee.  After careful consideration and discussion of the Group’s financial statements and underlying control 
systems  by  the  Board  and  Audit  Committee,  including  extensive  review  and  collaboration  with  the  Company’s 
executive  team  to  remedy  issues  identified,  the  Group’s  internal  controls  and  risk  management  systems  were 
considered to be effective throughout the year ended 31 December 2021 and up to the date of approval of the Annual 
Report and Accounts.  

The  Board  and  Audit  Committee  are  responsible  for  establishing  and  monitoring  internal  control  systems  and  for 
reviewing the effectiveness of these systems.  The Board views the effective operation of a rigorous system of internal 
control as critical to the success of the Group; however, it recognises that such systems are designed to manage rather 
than  eliminate  risk  of  failure  and  can  provide  only  reasonable  and  not  absolute  assurance  against  material 
misstatement or loss.  The key elements of the Group’s internal control system, all of which have been in place during 
the financial year and up to the date these financial statements were approved, are as follows: 

Control environment and procedures 

43 

 
 
The Group has a clear organisational structure with defined responsibilities and accountabilities.  It adopts the highest 
values  surrounding  quality,  integrity  and  ethics,  and  these  values  are  documented  and  communicated  clearly 
throughout the whole organisation. 

Detailed written policies and procedures have been established covering key operating and compliance risk  areas.  
These are reviewed and updated at least once a year.  The effectiveness of the systems of internal control is reviewed 
at least annually by the Board.  The Board reviews and evaluates the internal control policies and procedures in place 
against  the  nature  of  the  Group’s  business,  the  size  of  its  workforce  and  the  competing  risks  and  interests  being 
managed.  Through these actions and considerations, the Board has satisfied itself that the controls been effective for 
the year ended 31 December 2021. 

Identification and evaluation of risks 

The Board actively identifies and evaluates the risks inherent in the business, and ensures that appropriate controls 
and procedures are in place to manage these risks.  The Board obtains an update regarding the portfolio companies 
on a regular basis, and reviews the performance of the Group and its portfolio companies on a quarterly basis, although 
performance of specific investments may be reviewed more frequently if deemed appropriate.  The Board also obtains 
a risk management report from members of senior management on a regular basis.  The key risks and uncertainties 
faced by the Group, as well as the relevant mitigations, are set out on pages 19 to 25.  

Information and financial reporting systems 

The Group evaluates and manages significant risks associated with the process for preparing consolidated accounts by 
having in place systems and controls that ensure adequate accounting records are maintained and that transactions 
are recorded accurately and fairly to permit the preparation of financial statements in accordance with IFRS.   The 
Board  approves  the  annual  operating  budgets  and  each  quarter  receives  details  of  actual  performance  measured 
against the budget. 

Principal and emerging risks and uncertainties 

The operations of the Group and the implementation of its objectives and strategy are subject to a number of key risks 
and uncertainties.  Risks are formally reviewed by the Board and Audit Committee at least annually and appropriate 
procedures are put in place to monitor and, to the extent possible, mitigate these risks.  Were more than one of the 
risks to occur together, the overall impact on the Group may be compounded.  A summary of the key risks affecting 
the Group and the steps taken to manage these is set out on pages 19 to 25.  

Relations with shareholders 

The Company is committed to a continuous dialogue with shareholders as it believes that this is essential to ensure a 
greater understanding of and confidence amongst its shareholders in the medium and longer term strategy of the 
Group.  It is the responsibility of the Board as a whole to ensure that a satisfactory dialogue does take place.  

The  Board’s  primary  shareholder  contact  is  through  the  Chairman.  The  Senior  Independent  Director  and  other 
Directors, as appropriate, make themselves available for contact with major shareholders and other stakeholders in 
order to understand their issues and concerns. The Chairman and the other Directors met with major shareholders, IP 
commercialisation sector brokers and analysts, and other stakeholders, on numerous occasions throughout the year 
in  order  to  discuss  the  Company  and  its  business  as  well  as  to  receive  feedback  on  the  Company’s  remuneration 
programme and other related matters.     

The Company uses the AGM as an opportunity to communicate with its shareholders.  Notice of the AGM, which will 

44 

 
 
be held at 14:00 EDT on 27 July 2022 at the Company’s headquarters located at 374 Congress Street, Suite 308, Boston, 
MA 02210 USA, is enclosed with this Report and Accounts.  In accordance with the Code, the Notice of AGM is sent to 
shareholders at least 20 working days before the meeting.  Details of the resolutions and the explanatory notes thereto 
are included with the Notice.  To ensure compliance with the Code, the Board proposes separate resolutions for each 
issue and proxy forms which allows shareholders who are unable to attend the AGM to vote on each resolution.  The 
results of all proxy voting shall be published on the Group’s website after the meeting and at the meeting itself to 
those shareholders who attend.  Shareholders who attend the AGM will have the opportunity to ask questions and 
the Chairman and the Directors are expected to be available to take questions. 

The Group’s website at www.alliedminds.com is the primary source of information on the Group.  The website includes 
an  overview  of  the  activities  of  the  Group,  details  of  its  portfolio  companies,  and  details  of  all  recent  Group  and 
portfolio company announcements. 

Political expenditure 

It is the Board’s policy not to incur political expenditure or otherwise make cash contributions to political parties and 
it has no intention of changing that policy. 

Going concern 

The Directors acknowledge that the current global socio-economic situation has the potential to disrupt all aspects of 
the Group’s business, including potential negative impacts on the Group’s financial position.  However, the Directors 
are closely monitoring these with portfolio company management in order to mitigate against such impact, including 
careful financial planning to allow for continued operations.   The Directors confirm that, after taking all applicable 
factors  into  consideration,  they  have  a  reasonable  expectation  that  the  Group  will  have  adequate  resources  to 
continue operations for a period of not less than 12 months from the date of approval of the financial statements.  For 
this  reason,  they  continue  to  adopt  the  going  concern  basis  in  preparing  the  financial  statements.    For  further 
explanation, see note 1 of the financial statements on page 102. 

ON BEHALF OF THE BOARD 

Harry Rein 
Chairman  
14 June 2022 

45 

 
 
 
 
 
Sustainability 

The Directors note the obligation for Allied Minds to report on its climate-related risk in line with the recommendations 
of the global Taskforce on Climate-related Financial Disclosures (TCFD).  

The group has not included the following recommended disclosures: 

  Disclosure of the organisations governance around climate-related risks and opportunities 
  Disclosure of the actual and potential impacts of climate-related risks and opportunities on the group’s business, 

strategy and financial planning where such information is material 

  Disclosure of how the group identifies, assesses and manages climate-related risks 
  Disclosure  of  the  metrics  and  targets  used  to  assess,  manage  and  report  relevant  climate-related  risks  and 

opportunities where such information is material 

The group has not been able to collate the necessary information for the group for the current period as it was not 
considered appropriate, in line with the group’s current strategy, and prior to the forthcoming changes to the Board. 

The  Group  is  currently  in  the  process  of  evaluating  those  risks  relating  to  its  portfolio  companies  and  intends  to 
incorporate TCFD disclosures into its future reporting over the next calendar year. This will be taken forward by the 
Board under its new composition following the conclusion of the current recruitment process.   

Policy Statement 

Allied Minds aims to conduct its business in a socially responsible manner, to contribute to the communities in which 
it operates and to respect the needs of its employees and all of its stakeholders.   

The  Group  is  committed  to  operating  the  business  while  ensuring  a  safe  environment  for  employees  as  well  as 
minimising the overall impact on the environment. 

Allied Minds endeavours to conduct  its  business  in accordance  with established best practice, to be  a responsible 
employer and to adopt values and standards designed to help guide staff in their conduct and business relationships. 

Greenhouse Gas (GHG) Emissions 

Given  the  overall  size  of  the  Group,  we  consider  the  direct  environmental  impact  of  the  Group  as  relatively  low.  
However,  we  firmly  recognise  our  responsibility  to  ensure  that  our  business  operates  in  an  environmentally 
responsible and sustainable manner.  The Group complies with all current regulations on emissions including GHG 
emissions, where such regulation exists in our markets. 

Though  the  Group’s  day-to-day  operational  activities  have  a  relatively  limited  impact  on  the  environment,  we  do 
recognise that the more significant impact occurs indirectly through the nature and operations of the companies that 
we choose to support with human and financial capital. 

The Group therefore considers it important to establish and nurture businesses that comply with existing applicable 
environmental,  ethical  and  social  legislation.    It  is  also  important  that  these  businesses  can  demonstrate  that  an 
appropriate  strategy  is  in  place  to  meet  future  applicable  legislative  and  regulatory  requirements  and  that  these 
businesses can operate to specific industry standards, striving for best practice. 

The  section  below  includes  our  first  year  of  reporting  under  the  new  Streamlined  Energy  &  Carbon  Reporting 
requirements.  The reporting period is the same as the Group’s financial year, 1st January 2021 to 31st December 2021. 

46 

 
 
 
 
Organisation Boundary and Scope of Emissions 

We  have  reported  on  all  of  the  emission  sources  required  under  the  Companies  Act  2006  (Strategic  Report  and 
Directors’ Reports) Regulations 2018.  These sources fall within the Group’s consolidated financial statement. 

An operational control approach has been used in order to define our organisational boundary.  This is the basis for 
determining the Scope 1 and 2 emissions for which the Group is responsible.   

Methodology 

For the Group’s reporting, the Group has employed the services of a specialist adviser, Verco, to quantify and calculate 
the Greenhouse Gas (GHG) emissions associated with the Group’s operations. 

The following methodology was applied by Verco in the preparation and presentation of this data: 

 

the Greenhouse Gas Protocol published by the World Business Council for Sustainable Development and the World 
Resources Institute (the “WBCSD/WRI GHG Protocol”);  

  application of appropriate emission factors from Defra, eGrid and EPA to the Group’s activities to calculate GHG 

emissions; 

 

 

scope  2  reporting  methods  –  application  of  location-based  and  market-based  emission  factors  for  electricity 
supplies; 

inclusion of all the applicable Kyoto gases, expressed in carbon dioxide equivalents, or CO2e; 

  presentation of gross emissions as the Group does not purchase carbon credits (or equivalents); 

  presentation of annual energy use; and 

  where data was missing, values were estimated using an extrapolation of available data. 

Absolute Emissions 

The total Scope 1 and 2 GHG emissions from the Group’s operations in the year ending 31st December 2021 were:  

  13.5 tonnes of CO2 equivalent (tCO2e) using a ‘location-based’ emission factor methodology for Scope 2 emissions; 

and 

  13.8 tonnes of CO2 equivalent (tCO2e) using a ‘market-based’ emission factor methodology for Scope 2 emissions. 

Scope 1 emissions from onsite combustion of natural gas and refrigerant gas losses have been included in the reporting 
scope, although there was no such consumption and therefore no Scope 1 emissions have been reported. 

Scope 2 emissions included purchased electricity using the location-based and market-based method.  

Intensity Ratio 

As well as reporting the absolute emissions, we express the Group’s GHG emissions as tonnes of CO2 equivalent per 
full-time (FTE) employee, excluding remote workers, and as tonnes of CO2  equivalent per square foot of occupied 
office space.  These were decided as the most appropriate metrics for the Group. 

The intensity metrics have been calculated as follows: 

47 

 
 
 
  0.795 tCO2e per full-time employee (FTE) using the location-based method and 0.812 tCO2e per full-time employee 

(FTE) using the market-based method; and 

  0.001 tCO2e per ft2 using the location-based method and 0.001 tCO2e per ft2 using the market-based method. 

Target and Baselines 

The Group’s objective is to maintain or reduce its GHG emissions per FTE and per square footage of occupied office 
space each year, and to report each year on whether it has been successful in this regard. 

The  Company’s  absolute  emissions  have  seen  a  decrease  of  28%  using  the  location-based  method  for  Scope  2 
emissions, and a decrease of 27% using the market-based method for Scope 2 emissions.  This was due to a decrease 
in electricity consumption. 

There was an increase in emissions per full-time employee using both location-based and market-based methods.  This 
was due to a decrease in the number of employees. 

There was a decrease in emissions per ft2 of occupied space using both location-based and market-based methods.  
This was due to decrease in total emissions with no change in the associated footage. 

Key Figures 

Allied Minds plc - Breakdown of emissions by scope

2020

2021

0

0

18.9

18.7

13.8

13.5

0

5

10
tCO2e

15

20

Scope 2 (market-based)

Scope 2 (location-based)

Scope 1

GHG emissions 

Scope 11 
Scope 22 
Scope 23 
Total GHG emissions (Location-based 
Scope 2) 
Total GHG emissions (Market-based 
Scope 2) 

Tonnes 
CO2e 
- 
13.5 
13.8 

2021 
tCO2e / 
emp. 4 
- 
0.795 
0.812 

tCO2e / 
sq. ft. 5  
- 
0.001 
0.001 

Tonnes 
CO2e 
- 
18.7 
18.9 

2020 
tCO2e / 
emp. 4 
- 
0.720 
0.727 

tCO2e / 
sq. ft. 5  
- 
0.002 
0.002 

13.5 

0.795 

0.001 

18.7 

0.720 

0.002 

13.8 

0.812 

0.001 

18.9 

0.727 

0.002 

48 

 
 
 
 
  
 
 
 
 
 
 
 
1 Scope 1 being emissions from the Group’s combustion of fuel and operation of facilities. 
2 Scope 2 being electricity emissions (from location-based calculations), heat, steam and cooling purchased for 
the Group’s own use. 
3 Scope 2 being electricity emission (from market-based calculations), heat, steam and cooling purchased for the 
Group’s own use. 
4 Employee numbers (FTE excluding remote workers): 17 (FY2021), 26 (FY2020) 
5 Occupied office space: 9,866 ft2 (FY2021 and FY2020) 

Total Energy Use 

The total energy use for the Company for FY2021 was 44,191 kWh. 

Electricity 
(kWh) 

Energy Use 

Gas (kWh) 

Total Energy Use 
(kWh) 

2021 

2020 

44,191 

70,532 

-    

-    

44,191 

70,532 

Energy Efficiency Actions 

The Group did not implement any new energy efficiency actions during the reporting year.  Each of the businesses had 
its employees working from home for a large portion of the year. 

Understanding the Indirect Environmental Impacts of our Business Activities 

The Group’s day-to-day operational activities have a limited impact on the environment.  The Group does recognise 
that the more significant impact occurs indirectly, through the investment decisions made and the operation of the 
companies that the Group chooses to invest in.  The Group therefore considers it important to establish and invest in 
businesses that comply with existing applicable environmental, ethical and social legislation.  It is also important to 
the Group that these businesses can demonstrate that an appropriate strategy is in place to meet future applicable 
legislative and regulatory requirements and that these businesses can operate to specific industry standards, striving 
for best practice. 

Our Business Ethics and Social Responsibility 

The Group seeks to conduct all of its operating and business activities in an honest, ethical and socially responsible 
manner.    We  are  committed  to  acting  professionally,  fairly  and  with  integrity  in  all  our  business  dealings  and 
relationships wherever we operate, and for the Group’s directors and staff to have due regard to the interest of all of 
its stakeholders including investors, partners, employees, customers, suppliers and the businesses in which the Group 
invests.    We  expect  our  entire  workforce  to  maintain  high  standards  in  accordance  with  our  internal  policies  on 
conduct.    The  Company  has  in  place  avenues  through  which  employees  can  raise  matters  confidentially  or 
anonymously and the Board, through the Audit Committee, regularly reviews whistleblowing reports provided by the 
whistleblowing officer and the Chairman of the Audit Committee. 

49 

 
 
 
  
                             
                             
 
We take a zero tolerance approach to bribery and corruption and implement and enforce effective systems to counter 
bribery.  The Group is bound by the laws of the UK, including the Bribery Act 2010, and has implemented policies and 
procedures to address such laws, as well as the laws in each jurisdiction where the Group operates, including the US. 

The  Group’s  management  and  employees  are  fundamental  to  our  success  and  as  a  result  we  are  committed  to 
encouraging  the  ongoing  development  of  our  staff  with  the  aim  of  maximising  the  Group’s  overall  performance.  
Emphasis is placed on staff development through work-based learning, with senior members of staff acting as coaches 
and mentors.  Allied Minds has continued to employ regular all-staff update meetings as the main source of employee 
communication. 

Stakeholder Engagement  

Section 172 of the Companies Act requires Directors to take into consideration the interests of stakeholders in their 
decision  making.    The  Board  is  committed  to  understanding  and  engaging  with  all  key  stakeholder  groups  of  the 
Company in order to maximise value and promote long-term Company success in line with its strategic objectives.  The 
Board recognises its duties under Section 172 and continuously has regard to the likely consequences of any decision 
for the long term, how the Company’s activities and decisions will impact employees, those with which it has a business 
relationship, the community and environment, and its reputation for high standards of business conduct.  In weighing 
all  of  the  relevant  factors,  the  Board,  acting  in  good  faith  and  fairly  between  members  of  the  Company,  makes 
decisions and takes actions that it considers will best lead to the long-term success of the Company in accordance with 
its strategy.  The Board strives to be a good employer to its workforce, responds to shareholder feedback, supports its 
communities and focuses on maintaining strong partner relationships. 

During  the  year,  the  Board  assessed  its  current  activities  between  the  Board  and  its  stakeholders  through  direct 
conversations  with  investors,  receiving  reports  from  the  executive  team  regarding  workforce  feedback,  direct 
engagement with portfolio company management teams, and review of key partners at Board meetings throughout 
the course of the year, all of which demonstrated that the Board actively engages with its stakeholders and takes their 
various objectives into consideration when making decisions.  Furthermore, in its decision-making, the Board evaluates 
and considers the long-term effects and consequences resulting from such decisions.  For example, in line with the 
Group’s strategy to focus exclusively on funding and operating its existing portfolio companies with the objective of 
maximising value for its shareholders, the Board considers how the decision to invest additional capital in Federated 
Wireless and protect its ownership in such company was an appropriate action after considering the interests of its 
shareholders, impact to the rest of the portfolio, partnership relationships, and other long-term operational impact.  
This statement also focuses on how the Directors have had regard during the year to the matters set out in Section 
172(1)(a) through (f) of the Act as considered further below. 

The  Board  identified  that  its  key  stakeholders  include  shareholders,  employees,  portfolio  companies,  partners, 
advisors and communities.  Specifically, actions the Board has taken to engage with its stakeholders in 2021 include: 

SHAREHOLDERS (Companies Act 2006, sections 172(1)(a) and (f)) 
Why they matter to us 

What matters to them 

They  are  our  investors  and  we  measure  success 
through delivering value to our shareholders.  Our 
shareholders play an important role in monitoring 
and safeguarding the governance of the Group. 
Broad range of issues spanning from financial and 
operational  performance,  strategic  execution, 
investment plans and capital allocation. 

50 

 
 
 
 
How the Board engaged 

How they influenced the Board’s decision making 

Engaged  with  our  major  shareholders  and 
discussed their viewpoints and concerns, including 
via  teleconference  and  email  correspondence 
throughout  the  year.  In  particular  we  discussed 
with our shareholders the commencement of the 
on market share buyback programme launched on 
23 June 2021.  

Chairman  actively  contacts  and  make  himself 
available  to  shareholders  who  have  questions, 
issues or concerns to raise. 
Shareholder feedback, opinions and concerns are 
taken  into  consideration  throughout  the  year  as 
the  Board  makes  decisions  on  the  Company’s 
strategy, investment decisions, capital allocation, 
remuneration and other key matters.  The Board 
actively  engages  with  shareholders  for  such 
feedback  ahead  of  making  key  decisions  when 
appropriate  and  in  accordance  with  regulatory 
requirements. 

EMPLOYEES (Companies Act 2006, section 172(1)(b)) 
Why they matter to us 

What matters to them 

How the Board engaged 

Our 
talented,  dedicated  and  experienced 
workforce is a key asset to the Group and critical 
for the Group’s success. 
Opportunities for career development, culture of 
inclusion  and  diversity,  compensation  and 
benefits, acknowledgement for high performance 
and  ability  to  meaningfully  contribute  to  the 
Group’s success. 
including  NEDs 
Monitored  company  culture, 
visiting  and 
interacting  with  the  Company’s 
employee base, and received reports from senior 
executives on morale throughout the year. 

How they influenced the Board’s decision making 

For additional information on employee retention, 
rewarding our workforce and diversity, please see 
page 61. 
The  Board  is  committed  to  creating  a  positive 
working environment in line with the Company’s 
culture  that  retains  and  rewards  our  workforce.  
For additional information on steps taken, please 
see page 60.  

PORTFOLIO COMPANIES (Companies Act 2006, sections 172(1)(a) and (c)) 
Why they matter to us 

The  success  of  our  portfolio  companies  is  what 
enables us to bring value to our shareholders.  We 

51 

 
 
 
 
 
 
What matters to them 

How the Board engaged 

in 

invested 

strategic 

supporting  our  portfolio 
are 
companies,  the  management  teams  at  those 
companies,  and  helping  them  achieve  their 
operational and strategic goals. 
objectives,  meeting 
Achieving 
performance milestones, fundraising, growth, and 
overall company success. 
Met  with  executive  teams  of  multiple  portfolio 
companies in person or via video teleconference 
to better understand such companies’ objectives, 
strategies,  and  goals  and  provide  feedback  and 
offer  ongoing  assistance  to  help  further  such 
companies’ progress and growth. 

Active  engagement  through  representation  on 
portfolio  company  boards  to  assist  companies 
with 
fundraising  activities  and  partnership 
opportunities. 

How they influenced the Board’s decision making  Understanding  the  various  objectives  of  our 
portfolio  companies  allows  the  Board  to  make 
informed  and  thoughtful  decisions regarding  the 
portfolio as a whole for the overall benefit of the 
Group. 

PARTNERS AND CUSTOMERS (Companies Act 2006, sections 172(1)(c) and (e)) 
Why they matter to us 

Strategic  partners  throughout  the  portfolio  help 
the  Group  succeed  as  a  whole.    Their  points  of 
view  provide  unique  perspectives  in  the  various 
markets 
in  which  our  portfolio  companies 
operate. 

What matters to them 

revenue. 

to  generate 

Key customer relationships through the portfolio 
are critical to our portfolio companies’ success and 
  Customer 
ability 
satisfaction,  demands  and  requirements  help 
define success for our companies. 
These  partners  have  invested  in  our  portfolio 
companies  and/or  have  strategic  partnerships  in 
place  with  our  portfolio  companies.    They  want 
our  companies 
their 
partnership arrangements to be well-executed.   

to  succeed  and 

for 

Customers  want  products  and  services  that  will 
bring them value and fulfill their business needs.  
Successful relationships with our companies will in 
turn bring success to such customers. 

52 

 
 
 
 
 
 
How the Board engaged 

How they influenced the Board’s decision making 

Direct  engagement  with  key  partners  of  the 
Company and its portfolio companies by Executive 
Director  participation  and 
interaction  on 
strengthening  relationships  and  understanding 
objectives. 

Working  with  portfolio  company  management 
teams to understand customer needs that in turn 
dictate certain aspects of how to further develop 
or grow such company’s technology and products. 
The  Board  routinely  considered  the  interests  of 
our  various  partners  to  ensure  that  they  are 
aligned  with the  Company’s  strategy,  values  and 
objectives. 

The Board considers the needs and interests of key 
customers  to  better  understand  the  portfolio 
company businesses and to influence key strategic 
decisions  through 
its  representation  on  the 
portfolio company boards of directors. 

ADVISORS (Companies Act 2006, sections 172(1)(c) and (e)) 
Why they matter to us 

What matters to them 

How the Board engaged 

How they influenced the Board’s decision making 

to 

the  Group  across 

Independent  and  third  party  perspectives  allow 
the Board to make better decisions on behalf of all 
of its stakeholders. 
Good  communication  and  the  ability  to  work 
closely  with  the  Company  to  enable  them  to 
provide  strategic  and  thoughtful  advice  and 
excellent  service  to  help  guide  the  Board  and 
its 
provide  support 
operations. 
Direct engagement with advisors and key service 
providers  to  discuss  Company  strategy  and  to 
receive  advice  and  recommendations  from  such 
advisors on a variety of matters.   
The  Board  considers  and  values  the  objective 
input and advice provided by its trusted advisors 
and  relies  on  such  advice  in  various  aspects  of 
decision  making  when  determining  how  to 
navigate the various transactions, issues, strategic 
shifts,  regulatory  matters,  and  other  matters 
facing the Board. 

COMMUNITIES / ENVIRONMENT (Companies Act 2006, section 172(1)(d)) 
Why they matter to us 

We are committed to maintaining strong ethical 
and corporate responsibility principles.  We care 
about doing business responsibly.   

53 

 
 
 
 
 
 
What matters to them 

How the Board engaged 

How they influenced the Board’s decision making 

Sustainability and environmental impact resulting 
from operations. 
Through the Group’s sustainability strategy, aimed 
to make a positive contribution to the community 
and environment by reducing our carbon footprint 
and  energy  use.    Please  see  pages  53  to  56  for 
additional information. 
the  direct 
to 
The  Board  aims 
environmental impact of the Group’s operations. 

reduce 

The Board believes that appropriate steps and considerations have been taken during the year so that each Director 
has an understanding of the various key stakeholders of the Company.   

The  Board  recognises  its  responsibility  to  contemplate  all  such  stakeholder  needs  and  concerns  as  part  of  its 
discussions, decision-making, and in the course of taking actions and will continue to make stakeholder engagement 
a top priority in the coming years. 

Focus on Culture 

The Company is committed to maintaining a dynamic culture focused on bringing value to its shareholders by taking 
a hands-on approach in supporting its portfolio companies, and in particular, working directly with the management 
teams at such companies to help them achieve milestones, accelerate growth and realise monetisation opportunities.  
Our  workforce  maintains  the  appropriate  balance  of  skills,  capabilities,  experience  and  training  that  allows  it  to 
effectively  execute  on  its  strategy.    Our  Non-Executive  Directors  have  decades  of  experience  in  venture  capital 
investing and are well-positioned to assist our portfolio companies towards achieving successful exits.  Our culture is 
critical to our success and we strive to align our workforce through the way we conduct our business.  Over the course 
of the year, we have continued to embed our values by offering career development opportunities throughout our 
workforce, providing direct access and engagement between executives and senior management with the rest of the 
workforce, and rewarding high performance, all of which encourages our employees to be engaged and invested in 
the execution of our strategy.    

Employee Diversity and Employment Policies 

The Group seeks to operate as a responsible employer and has adopted standards which promote corporate values 
designed to help and guide employees in their conduct and business relationships.  The Group seeks to comply with 
all  laws,  regulations  and  rules  applicable  to  its  business  and  to  conduct  the  business  in  line  with  applicable  and 
established best practice.  The Group’s policy is one of equal opportunity in the selection, training, career development 
and  promotion  of  employees,  regardless  of  age,  gender,  sexual  orientation,  ethnic  origin,  religion  and  whether 
disabled or otherwise.  The Group is committed to recruitment and retention of the talent required to execute on 
maximising shareholder value, as described above.  Specifically, in line with company culture, the Group is committed 
to providing a working environment that allows its workforce to succeed, including providing career advancement 
opportunities  internally within  the  Group  and  providing  flexible work  arrangements  that  allow  employees  to earn 
additional degrees.  The Group engages with its workforce throughout each year to receive feedback and evaluate 
whether practices and behaviour throughout the business are aligned with the Group’s purpose, values and strategies.  
When issues are identified, the Group takes corrective actions such as revising policies and implementing changes 
collaboratively  with  its  workforce  to  improve  alignment  and  overall  culture.    Allied  Minds  and  its  consolidated 
companies had 19 employees as at 31 December 2021.  A breakdown of employees by gender as at 31 December 2021 

54 

 
 
 
can be seen in the illustrations below.  Allied Minds supports the rights of all people as set out in the UN Universal 
Declaration of Human Rights and ensures that all transactions the Group enters into uphold these principles. 

Total Employees

Senior Management

Directors

21%

79%

0%

100%

Female Male

0%

100%

55 

 
 
 
 
 
 
 
 
 
Directors’ Remuneration Report 

Statement by Chairman of the Remuneration Committee 

I am pleased to present, on behalf of the Board, the Directors’ Remuneration Report for the year ended 31 December 
2021.   

What’s in this report? 

The  Directors’  Remuneration  Report  sets  out:  (i)  an  annual  statement  by  the  Chairman  of  the  Remuneration 
Committee on pages 62 to 65; (ii) the current Remuneration Policy for the Company on pages 60 to 69, and an Annual 
Report on Remuneration on pages 70 to 85 which describes the implementation of the current Remuneration Policy 
during 2021, and expected implementation in 2022.  It has been prepared in accordance with the Large and Medium-
sized Companies and Groups (Accounts and Reports) Regulations 2008, as amended.  The current Remuneration Policy 
was developed taking into account the principles of the UK Corporate Governance Code 2018, the Listing Rules and 
shareholders’ executive remuneration guidelines.  

The Statement by Chairman of the Remuneration Committee on pages 56 to 59, together with the Annual Report on 
Remuneration on pages 70 to 85, will be subject to an advisory vote at the 2021 AGM. 

Remuneration Overview 

Our current Remuneration Policy received 85.13% shareholder support at our 2019 AGM, took effect from that date, 
and has operated for the past three years. In accordance with section 439A of the Companies Act, the Remuneration 
Policy  is  subject  to  shareholder  vote  every  three  years  and  will  be  subject  to  binding  shareholder  vote  at  the 
forthcoming AGM of the Company expected to be held on 27 July 2022.  The Remuneration Committee reviewed the 
approach to remuneration for the senior management to assess whether it continues to (i) meet its design objectives, 
(ii)  support  the  ongoing  business  strategy,  and  (iii)  balance  good  governance  practice  in  the  UK-listed  company 
environment  with the ability to attract  and retain US-based management and employees of the  highest calibre to 
execute on this business strategy. The Remeneration Committee determined that  the overall remuneration structure 
continues to be broadly appropriate and it would seek renewal of the current Remuneration Policy.  

The Company believes that remuneration should be weighted toward rewarding entrepreneurial achievement and the 
creation  of  value  over  time.    In  2019,  after  engaging  in  extensive  discussions  with  its  major  shareholders,  the 
Remuneration Committee approved a number of changes to the remuneration programme, as detailed in our 2019 
Annual Report and Accounts, to better align remuneration with the Company’s revised strategy focused on supporting 
its existing portfolio companies and maximising monetisation opportunities.  During 2021, we continued to execute 
upon such strategy and evaluate the appropriateness of the remuneration programme as such changes came into 
effect in 2021.   

The 2020 Directors’ Remuneration Report received a 61.06 % vote in favour at the 2021 AGM, as detailed on page 79.  
While  this  resolution  was  passed,  the  Committee  was  disappointed  that  there  was  a  significant  minority  of  votes 
against the advisory resolutions.   

Overall, the Committee considered that the remuneration programme, including the changes implemented in 2019, 
continued to be broadly appropriate and aligned with the Company’s revised strategy while balancing typical UK-listed 
market practice with US practice in our market for talent.  In line with our commitment to maintaining an open and 
transparent dialogue with shareholders, the Company consulted with its major shareholders in the second half of 2021 
to gain their input.  

56 

 
 
After extensive engagement with its major shareholders, the Board noted that shareholder concerns were primarily 
focused  on  remuneration  schemes  in  place  for  2021  and  prior  which  have  since  been  addressed  through  the 
substantial amendments the Company made to its remuneration programme for 2021 and onwards, as described on 
pages 66 to 69 and further detailed in the Group’s 2019 Annual Report and Accounts.  The Committee believes that 
such  changes  have  and  continue  to  appropriately  address  shareholder  concerns  while  supporting  the  Company’s 
strategy and aligning Executive Directors’ interests directly with shareholders.  

The  Committee  will  continue  to  monitor  the  alignment  and  effectiveness  of  the  Remuneration  Policy  and  its 
implementation in light of the Company’s current strategy and developments in the UK remuneration environment.  
The Committee remains conscious of the current external economic environment, and will be mindful of this when 
determining 2022 out-turns. 

Resignation of Joseph Pignato   

With effect from 14 January 2021, Mr. Pignato resigned as Chief Executive Officer and as an Executive Director of the 
Company.  He continued to serve as Chief Financial Officer of the Company for an interim period until 14 April 2021, 
and has remained a paid consultant as part of the finance function of the Company.  

Performance and Reward for 2021 

No performance-based LTIP awards vested to the Executive Director in 2021. 

The Work of the Remuneration Committee 

The  Remuneration  Committee  has  responsibility  for  setting  the  Remuneration  Policy  for,  and  determining 
remuneration of, the  Executive  Directors  and senior management,  and  reviewing  pay  and  conditions of  the  wider 
workforce.  

The Committee met once during the year.  All members were present at all meetings during the year.  In addition, 
Bruce Failing, the Chairman of the Committee, met several times during the year with members of senior management 
in order to review all elements of remuneration and their operation.  The Committee also received professional advice 
from Deloitte LLP where appropriate. 

During the year, the key activities carried out by the Committee were: 

Review of Remuneration Programme 

  Conducted a review of all elements of remuneration for the senior management to determine their alignment 

and effectiveness in light of the Company’s strategy; 

  Obtained  and  reviewed  feedback  received  from  major  shareholders  and  shareholder  advisory  services,  in 
connection with each of the implementation of the current Remuneration Policy and the subsequent changes 
to the remuneration programme in late 2019;  

Remuneration for 2021 

  Determined the 2021 cash incentive bonus and prior LTIP award outcomes for employees; 

  Reviewed the remuneration reporting regulations in connection with the review of the Group’s Remuneration 

Policy and preparation of the Directors’ Remuneration Report; 

57 

 
 
  Reviewed remuneration and related policies for the wider workforce, including taking into consideration the 

impact of COVID-19; 

  Approved the delivery of a proportion of 2021 fees to Non-Executive Directors in the form of equity-based 

payments (subject to time-based vesting only);  

  Reviewed and approved the remuneration elements of the resignation of Joseph Pignato, details of which are 
provided on pages 80 to 81.  As set out elsewhere in the Annual Report, effective as of 14 January 2021, Mr. 
Pignato stepped down as an Executive Director.  In furtherance of its focused strategy, the Company’s Board 
and management determined that the most effective and efficient path forward is for the Company to be a 
Non-Executive Board-led company.  The Company does not have any current intention of appointing a new 
Chief  Executive  Officer.  The  scope  of  the  Directors’  Remuneration  Report  going  forward  will  therefore  be 
limited  to  reporting  on  the  remuneration  of  non-executive  directors  and  details  of  any  payments  to  past 
executive directors. 

Remuneration for 2022 

  Determined base salaries of the senior management, for the period starting 1 January 2022; 

  Determined the 2022 cash incentive bonus award performance targets;  

Exercise of Discretion 

No  discretion  has  been  exercised  in  relation  to  the  formulaic  outturns  under  the  Company’s  incentive  plans  for 
Executive Directors. 

Alignment to the UK Corporate Governance Code Principles  

When  reviewing  the  appropriateness  of  the  Remuneration  Policy  and  determining  its  operation  for  2021,  the 
Committee took into consideration, and feels it has appropriately addressed, the following design principles set out in 
the revised Corporate Governance Code: 

Clarity 

Simplicity 

Risk 

  The Committee welcomes open and frequent dialogue with shareholders on the 

approach to remuneration. 

  We have sought to clearly explain how we have implemented the Remuneration 
Policy in the year and how the Committee intends to operate it for the year ahead. 
  Following the cancellation of all outstanding performance awards and the future 
operation of the LTIP for Executive Directors, in addition to the Executive Directors 
voluntarily  forfeiting  their  interests  in  the  MIP  and  outstanding  stock  options 
awards, the only performance-based incentive plans in operation for the Executive 
Director are the annual Incentive Bonus Awards and the Phantom Plan. 

  The remuneration approach taken for our Executive Director is cascaded down the 

organisation as appropriate. 

  The Committee considers that the structure of incentive arrangements does not 

encourage inappropriate risk-taking.  

  Under  the  Incentive  Bonus  Awards,  discretion  may  be  applied  where  formulaic 

outturns are not considered reflective of overall performance. 

  No bonus payments arising under the Phantom Plan will be made to participants 
until the Company has generated $109.2 million of gross proceeds (plus any future 
additional  invested  capital  made  after  October  1,  2019)  in  one  or  more  future 
liquidity events. 

  Malus and clawback provisions apply to the Incentive Bonus Awards. 

58 

 
 
Predictability 

  Our Remuneration Policy contains details of threshold and maximum opportunity 
levels  under  our  Incentive  Bonus  Awards,  with  actual  outcomes  dependent  on 
performance achieved against predetermined measures and target ranges. 

Proportionality 

Alignment to 
culture 

  The Committee’s ability to apply discretion ensures appropriate outcomes in the 

context of long-term performance. 

  The  Committee is satisfied that the Remuneration Policy does  not  reward poor 
performance.  Our performance measures and target ranges under the Incentive 
Bonus Awards, and the construct of the Phantom Plan, are aligned to Company 
strategy. 

  Our reward arrangements are designed to reward delivery of the Group’s strategy 
which  is  focused  on  supporting  our  six  existing  portfolio  companies  and 
maximising  monetisation  opportunities  for  portfolio  company  interests.  This  is 
achieved  through  our  Incentive  Bonus  Award  MBOs  and  the  operation  of  the 
Phantom Plan. 

  Our  remuneration  structure  for  Executive  Directors  cascades  as  appropriate 

throughout the Company. 

We continue to appreciate any feedback shareholders may have. 

Bruce Failing 
Chairman of the Remuneration Committee 
14 June 2022 

59 

 
 
 
 
 
Remuneration Policy (pages 60 to 69)  

The  Remuneration  Policy  for  the  Executive  and  Non-Executive  Directors  (Policy)  was  approved  by 
shareholders at the 2019 AGM and is proposed for shareholder approval at the 2022 AGM. If approved, 
the Policy will take effect from the date of the 2022 AGM. If the Policy is not approved, the current policy 
will remain in effect.  

The Committee will consider the Policy annually to ensure that it continues to align with the Company’s 
strategic objectives; however, it is intended that the Policy will apply for three years from the 2022 AGM. 

Where appropriate, commentary has been added to the policy to reflect the changes to the remuneration 
program in late 2019 as described above. 

The Remuneration Policy Table for Executive and Non-Executive Directors 

The table below sets out the Policy for each element of remuneration for Executive and Non-Executive 
Directors and how they support the Company’s short- and long-term strategic objectives. 

Operation 

Opportunity 

Performance metrics 

Element of 
remuneration and 
how it supports the 
Company’s objectives 

An Executive Director’s basic salary is considered by the 
Committee on appointment and normally reviewed once per 
year or when there is a significant change to role or 
responsibility. 
Salary will normally be paid twice per month in cash. In 

Salary 
Provides an 
appropriate level of 
salary in order to be 
competitive and to 
maintain the ability to  exceptional circumstances, part of the salary may be deferred  More significant increases may 
be made from time to time, for 
recruit and retain 
example to recognise an 
Executive Directors of  date. 
increase 
to the individual’s role and 
the required calibre. 
responsibilities, or a significant 
increase in the scale or size of the 
Company. 

There is no prescribed maximum  There are no performance 
annual salary or increase, 
conditions attached to the 
however annual increases will 
payment of salary, although 
there are a number of 
normally be in line with those of 
the wider workforce. 
performance-based factors 
both at the individual and 
Company level that 
influence the level of 
salaries provided to 
Executive Directors. 

Salaries and salary increases are set taking into consideration 
a number of factors including (but not limited to): 

at the request of the individual and become payable at a later 

  scale, scope and responsibility of the role; 
  skills and experience of the individual; 
  individual and Company performance; 
  the impact on other remuneration elements and the total 
remuneration package; 
  the individual’s marketability; 
  pay and conditions across the Company; 
  the wider economic environment; and 
  market-appropriate pay positioning against relevant US and    
UK listed peers and other companies of a similar size 
and complexity. 

The cost of benefits provided 
varies from year to year in 
accordance with market 
conditions, therefore there is no   
prescribed monetary limit. 

N/A 

Benefits 
Provides a benefits 
package in line with 
US employment 
market practice. 

The main benefits provided to Executive Directors include 
(but are not limited to): 
  life insurance; 
  disability insurance; 
  medical benefits and dental care; 
  a car allowance; and 
  an annual payment to cover personal legal and tax advice.   
Executive Directors may also participate in any all-employee 
share plans that may be operated by the Group from time to 
time on the same terms as other employees. 

Additional benefits, which may include relocation expenses, 
housing allowance or other benefits-in-kind, may be provided 
in certain circumstances if considered appropriate and 
reasonable by the Committee, for example on recruitment. 

60 

 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Element of 
remuneration and 
how it supports the 
Company’s objectives 

Pension 

Provides pension 
benefits in line with 
US employment 
market practice. 

The Company is not 
required to provide 
pension benefits in 
order to be 
competitive and to 
ensure its ability to 
recruit and retain 
Executive Directors. 

Incentive Bonus  
Awards 

Incentivises the 
achievement of pre-
determined strategic 
goals – management 
by objectives (MBOs) 
– over a single year 
period. 

Allied Minds Long 
Term Incentive Plan 
(LTIP) 

Incentivises and 
rewards the 
achievement of the 
Company’s long-term 
strategic objectives. 

Provides alignment 
with shareholders 
through long-term 
time horizons and the 
facilitation of share 
ownership. 

Operation 

Opportunity 

Performance metrics 

A consistent pension policy operates for all employees across 
the Company, creating alignment between Executive 
Directors and the wider workforce. 

In line with US market practice, no element of the Executive 
Directors’ remuneration is pensionable, and the Company 
does not operate any pension scheme or other scheme 
providing retirement or similar benefits. 

However, in line with the approach taken for all employees, the 
Company offers a retirement plan in accordance with 
subsection 401(k) of the Internal Revenue Code in which 
Executive Directors may make voluntary pre-tax contributions 
toward their own retirement. The Company does not make any 
payments or contributions to such 401(k) Plan. 

Annual MBOs and their respective weightings and targets, are 
set at or around the start of each financial year. 

An Executive Director’s incentive bonus award is considered 
by the Committee upon completion of each financial year. 

The decision to provide any award and the amount and terms 
of any such award, are determined based on the level of 
achievement against the MBOs set at the start of the year. 

The Committee may exercise its discretion and make 
adjustments to the formulaic payout level (both upwards and 
downwards, including a reduction to zero) if the formulaic 
outcome is not considered to be appropriate. When making 
this judgement, the Committee will consider a number of 
factors, including (but not limited to) the overall shareholder 
experience, underlying business performance (including 
financial, operational and technical performance) and 
individual performance during the year. 

An award over Company stock is typically made to Executive 
Directors annually, subject to pre-determined performance 
measures which are typically tested over a period of three 
years. 

The specific performance measures, weightings and targets 
are set at or around the start of each financial year. 

Performance will normally be tested after three years, 
subject to the Committee’s assessment of the extent to 
which the performance measures have been met. This 
assessment may take into account any additional relevant 
factors, at the Committee’s discretion. 

A further two-year holding period will typically apply to 
awards, giving a total period between the date of the initial 
award was made and the end of the holding period of five 
years. 

Awards are subject to malus and clawback provisions, as 
described in the notes to this Policy table. 

Operation for 2020 onwards: the LTIP has been retired for 
Executive Directors, senior management and other 
employees, with no further awards to be made under this 
plan to these persons. In addition, the Executive Directors 
voluntarily agreed to forfeit the performance-based LTIP 
awards made to them in 2017 and 2018, and no LTIP awards 
were made in 2019 to them. 

61 

N / A    

N / A  

Incentive Bonus opportunities 
are capped at 225% of salary per 
annum, which is only achieved if 
performance significantly 
exceeds expectations across all 
MBOs set for the year. 

The level of annual bonus 
payable for on-target 
performance is set at a level 
significantly below the maximum 
opportunity, and will be 
disclosed each year in the Annual 
Report on Remuneration. 

Operation for 2020 onwards: 
Incentive Bonus opportunities 
will be capped at 150% of salary 
per annum. 

The Committee and senior 
management review the 
Group’s MBOs annually 
prior to the start of each 
financial year to ensure the 
detailed performance 
measures and weightings 
are appropriate and 
continue to support the 
business strategy. 

MBOs may include financial, 
operational, technical and 
other performance targets. 

The MBOs will be weighted 
primarily towards Group, 
and not individual, MBO 
performance. 

LTIP awards are normally granted 
to an individual each financial year 
and are capped at 300% of salary. 
The award will only vest in full if 
performance significantly exceeds 
expectations over the 
performance period. 

The proportion of the award that 
will vest for threshold 
performance will be 16.67%. 

When attracting a new executive 
director of the required calibre, 
an additional LTIP award of up to 
300% of salary may be granted in 
the executive’s first year of 
appointment if deemed 
appropriate by the Committee. 
Thereafter, LTIP awards granted 
to the executive would be made 
under the normal policy 
maximum above. 

The Committee may vary 
specific measures and 
targets applicable to LTIP 
awards from year to year, to 
ensure they continue to 
support the achievement of 
the Company’s strategy and 
to ensure that the target 
range remains sufficiently 
stretching. 

In respect of the LTIP 
awards to be granted in 
2019, 60% of vesting will be 
based on the Company’s 
relative total shareholder 
return (rTSR) performance 
in respect of a three-year 
performance period, and 
40% of vesting will be based 
upon the monetisation of 
portfolio companies over 
such period. 

 
 
 
 
 
Element of 
remuneration and 
how it supports the 
Company’s objectives 

Allied Minds Phantom 
Plan 
Rewards participants 
for a successful 
portfolio company 
liquidity event, a key 
strategic objective of 
the Group and its 
shareholders, thereby 
providing alignment 
between the interests 
of participants and 
shareholders. 
Operation of such 
plans is common 
practice amongst our 
peers in the venture 
creation / IP 
commercialisation 
sectors, therefore the 
Phantom Plan allows 
the Company to 
provide a market- 
competitive 
remuneration offering 
within the relevant 
market for talent 
across this industry. 

Share ownership 
requirement 
Encourages 
Executive Directors 
to build a meaningful 
shareholding in the 
Company, providing 
alignment between 
the long-term 
interests of Executive 
Directors and 
shareholders. 

Non-Executive 
Directors’ Fees 
Provides an 
appropriate level of 
fees in order to be 
competitive and to 
maintain the ability 
to recruit and retain 
Non-Executive 
Directors of the 
required calibre and 
experience. 
Partial delivery in 
Company stock 
encourages alignment 
of interests with 
shareholders. 

Operation 

Opportunity 

Performance metrics 

The Phantom Plan is a performance-based, cash settled 
bonus plan for Allied Minds’ Executive Directors and 
management. 
The Plan is triggered by a successful portfolio liquidity 
event, including (i) a portfolio company IPO, (ii) the sale of 
all or substantially all of a portfolio company’s assets, (iii) 
the sale of at least two-thirds of the outstanding shares of a 
portfolio company’s voting equity, (iv) the merger or 
consolidation of a portfolio company with or into another 
entity, or (v) a portfolio company’s liquidation. 
Upon a liquidity event, Allied Minds will deduct the amount 
it invested in such portfolio company and deduct the 
accrued interest in respect of such investment, and will then 
allocate 10% of the remaining net proceeds to the Phantom 
Plan account for allocation among the participants. 

Participants receive “units”, which equates to a pro-
rata share of the Phantom Plan pool. 
Vesting of units is determined at the time of grant 
of the units. 

Operation for 2020 onwards: the Phantom Plan will not be 
available to any new unitholders nor will any companies 
be added to the Plan. 

The maximum aggregate number 
of units that may be awarded 
under the Phantom Plan is 
200,000 units. 
Awards to Executive Directors 
under the Phantom Plan may 
not exceed 30,000 units. 
Upon a liquidity event Allied 
Minds will distribute 80% of the 
Phantom Plan account to the 
participants based on their pro 
rata share of all vested units on 
the date of the applicable 
liquidation event, and the 
remaining 20% of the Phantom 
Plan account will be distributed 
to participants at the discretion 
of the Committee. 

Operation forrom 2020 
onwards: Executive Directors 
are subject to a cap of 25% of 
any allocated proceeds in 
connection with a specific 
liquidity event. 

Executive Directors are required to acquire and maintain a 
minimum ownership level of ordinary shares in the Company. 

N/A 

This  minimum  level  is set  at  the  equivalent  of  400%  of 
salary for the CEO. 

No amounts accrue under 
the Phantom Plan, and no 
amounts are distributed to 
participants, until and 
unless a successful portfolio 
company liquidity event 
occurs, and the cash 
generated in such liquidity 
event exceeds the amount 
Allied Minds invested in 
such portfolio company, 
plus accrued interest and 
expenses in respect of such 
investment. No other 
performance metrics apply. 

Operation for 2020 
onwards: an additional 
underpin has been 
introduced, such that no 
payments arising under 
the Phantom Plan will be 
made to participants until 
the Company has 
generated $109.2 million 
of gross proceeds (plus any 
future additional invested 
capital) in one or more 
future liquidity events. 

N/A 

There is no prescribed 
maximum fee or increase, 
however total fees payable are 
subject to the limits set out in 
the Articles of Association. 

N/A 

Non-Executive Directors receive an annual fee, with 
additional fees paid to reflect additional time 
commitment and responsibilities for certain roles, e.g. 
Chairmanship of a Board Committee / the Board. 
Non-Executive Directors’ fee levels are typically 
reviewed annually, taking into consideration a number 
of factors, including (but not limited to): 

scale, scope and responsibility of the role; 
relevant skills and experience required; and 

 
 
  market-appropriate pay positioning against relevant US and 
UK listed peers and other companies of a similar size and 
complexity. 

Non-Executive Directors are not entitled to participate in 
any Company pension scheme or to receive benefits, other 
than the reimbursement of reasonable and properly 
documented expenses incurred in performing the duties of 
their office (and any associated taxes). 

62 

 
 
 
Operation 

Opportunity 

Performance metrics 

Element of 
remuneration and 
how it supports the 
Company’s objectives 

Non-Executive Directors do not receive any 
performance-related awards. 
Given the US-based nature of the Group’s business, and 
the need to attract and retain independent directors with 
significant US business and leadership experience, a 
proportion of the fees are paid in stock (with the 
remainder paid in cash). The stock element is subject to 
time-based vesting over a three-year period, however no 
performance conditions are applied. 

Careful consideration has been given as to whether including 
an equity component would affect the independence of the 
Non-Executive Directors, and the conclusion was reached 
that it would not, given the level of the awards and the 
fact that they are not performance-related. 

Common award terms 

The Committee will operate the LTIP in accordance with the Policy table above and the respective 
rules. Awards under these schemes: 

  will normally take the form of restricted share units (RSUs) in respect of shares in Allied 
Minds,  although  instruments  with  similar  economic  effect  may  be  used  if  considered 
appropriate; 

  may incorporate the right to receive an amount (paid in cash or additional shares) equal 
to the value of dividends that would have been paid on the shares under the award that 
vests up to the time of vesting (and where awards are subject to a holding period, the end 
of the holding period). This amount may be calculated assuming the dividends have been 
reinvested in the Company’s shares; 

  may exceptionally be cash-settled at the Committee’s discretion; 

  may  have  the  applicable  performance  conditions  amended  or  substituted  by  the 
Committee  if  an  event  occurs  which  causes  the  Committee  to  determine  an  amended  or 
substituted  performance  condition  would  be  more  appropriate  and  not  materially  less 
difficult to satisfy; and 

  may be appropriately adjusted in the event of any variation of the Company’s share capital 
or any demerger, delisting, special dividend or other event that may affect the Company’s 
share price. 

Any use of these discretions above would, where relevant, be explained in the relevant year’s 
Annual  Report  on  Remuneration  and  may  (if  deemed  appropriate)  be  subject  to  prior 
consultation with the Company’s major shareholders. 

As noted, the Committee has determined that no further awards will be made under 
the LTIP to Executive Directors, senior management or other employees. 

63 

 
 
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
Minor amendments 

The Committee may make minor amendments to the Policy set out in this report (for regulatory, 
exchange control, tax or administrative purposes or to take account of a change in legislation) 
without obtaining shareholder approval for the amendment(s).  

Malus and clawback 

Awards under the annual Incentive Bonus and the LTIP are subject to malus provisions (allowing for the 
reduction of deferred awards) and clawback provisions (the recovery of awards to which the participants 
are entitled) in the case of: 

  Material misstatement of the Group accounts; 

  A material correction of any figures used to assess satisfaction of any performance conditions; 

  A participant’s gross misconduct; 

  Serious reputational damage; or 

  Corporate failure. 

Under both plans, the clawback provision applies for the two-year period following vesting. 

Legacy awards 

The Committee reserves the right to make any remuneration payments and payments for loss of office, 
notwithstanding that they are not in line with the Policy set out in the table on the previous pages, where 
the terms of the payment were agreed: 

  before the 2016 AGM (being the date on which the previous Policy came into effect); 

  before the Policy set out above came into effect at the 2019 AGM, provided that the terms of the 
payment were consistent with the shareholder-approved Remuneration Policy in force at the time they 
were agreed; or 

  at a time when the relevant individual was not a Director of the Company and, in the opinion of the 
Committee, the payment was not in consideration for the individual becoming a Director of the 
Company. 

For these purposes “payments” include the Committee satisfying awards of variable remuneration and, 
in relation to an award over  shares,  the  terms of the  payment are “agreed” at  the time  the award is 
granted. 

Details of any such payments will be set out in the Annual Report on Remuneration as they arise. 

Consideration of employee remuneration arrangements and policies elsewhere in the company 

Although the Policy set out above applies only to Executive and Non-Executive Directors of the Company, 
in practice the Committee is responsible for setting the policy for, and determining remuneration of, the 
Company’s  senior  management  team,  and  reviewing  workforce  remuneration  and  related  policies.  In 
considering changes to the remuneration of the Executive Directors, for example when determining salary 
increases, the Committee is mindful of pay and conditions in the wider Group. 

64 

 
 
The Group’s senior management team also participate in the components of remuneration set out above 
(i.e. salary, benefits, pension, Incentive  Bonus, LTIP and Phantom Plan). The operation of the  incentive 
schemes for senior management varies from Executive Directors where appropriate, for example award 
maxima and vesting criteria. 

All US employees at the Allied Minds (parent company) level are eligible for discretionary incentive bonus 
awards. While a range of bonus plans are operated at the portfolio company level, appropriate to the 
relevant business, the main drivers of these portfolio company plans, in common with the annual Incentive 
Bonus awards to Executive Directors, are the achievement of company milestones, and other company 
and individual objectives. 

In addition, the Company remains committed to fostering alignment with shareholders. Therefore, equity 
incentive plans are operated within the portfolio companies, with the aim of incentivising and rewarding 
employees of those companies to achieve long-term shareholder value and the delivery of the Company’s 
long-term strategic and business objectives. 

As noted, in light of the Company's revised strategy, the LTIP has been retired for all Executive Directors, 
senior management and other employees, and the Phantom Plan has been closed to new participants and 
new portfolio companies. 

How the views of shareholders and employees are taken into account 

Through the Board, the Committee is regularly updated as to employees’ views on remuneration generally 
and receives periodic updates in relation to salary and bonus reviews across the Company. As set out above, 
in setting remuneration for the Executive Directors, the Committee takes note of the overall approach to 
reward employees in the Company and salary increases will ordinarily be considered in light of those of the 
wider workforce. Thus, the Committee is satisfied that the decisions made in relation to Executive Directors’ 
pay are made with an appropriate understanding of the wider workforce. 

The Committee values the input of shareholders and is committed to dialogue on material matters. Any 
feedback  received  from  time  to  time  from  shareholders,  and  the  AGM  voting  results  in  respect  of 
remuneration-related resolutions, are considered as part of the Committee’s annual review of the Policy. 
When developing the 2019 Policy, a key part of the process was  the  engagement with the  Company’s 
major shareholders and proxy voting agencies on the proposed remuneration changes, prior to finalising 
the Policy. 

The Committee will seek to engage formally with shareholders and their representative bodies when it is 
proposed that any material changes are to be made to the Policy, and also welcomes and appreciates 
feedback at any other time. Extensive shareholder meetings were undertaken ahead of changes to the 
remuneration program in late 2019. 

Approach to recruitment remuneration 

The Committee will apply the principles set out in the Policy table above for any new Executive Director 
recruited to the Board, in particular: 
  Providing  a  remuneration  package  that  attracts,  retains  and  motivates  individuals  of  the  required 
calibre, while at all times ensuring that the Company pays no more than necessary; 

65 

 
 
  Taking  into  consideration  a  number  of  factors  when  determining  the  appropriate  package  on 
recruitment, including the individual’s skills and experience, scale, scope and responsibility of the role, 
and pay conditions across the Company; 

  Ongoing remuneration arrangements for the individual will be limited to those elements listed within 
the Policy table above; 

  Additional  benefits  in  kind,  pensions  and  other  allowances,  such  as  relocation,  education  and  tax 
equalisation, may be provided in order to recruit the intended candidate; and 

  Full disclosure will be made of the recruitment package provided to the individual within the next Annual 
Report on Remuneration, including rationale for the decisions made where appropriate. 

Salaries may be set below market levels on appointment with a view to increase them to broad market 
levels,  subject  to  individual  performance  and  progression  within  the  role,  by  making  phased  salary 
increases above inflation levels. 

The maximum  level of variable  remuneration  under the  annual  Incentive  Bonus  and  LTIP  that  may  be 
awarded will be within the usual maximums set out in the Remuneration Policy, subject to the exceptional 
limit provided under the LTIP. However, as noted, in light of the Company's revised strategy, the LTIP has 
been retired for all Executive Directors, senior management and other employees. 

The Committee may make awards on hiring an external candidate to buy out remuneration arrangements 
forfeited on leaving a previous employer. In doing so, the Committee will seek to structure buyout awards 
on a comparable basis to awards forfeited, taking into account relevant factors including any performance 
conditions attached to these awards and the likelihood of achieving these conditions, the form in which they 
were granted (e.g. cash or shares) and the timeframe of awards. It is intended that the value awarded would 
be no higher than the expected value of the forfeited awards. The Committee would seek as far as possible 
to make such buyout awards under the Company’s existing share plans but, if necessary, may rely on the 
Listing Rules provision which allows for the grant of awards to facilitate, in exceptional circumstances, the 
recruitment of a Director without seeking prior shareholder approval. 

In addition to the above principles, the following additional considerations may be applied as appropriate 
depending on the circumstances: 

In the case of internal promotion, any pre-existing arrangements arising from an individual’s previous 

 
role will continue to be honoured in line with their original terms and conditions. 

 
In the case of promotion to Executive Director following an acquisition or other business combination, 
the  Committee  may  permit  equity-based  incentive  arrangements  to  continue  in  force  if  they  can  be 
“rolled-up” into awards over Allied Minds’ shares provided the performance and vesting conditions are 
considered appropriate. 

 
In the case of the recruitment of an executive at a time of the year when it would be inappropriate or 
not possible to provide an LTIP award for that year (for instance due to price sensitive information or if 
there is insufficient time to assess performance), the quantum in respect of the months employed during 
the  year  may  be  transferred  to  and  amalgamated  with  the  subsequent  year’s  award  if  considered 
reasonable to do so by the Committee.

66 

 
 
Similarly, the Remuneration Policy for a new Chairman or Non-Executive Director would be to apply the 
same remuneration elements as applicable to existing Non-Executive Directors under the Remuneration 
Policy. 

Remuneration Policy on payment for loss of office 

The  Directors  believe  the  policy  on  payments  for  loss  of  office  detailed  below  are  aligned  with  UK 
corporate governance expectations and local market practice, and appropriate to attract and retain senior 
management of the highest calibre. 

The Committee reserves the right to make payments where they are made in good faith in discharge of 
an existing obligation (or by way of damages for breach of such an obligation) or by way of settlement or 
compromise of any claim arising in connection with the termination of a Director’s office or employment 
where  they  are  in  the  best  interests  of  Allied  Minds  and  its  shareholders  and  reflecting  the  directors’ 
contractual and legal rights. 

If an Executive Director’s employment is terminated by the Company for “Cause”, the Director shall only 
be entitled to amounts that are accrued or owing but not yet paid and reimbursement of any properly 
incurred business expenses but excluding any bonus payments or other compensation provided pursuant 
to the Company’s incentive compensation plan (such amounts, the “Standard Benefit”). 

If the Executive Director terminates the service contract for “Good Reason” or the Company terminates 
the service contract without Cause, the Executive Director shall be entitled to: 

  payment of twelve (12) months’ base salary in accordance with regular payroll; 

  an  annual  incentive  award  equal  to  the  product  of:  (A)  the  level  of  Group  and  individual  MBO 
performance during the current year, as determined by the Committee; and (B) a fraction based on the 
number of days in which the Executive Director was employed during that year; or, alternatively, an annual 
incentive award equal to the product of: (A) the Executive Director’s average bonus for the prior three (3) 
years; and (B) a fraction based on the number of days in which the Executive Director was employed during 
that year; 

  payment of the portion of the premiums paid by the Company at the time of such termination under 
COBRA  for  medical,  dental,  hospitalisation  and  other  employee  welfare  benefit  plans,  programs  and 
arrangements  covered  by  COBRA,  for  a  period  of  twelve  (12)  months  for  the  Director  and  eligible 
dependents; and 

  payment of the Standard Benefit. 

In the event of death or disability, similar payments will be made as those payable as a termination for 
Good Reason save that the payment of base salary shall only continue for 90 days after the death of the 
Executive  Director  and/or  until  the  commencement  of  long  term  disability  payments  in  the  case  of 
termination due to disability. 

If  the  Executive  Director  terminates  employment  with  Allied  Minds  without  Good  Reason  (and  not 
because of death or due to disability), the Executive Director shall be entitled solely to payment of the 
Standard Benefit. 

67 

 
 
LTIP participants who cease to be employees, directors or service providers to the Group will normally 
forfeit any unvested awards. However, if a participant leaves as a result of death, disability, dismissal other 
than for cause or any other reason determined by the Committee, awards will normally vest on the normal 
vesting  date  on  a  pro-rata  basis  taking  into  account  performance  and  the  period  of  time  during  the 
applicable performance measurement period in which the participant continuously provided services. The 
Committee may in its discretion determine that there are exceptional circumstances justifying vesting to 
a greater or lesser extent. The Committee also has discretion to determine that awards will vest at the 
time  of  cessation  of  employment,  taking  into  account  performance  up  to  that  time,  and  pro-rated  to 
reflect the time worked in the performance period (with discretion to determine vesting to a greater or 
lesser extent). 

Impact of change of control on awards under LTIP 

If there is a change of control of the Company, the number of ordinary shares over which awards will vest 
will be calculated on the basis of the extent to which the performance criteria applicable to those awards 
have been satisfied as at the date of the change of control. The resulting number of shares will then be 
reduced on a pro-rata basis to reflect the reduced period between the date the award was made and the 
date of the change of control, unless the Committee decides otherwise. In exceptional circumstances, the 
Committee may recommend full vesting with respect to a change of control. This discretion to accelerate 
vesting upon a change of control is included in the LTIP to meet the expectations of a US-based workforce. 

Illustration of application of the Remuneration Policy – updated for implementation in respect of 2020 

The value and composition of the Executive Director’s remuneration package for the year ending 31 
December 2020 is illustrated in the chart below under the following four scenarios: 

Minimum 

On-target 

Maximum 

Maximum plus 50%  
share price growth 

2020 salary ($500,000) plus estimated value of benefits 

Two-thirds of 
maximum 
opportunity 

100% of the 
maximum 
opportunity 

100% of the 
maximum 
opportunity 

None 

None 

None 

Fixed Pay 

Incentive 
Bonus 

LTIP 

- 

- 

68 

 
 
  
69 

 
 
.

0
2
0
2
d
n
a
1
2
0
2
r
e
b
m
e
c
e
D
1
3
d
e
d
n
e
s
r
a
e
y
l

a
i
c
n
a
n
i
f
e
h
t

r
o
f

s
r
o
t
c
e
r
i
D
r
o
f
n
o
i
t
a
r
e
n
u
m
e
r

r
o
f
e
r
u
g
i
f

l

l

a
t
o
t
e
g
n
i
s
e
h
t

l

t
u
o
s
t
e
s
e
b
a
t
g
n
w
o

i

l
l

o
f
e
h
T

l

a
t
o
T

l

a
t
o
T

l

e
b
a
i
r
a
V

d
e
x
i
F
l

a
t
o
T

)
5
(
n
o
i
s
n
e
P

)
4
(
P
B
E

e
v
i
t
n
e
c
n

I

)
3
(
s
u
n
o
B

)
2
(
s
t
i
f
e
n
e
B

l

/
y
r
a
a
s
e
s
a
B

)
1
(
s
e
e
f

0
2
0
2

1
2
0
2

0
2
0
2

1
2
0
2

0
2
0
2

1
2
0
2

0
2
0
2

1
2
0
2

0
2
0
2

1
2
0
2

0
2
0
2

1
2
0
2

0
2
0
2

1
2
0
2

0
2
0
2

1
2
0
2

0
0
0
’
$
n

I

3
2
0
,
1

4
.
8
1

0
8
4

―

3
4
5

.

4
8
1

―

―

5
0
1

―

5
7
3

―

3
4

4
1

.

0
0
5

7
1

4
6
1

5
9

9
6

0
6
1

0
0
1

5
8

4
1

―

―

―

―

0
5
1

5
9

9
6

0
6
1

0
0
1

5
8

―

―

―

―

―

―

4
1

―

―

―

―

―

―

―

―

―

―

―

―

―

―

―

―

―

0
5
1

5
9

9
6

0
6
1

0
0
1

5
8

s
r
o
t
c
e
r
i
D
e
v
i
t
u
c
e
x
E

)
6
(
o
t
a
n
g
P
e
o
J

i

e
v
i
t
u
c
e
x
E
-
n
o
N

s
r
o
t
c
e
r
i
D

i

n
e
R
y
r
r
a
H

)
7
(
l

a
d
r
e
L

k
r
a
M

g
n

i
l
i

a
F
e
c
u
r
B

:
s
e
t
o
  N

.

M
G
A
e
h
t

t
a
e
t
o
v
y
r
o
s
i
v
d
a
n
a
o
t

j

t
c
e
b
u
s
e
b

l
l
i

w
n
o
i
t
a
r
e
n
u
m
e
R
n
o
t
r
o
p
e
R

l

a
u
n
n
A
e
h
T

)
n
o
i
t
a
m
r
o
f
n

i

d
e
t
i
d
u
a
(

r
o
t
c
e
r
i
D
h
c
a
E
r
o
f
n
o
i
t
a
r
e
n
u
m
e
R
f
o
e
r
u
g
i
F
l

a
t
o
T
e

l
g
n
i
S

)
5
8
o
t
0
7
s
e
g
a
p
(
n
o
i
t
a
r
e
n
u
m
e
R
n
o
t
r
o
p
e
R

l

a
u
n
n
A

E
C
N
A
N
R
E
V
O
G
D
N
A
T
N
E
M
E
G
A
N
A
M

e
h
t

r
o
f
d
e
t
a
r
-
o
r
p

,
s

i

m
u
m
e
r
p
e
c
n
a
r
u
s
n

i

r
e
h
t
o
d
n
a

l

a
t
n
e
d

,
l
a
c
i
d
e
m
o
t
n
o
i
t
u
b
i
r
t
n
o
c
y
n
a
p
m
o
C
r
o
/
d
n
a
e
c
n
a
w
o

l
l

a
r
a
c
,
e
b
a
c
i
l

l

p
p
a
e
r
e
h
w

,
s
e
d
u
l
c
n

I

e
v
i
t
u
c
e
x
E
-
n
o
N

e
h
t

o
t

d
e
t
n
a
r
g

d
n
a

k
c
o
t
s

n

i

i

d
a
p

s
e
e
f

e
h
t

f
o

n
o
i
t
r
o
p

e
h
t

t
n
e
s
e
r
p
e
r

s
r
o
t
c
e
r
i
D

e
v
i
t
u
c
e
x
E
-
n
o
N

r
o
f

s
t
n
e
m
y
a
p

d
e
s
a
b

s
e
i
t
i
u
q
E

.
s
r
o
t
c
e
r
i
D
e
v
i
t
u
c
e
x
E
s
a
g
n
i
v
r
e
s

r
a
e
y
e
h
t

f
o
n
o
i
t
r
o
p
e
h
t

r
o
f
d
e
t
a
r
-
o
r
p

,
s
d
r
a
w
a
s
u
n
o
b
e
v
i
t
n
e
c
n

i

h
s
a
c

l

a
u
n
n
a
s
e
d
u
l
c
n

i

s
u
n
o
b
e
v
i
t
n
e
c
n

I

.

d
r
a
o
B
e
h
t
n
o
d
e
v
r
e
s

y
e
h
t

r
a
e
y
e
h
t

f
o
n
o
i
t
r
o
p

-
e
m

i
t
a
n
o
(
d
e
t
s
e
v
s
d
r
a
w
a
e
h
t
e
t
a
d
e
h
t
n
o
e
u
a
v
e
h
t
n
o
d
e
s
a
b
(
0
2
0
2
d
n
a
9
1
0
2
n

l

i

d
e
t
s
e
v
h
c
i
h
w
9
1
0
2
d
n
a
,

8
1
0
2

,

7
1
0
2

,

6
1
0
2

,

5
1
0
2
n

i
s
r
o
t
c
e
r
i
D

0
7

.

d
r
a
o
B
e
h
t
n
o
d
e
v
r
e
s

y
e
h
t

r
a
e
y
e
h
t

f
o
n
o
i
t
r
o
p
e
h
t

r
o
f
d
e
t
a
r
-
o
r
p

,
s
e
e
f

’
s
r
o
t
c
e
r
i
D
e
v
i
t
u
c
e
x
E
-
n
o
N
d
n
a
’
s
r
o
t
c
e
r
i
D
e
v
i
t
u
c
e
x
E

l

a
u
t
c
A

)
1
(

)
2
(

)
3
(

)
4
(

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
:
9
1
0
2
(

)
0
2
0
2
(

l
i

n
s
i

n
o
i
t
a
i
c
e
r
p
p
a

e
c
i
r
p
e
r
a
h
s

o
t

l

e
b
a
t
u
b
i
r
t
t
a

s
i

h
c
i
h
w
s
d
r
a
w
a

e
s
e
h
t

f
o
t
n
u
o
m
a

e
h
T

.
)
d
e
u
s
s
i

e
r
e
w
s
e
r
a
h
s

e
h
t
d
n
a

)
s
i
s
a
b
y
l
n
o

.
)
l
i

n

s
n
o
i
t
u
b
i
r
t
n
o
c

x
a
t
-
e
r
p

y
r
a
t
n
u
o
v

l

e
k
a
m
y
a
m

s
r
o
t
c
e
r
i
D
e
v
i
t
u
c
e
x
E

h
c
i
h
w
n

i

e
d
o
C

e
u
n
e
v
e
R

l

a
n
r
e
t
n

I

e
h
t

f
o

)
k
(
1
0
4

n
o
i
t
c
e
s
b
u
s

h
t
i

w
e
c
n
a
d
r
o
c
c
a

n

i

n
a
p

l

t
n
e
m
e
r
i
t
e
r

a

s
r
e
f
f
o

y
n
a
p
m
o
C

e
h
T

.
r
a
e
y

l

a
i
c
n
a
n
i
f

t
s
a

l

e
h
t

g
n
i
r
u
d

s
r
o
t
c
e
r
i
D

o
t

e
d
a
m
e
r
e
w
s
t
n
e
m
e
l
t
i
t
n
e

n
o
i
s
n
e
p

r
o
f

s
t
n
e
m
y
a
p

o
N

)
5
(

E
C
N
A
N
R
E
V
O
G
D
N
A
T
N
E
M
E
G
A
N
A
M

.

l

n
a
P
h
c
u
s
o
t

s
n
o
i
t
u
b
i
r
t
n
o
c

r
o
s
t
n
e
m
y
a
p
y
n
a
e
k
a
m

t
o
n
s
e
o
d
y
n
a
p
m
o
C
e
h
T

.
t
n
e
m
e
r
i
t
e
r
n
w
o
r
i
e
h
t
d
r
a
w
o
t

n
o

n
o
i
t
a
n
g
i
s
e
r

s
i
h

f
o

t
c
e
f
f
e

e
h
t

f
o

s
l
i

a
t
e
D

.

1
2
0
2

y
r
a
u
n
a
J

3
1

n
o

r
o
t
c
e
r
i
D

e
v
i
t
u
c
e
x
E

d
n
a

r
e
c
i
f
f

O

e
v
i
t
u
c
e
x
E

i

f
e
h
C

s
a

d
e
n
g
i
s
e
r

o
t
a
n
g
P

i

.
r

M

)
6
(

n
o
s
i
s
a
b
e
m

i
t

l
l

u
f

a
n
o
r
e
c
i
f
f

O
e
c
n
a
n
i
F

i

f
e
h
C
s
a
d
e
t
n
o
p
p
a

i

s
a
w
o
t
a
n
g
P
r

i

M

.

1
8
o
t
0
8
s
e
g
a
p
n
o
n
e
v
i
g

e
r
a

s
t
i
f
e
n
e
b
d
n
a
s
t
n
e
m
y
a
p
g
n
d
n
a
t
s
t
u
o

i

f
o
d
n
e
p
i
t
s

r
a
c
a
,

l

,

7
1
9
1
2
1
$
f
o
y
r
a
a
s
a
d
e
v
i
e
c
e
r
o
t
a
n
g
P
r

i

M

,
e
r
u
n
e
t

s
i
h
t
g
n
i
r
u
D

.

1
2
0
2

l
i
r
p
A
3
1
n
o
t
s
o
p
s
i
h
t

m
o
r
f
d
e
n
g
i
s
e
r
d
n
a
1
2
0
2
y
r
a
u
n
a
J
4
1

n
a

i

s
n
a
m
e
r

d
n
a

1
2
0
2

l
i
r
p
A

4
1

n
o

s
i
s
a
b

e
m

i
t
-
t
r
a
p

a

n
o

r
e
c
i
f
f

O
e
c
n
a
n
i
F

i

f
e
h
C

s
a

i

d
e
t
n
o
p
p
a

s
a
w
o
t
a
n
g
P

i

r

M

.
s
t
i
f
e
n
e
b

n

i

5
2
6
9
$

,

d
n
a

,

0
0
0
3
$

,

f
o

d
n
e
p
i
t
s

r
a
c

a

,

,

6
3
1
0
8
1
$

1
7

f
o

y
r
a
a
s

l

a

d
e
v
i
e
c
e
r

o
t
a
n
g
P

i

r

M

,
r
e
c
i
f
f

O

l

a
i
c
n
a
n
i
F

i

f
e
h
C

e
m

i
t
-
t
r
a
p

s
A

.
y
t
i
c
a
p
a
c

s
i
h
t

n

i

y
n
a
p
m
o
C
e
h
t

f
o
e
e
y
o
p
m
e

l

.

1
2
0
2
h
c
r
a
M
0
1
f
o
s
a
e
v
i
t
c
e
f
f
e
d
r
a
o
B
e
h
t

m
o
r
f
d
e
n
g
i
s
e
r

l

a
d
r
e
L

.
r

M

)
7
(

.
s
t
i
f
e
n
e
b
n

i

,

5
4
4
8
2
$
d
n
a
,

0
0
0
4
$

,

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT AND GOVERNANCE  

Individual Elements of Remuneration  

Share awards made during 2021 (audited information) 

Long Term Incentive Plan Vesting during 2021 (audited information) 

Non-Executive Director Awards 

Equity-based awards were granted to the Non-Executive Directors in 2015, 2016, 2017, 2018, and 2019, 
subject to time-based vesting in three equal instalments over a three year period. The LTIP was used as 
the mechanism to grant these awards, however they are not subject to performance conditions.  These 
awards partially vested in 2019, 2020 and 2021.  As a result of such vesting in 2019, ordinary shares were 
allotted  and  issued  to  Mr.  Rohr  (22,913)  and  Mr.  Rein  (24,170).    As  a  result  of  such  vesting  in  2020, 
ordinary shares were allotted and issued to Mr. Rein (36,154). As a result of such vesting in 2021, ordinary 
shares were allotted and issued to Mr Rein (74,100), Mr Failing (36,857) and Mr Lerdal (36,857). As a result 
of such vesting in 2022, ordinary shares are due to be allotted and issued to Mr Rein (136,113) and Mr 
Failing (90,742). 

Payments to Past Directors and Loss of Office Payments (audited information) 

With the exception of payments to past directors and loss of office payments previously disclosed in our 
2019 Annual Report and Accounts, no payments to past directors were made during the last financial year. 

During the year, Joe Pignato, was paid a severance package following his resignation as a Director of the 
Company on 14 January 2021 and the details of this package are set out on pages 77 to 78 of the Directors’ 
Report below. 

Total Pension Entitlements (audited information) 

No  payments  for  pension  entitlements  were  made  to  Directors  during  2021.    The  Company  offers  a 
retirement plan in accordance with subsection 401(k) of the Internal Revenue Code (401(k) Plan) in which 
Executive  Directors  may  make  voluntary  pre-tax  contributions  toward  their  own  retirement.    The 
Company does not make any payments or contributions to such 401(k) Plan. 

Statement of Directors’ Shareholding and Share Interests (audited information) 

Share ownership plays a key role in the alignment of our executives with the interests of shareholders, 
therefore the Committee operates a share ownership policy for Executive Directors.  The policy currently 
requires Executive Directors to acquire and maintain a minimum ownership level of ordinary shares in the 
capital of the Company equal to 400% of base salary.  At 31 December 2021, the Executive Director was 
making  progress  against  this  requirement.    Given  the  changes  to  the  management  structure  of  the 
Company, it was considered appropriate that no post-cessation shareholding requirements policy should 
be developed.  

The table below sets out the number of shares held by Directors as at 31 December 2021.   

72 

 
 
 
MANAGEMENT AND GOVERNANCE  

Shares 
held 
outright 

Total 

222,824  222,824 
- 
454,300  454,300 

 -    

Non―Executive 
Directors 
Harry Rein 
Mark Lerdal 
Bruce Failing 

Performance Graph  

The graph below illustrates the Company’s Total Shareholder Return (TSR) performance relative to the 
constituents of the FTSE 250 index excluding investment companies and the FTSE All Share index, from 
the Admission date of 25 June 2014 to 31 December 2021.  These indices were chosen since the Company 
was / is a constituent for a significant proportion of the relevant period.  The graph shows performance 
of a hypothetical £100 invested and its performance over that period.  

73 

 
 
 
 
 
 
 
 
 
 
MANAGEMENT AND GOVERNANCE  

Historical CEO remuneration outcomes 

The table below summarises the Chief Executive Officer single total figure for total remuneration, annual 
incentive bonus award, LTIP vesting as a percentage of maximum opportunity, payments made under the 
Phantom Plan, if any, and US Stock Plan share award vesting as a percentage of maximum opportunity, 
for the last seven financial years.  As the company listed in 2014, the comparative begins with the 2014 
period.  

2021 

2020 

2019 

2018 

2015 
  $1,192  $1,328  $9,178  $1,067 

2017 

2016 

$0,019  $1,023  $1,543 

n/a 

50.0%  58.40%  42.67%  87.33%  74.13% 

n/a 

0.00% 

0.00% 

0.00%  33.00%  94.33% 

n/a 

n/a 

2014 
$15,942 

n/a 

n/a 

n/a 

n/a 

n/a 

n/a 

n/a 

n/a 

n/a 

100% 

CEO single total figure 
for remuneration 
($’000) (1) 
     Joe Pignato(2) 
Annual incentive 
bonus award pay-out 
(% of maximum)(3) 
LTIP award vesting (% 
of maximum)(4) 
US Stock Plan award 
vesting (% of 
maximum)(5) 

Notes: 

(1)  With respect to 2019, the figures represent the remuneration to Joseph Pignato his appointment as 
Co-CEOs on 10 June 2019.  With respect to 2020, the figures represent the remuneration for Joseph 
Pignato for the full year. 

(2)  The 2019 figures for Mr. Pignato include the payments made to him under the Phantom Plan resulting 
from a successful portfolio company liquidity event in 2019 (as further described on page 86 of the 
2019 Annual Report and Accounts).  As illustrated on in the 2019 Annual Report and Accounts, the 
single total figure of remuneration excluding the Phantom Plan payment for each such individual was 
$673,000. 

(3)  With  respect  to  2015,  2014  and  2013,  the  percentage  of  maximum  is  not  applicable  because  the 
Company did not have any cap on incentive bonus award payments in those financial years.  As a 
percentage of base salary, the award was 65.7% in 2013, 125.0% in 2014 and 105.0% in 2015.  

(4)  No  performance-based  equity  awards vested to the CEO  under  the  LTIP  during  2020,  2019,  2016, 

2015, 2014 or 2013.   

(5)  All equity awards, including stock options and restricted stock, under the US Stock Plan became vested 

and fully exercisable, or vested and fully transferable, in connection with the IPO.  

74 

 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT AND GOVERNANCE  

Change in remuneration of Chief Executive Officer compared to US Group employees 

The table below sets out the increase in total remuneration of the Chief Executive Officer (Mr. Pignato), 
Non-Executive Directors and that of our US Group employees (excluding Directors) from 2020 to 2021.  
Our US Group employees were chosen since they are exposed to the same economic factors as the Chief 
Executive Officer, who is also US-based.  

Executive Directors 
Joe Pignato 
Non-Executive Directors 
Harry Rein 
Mark Lerdal(3) 
Bruce Failing 
Average of all US Group 
employees 

2020 to 2021 

Taxable 
benefits 
- 
17.44% 

Incentive 
Bonus 

1.63% 

― 
― 
― 

― 
― 
― 

Salary/fees 

(50%) 
0.00% 

6.67% 
 5.26% 
23.19% 

(6.66)% 

28.72% 

(51.76)% 

*Note, the percentages in the chart above are calculated based on actual fees paid to each individual.  
There have been several changes to the Board of Directors and management team as set forth below.  
The base salary for the Executive Director and the NED fees for 2020 and 2021 remain constant, as 
further detailed on page 76 below. 

(1)  Mr. Lerdal resigned as a Non-Executive Director effective as of 10 March 2021. 

Relative importance of spend on pay 

The chart below shows the total employee costs, and change in share price from 2020 to 2021. 

The information shown in this chart is based on the following: 

  Total employee pay: Total US Group employee staff costs from note 5 to the consolidated financial 
statements,  including  salaries  and  wages,  payroll  taxes,  healthcare  benefit,  and  share-based 
payments. 

  Returns to shareholders: Since the Group does not currently pay an annual dividend, returns to 
shareholders are represented by the change in the Group’s share price over the period from 31 
December 2020 to 31 December 2021.  

75 

 
 
 
 
 
 
 
 
 
 
MANAGEMENT AND GOVERNANCE  

39.7

32.5

21.4

8.5

6.3

Total employee costs ($)

Share price (p)

Special dividend

2020

2021

Statement of implementation of remuneration policy in the following financial year (2021) 

The Committee reviewed the remuneration approach in the year,  including the implementation of the 
changes  to  the  operation  of  the  remuneration  programme  made  in  2019  and  their  continued 
appropriateness,  and  input  was  received  from  the  Executive  Director  while  ensuring  that  conflicts  of 
interest were suitably mitigated. The approach to operation for 2021 has been set out below. 

Executive Director 

Given  the  announced  departure  of  the  Executive  Director,  no  changes  were  made  to  the  individual’s 
remuneration in 2021. Details of the resignation arrangements for the Executive Director are set out on 
pages 77 to 78. 

Chairman and Non-Executive Directors 

The 2021 fee arrangements of the Chairman and Non-Executive Directors remain unchanged from 2020: 

Cash Component 
Non-Executive Director Annual Fee 
Audit Committee Chair Annual Fee 
Remuneration Committee Chair Annual Fee 
Nomination Committee Chair Annual Fee 
Chairman of the Board Annual Fee 
Equity Component 
Non-Executive Director LTIP Award Value 
Chairman of the Board LTIP Award Value 

2020 

$75,000 
$25,000 
$10,000 
$10,000 
$75,000 

$50,000 
$75,000 

The additional fee for serving as Chairman shall only be payable where the Chairman is a Non-Executive 
Director.    Given  the  US-based  nature  of  the  Group’s  business,  and  the  need  to  attract  and  retain 

76 

 
 
 
 
 
 
 
MANAGEMENT AND GOVERNANCE  

independent directors with significant US business and leadership experience, the fees above include an 
equity component, which is subject to time-based vesting over three years. 

Service Contracts and Letters of Appointment  

The Executive Director’s  contracts do not provide for extended notice periods or compensation in the 
event of a change of control.  Details on the treatment of remuneration on loss of office or on a change 
of control are provided in the Remuneration Policy.     

The Non-Executive Directors have letters of appointment, which are for an initial fixed term of three years.  
The letters are reviewed and may be extended, and are terminable on one months’ notice by either party.  

The letters of appointment do not provide for any compensation on termination, other than payment of 
fees accrued or owing but not yet paid.  

The letters of appointment and service contracts are available for inspection at the Company’s registered 
office.  In accordance with the Code, all Directors submit themselves for election at the first AGM following 
their appointment to the Board, and for annual re-election by shareholders at each AGM. 

Resignation of Joseph Pignato   

As previously noted, with effect from 14 January 2021, Mr. Pignato resigned as Chief Executive Officer 
and as an Executive  Director of the  Company.   He continued  to serve as Chief Financial Officer of the 
Company for an interim period until 14 April 2021. 

The Remuneration Committee approved the arrangements below which are in line with the terms of the 
agreements  with  Mr.  Pignato  and  the  Company’s  Remuneration  Policy  approved  by  the  Company’s 
shareholders at the 2019 AGM, and as disclosed in full in the Company’s Section 430(2B) announcement 
on 15 January 2021.    

Pursuant to the terms of Mr. Pignato’s service contract, he will be entitled to: 

  payment of one year’s salary equal to $500,000 based on his rate of annual base salary;  

 

an  annual  incentive  award  for  2021  which  will  be  equal  to  the  product  of:  (A)  $373,360  (his 
average annual bonus for the three full years preceding his resignation) and (B) a fraction, the 
numerator of which is the number of days he was employed by the Company during 2021 and the 
denominator of which is the number of days in such year; and 

  participation  at  the  Company’s  expense  under  COBRA  for  six  months  for  him  and  each  of  his 
eligible  dependents  in  all  medical,  dental,  hospitalization  and  other  employee  welfare  benefit 
plans, programmes and arrangements covered by COBRA. 

Prior to the Resignation Date, Mr. Pignato had outstanding awards in the form of units (“Phantom Units”) 
granted  under  the  Allied  Minds  Phantom  Plan  (“Phantom  Plan”),  details  of  which  are  set  out  in  the 
Company’s Annual Report and Accounts for the year ended 31 December 2019.  The Phantom Units are 
settled in cash.  

As  set  out  in  the  Annual  Report  and  Accounts  for  the  year  ended  31  December  2019,  during  2019, 
Executive Directors and all current employees voluntarily agreed to introduce an underpin that $109.2 
million of gross proceeds (plus any future additional invested capital) must  be generated from one or 

77 

 
MANAGEMENT AND GOVERNANCE  

more liquidity events prior to any future allocations of proceeds in connection with an individual liquidity 
event under the Phantom Plan and to a personal cap (set at 25% for Executive Directors) of any allocated 
proceeds in connection with an individual liquidity event under the Phantom Plan.  As of the date hereof, 
Mr. Pignato’s total units would entitle him to his capped amount of 25% of any allocated bonus proceeds.  
In accordance with the terms of his Phantom Units, for the period ending on the date falling 24 months 
after  his  employment  terminates, Mr. Pignato will  remain  entitled  to  a  proportion of  the  payment  he 
would have received on a Liquidity Event had he remained an employee.  That proportion is 90% if the 
Liquidity Event occurs within 6 months after his employment termination date, 75% if 7-12 months after 
his employment termination date; 50% if 13-18 months after his employment termination date; 25% if 
19-24  months  after  his  employment  termination  date,  and  0%  if  later  than  24  months  after  his 
employment termination date.  

As at 31 December 2021, no payments were due to Mr. Pignato under the Phantom Plan.  

No further payments will be made to Mr. Pignato in connection with his resignation.  

Staff retention plan 

During 2021 the Board put in place a retention plan for the remaining full time employees at Allied Minds.  
They were paid a retention bonus of 50% of their base salaries payable in two tranches.  The first half was 
paid assuming they were still employed on 30 September 2021 and the second half will be paid assuming 
they are still employed on 30 April 2022.   

The Board has also put a similar program in place for 2022.  All employees will be paid a retention bonus 
of 100% of their base salaries assuming they are still employed on 30 April 2023.   

Limits on the number of shares used to satisfy share awards (dilution limits) 

All of the Group’s incentive schemes that contain an element that may be satisfied in Allied Minds plc 
shares  incorporate  provisions  that  in  any  ten-year  period  (ending  on  the  relevant  date  of  grant),  the 
maximum number of the shares that may be issued or issuable under all such schemes shall not exceed 
10%  of  the  issued  ordinary  share  capital  of  the  Company  from  time  to  time  (excluding  shares  issued 
pursuant to awards granted prior to IPO under the US Stock Plan). 

The  Committee  regularly  monitors  the  position  and  prior  to  the  making  of  any  share-based  award, 
considers the effect of potential vesting of outstanding awards to ensure that the Company remains within 
these limits.  Any awards which are required to be satisfied by market purchased shares are excluded from 
such calculations.  No treasury shares were held or utilised in the year ended 31 December 2021. 

Remuneration Committee: details and governance 

The full terms of reference of the Committee, which are reviewed annually, are available on the Group’s 
website at www.alliedminds.com.  In summary, the Remuneration Committee has specific responsibility 
for  advising  the  Board  on  the  remuneration  and  other  benefits  of  the  Executive  Director  and  senior 
management,  an  overall  policy  in  respect  of  remuneration  of  other  employees  of  the  Group  and 
establishing the Group’s policy with respect to employee incentivisation schemes. 

The  Remuneration  Committee  is  currently  comprised  of  the  following  independent  Non-Executive 
Directors, whose backgrounds and experience are summarised on pages 26 to 27: 

78 

 
 
MANAGEMENT AND GOVERNANCE  

  Bruce Failing (Chair) 
  Harry Rein 

Messrs.  Rein  and  Failing    served  during  the entire  financial  year.    Mr.  Lerdal  resigned  from the  Board 
effective as of 10 March 2022. 

Committee meetings are administered and minuted by the Company Secretary.   

Key  activities  carried  out  by  the  Committee    during  2021  are  set  out  in  the  Committee  Chairman’s 
statement on pages 56 to 59.  

External advisers 

The Remuneration Committee is authorised, if it wishes, to seek independent specialist services to provide 
information and advice on remuneration at the Company’s expense, including attendance at Committee 
meetings. 

During the year, the Remuneration Committee continued its review of executive remuneration and took 
into consideration professional advice from Deloitte LLP.  Fees paid to Deloitte LLP in connection with 
advice to the Remuneration Committee in 2021 were $27,744 USD (2020: $30,242).  Deloitte provided no 
other services or advice to the Group during the year.  The Remuneration Committee is satisfied that the 
advice  given  is  objective  and  independent.  Deloitte  LLP  is  a  founding  member  of  the  Remuneration 
Consultants Group and adhere to its Code of Conduct in relation to executive remuneration consulting in 
the UK. 

Statement of voting at general meeting 

The table below sets out the proxy results of the vote on the Group’s Remuneration Report at the Group’s 
2021 AGM and the Remuneration Policy at the Group’s 2019 AGM:  

Votes for 

Votes against 

Remuneration Report 
Remuneration Policy 

Number 
93,703,754 
129,448,525 

% of 
cast 
votes 

Number 
61.06 %  59,747,294 
85.13%  22,612,862 

% of 
Votes 
cast 
withheld 
votes 
38.94 % 
2,781,471 
14.87%  152,061,387  19,409,374 

Votes cast 
153451048 

As set out in the Statement of the Committee Chairman, the Committee was disappointed that there was 
a significant minority of votes against the Remuneration Report at the 2021 AGM.  

Overall,  the  Committee  considered  that  the  remuneration  programme, 
including  the  changes 
implemented in 2019 that came into effect for 2020, continued to be broadly appropriate and aligned 
with the Company’s revised strategy while balancing typical UK-listed market practice with US practice in 
our market for talent.  In line with our commitment to maintaining an open and transparent dialogue with 
shareholders, the Company consulted with its major shareholders in the second half of 2020 to gain their 
input.  

After extensive engagement with its major shareholders, the Board noted that shareholder concerns were 
primarily focused on remuneration schemes in place for 2019 and prior which have since been addressed 

79 

 
 
 
 
 
 
MANAGEMENT AND GOVERNANCE  

through the substantial amendments the Company made to its remuneration programme for 2020 and 
onwards.    The  Committee  believes  that  such  changes  have  and  continue  to  appropriately  address 
shareholder concerns while supporting the Company’s strategy and aligning Executive Directors’ interests 
directly with shareholders.  

Approval 

This  Directors’  Remuneration  Report,  including  both  the  Remuneration  Policy  and  Annual  Report  on 
Remuneration has been approved by the Board of Directors. 

Bruce Failing 
Chairman of the Remuneration Committee 
14 June 2022 

80 

 
 
 
MANAGEMENT AND GOVERNANCE  

Audit Committee Report 

The Audit Committee plays an integral role in assisting the Board in fulfilling its oversight responsibilities, 
and as a whole, has the competence relevant to the sector in which the Company operates.  In performing 
its  duties,  the  Committee  strives  to  maintain  effective  working  relationships  with  the  Board,  the 
Company’s management and the external auditors.  The Committee reviews the integrity of the financial 
statements  of  the  Group,  reviews  all  proposed  half-yearly  and  annual  results,  and  advises  the  Board 
whether  it  believes  the  annual  report  and  accounts,  taken  as  a  whole,  fairly  present  the  Company’s 
financial position and provide the necessary information to the shareholders of the Company to assess 
the Company’s position and performance, business model, and strategy. 

Membership 

The Committee comprises two independent Non-Executive Directors.  Members of the Committee are 
appointed  by  the  Board.    The  appropriate  members  of  the  Company  and  the  external  auditors  also 
participate in Committee meetings by invitation.  Following the resignation of Mr Lerdal, Mr Failing had 
been appointed as Chair of the Audit Committee on an interim basis pending the recruitment of a new 
non-executive director to step into this role in due course. 

During the year under review, the Chair of the Audit Committee was Mr. Lerdal who had relevant, recent 
financial experience with over thirty years of senior management and executive experience.  Messrs. Rein 
and Lerdal served on the Audit Committee during the entire financial year.   

The Committee met once in 2021, and the external auditors participated in this meeting.  Reflecting the 
meetings for which each member was then appointed to the Committee, all members were present at all 
meetings during the year during their term of service. 

Responsibilities 

The  Committee’s  main  responsibilities  are  to  monitor  the  integrity  of  the  financial  statements  of  the 
Company, including its annual and half-yearly reports and accounts and any other formal announcement 
relating to its financial performance; and reviewing and reporting to the Board on significant  financial 
reporting issues and judgements made and matters communicated to it by the auditor.  The roles and 
responsibilities of the Audit Committee additionally include to: 

•   Review  the  Company’s  internal  financial  controls  and  the  Company’s  internal  control  and  risk 

management systems; 

•   Advise on the need for and monitor and review the effectiveness of the Company’s internal audit 

function; 

•   Make  recommendations  to  the  Board,  for  it  to  put  to  the  shareholders  for  their  approval  in 
general  meeting,  in  relation  to  the  appointment  of  the  external  auditor  and  to  approve  the 
remuneration and terms of engagement of the external auditor; 

•   Review and monitor the external auditor’s independence and objectivity and the effectiveness of 
into  consideration  relevant  UK  professional  and  regulatory 

the  audit  process,  taking 
requirements; 

81 

 
MANAGEMENT AND GOVERNANCE  

•   Develop and implement policy on the engagement of the external auditor to supply non-audit 
services,  taking  into  account  relevant  ethical  guidance  regarding  the  provision  of  non-audit 
services by the external audit firm; and to report to the Board, identifying any matters in respect 
of which it considers that action or improvement is needed, and making recommendations as to 
the steps to be taken;  

  Conduct  a performance evaluation of the Committee annually, including review of Committee 
member experience and background, and discussion by the Board of each Committee member as 
further described  on  page  42,  to ensure  that it  continues  to be  effective and that each of the 
Directors  on  the  Committee  demonstrates  commitment  to  his  or  her  respective  role  and  has 
sufficient time to meet his or her commitment to the Company; and 

•   Report to the Board on how it has discharged its responsibilities. 

As  a  whole,  the  Committee  has  the  relevant  experience  and  skills  necessary  to  effectively  execute  its 
responsibilities.  The Committee carries out these duties for the Company, major subsidiary undertakings 
and the Group as a whole, as appropriate.  In 2021, the Committee discharged all such duties as further 
described below, including, without limitation, completing an annual review of its internal controls and 
risk management systems with its external auditors and reviewing the Financial Position, Prospects and 
Procedures of the Company on an ongoing basis throughout the year to enable the Board to make proper 
judgements. 

Activities during the year 

The Committee’s activities for the year ended 31 December 2021 included the responsibilities set forth 
above, as well as the items set forth below: 

Financial reporting 

•   Reviewed and approved the appropriate audit plan, before the start of the annual audit cycle; 

•   Reviewed and provided comments and recommendations in respect of the financial statements 
in the half-yearly report for the period ended 30 June 2021, and the financial statements in the 
Annual Report and Accounts for the year ended 31 December 2021; 

•   Reviewed  the  Company’s  approach  and  methodology  for  determining  the  fair  value  of 
investments and the preferred share liability.  Considered and recommended the involvement of 
an external valuation specialist firm to assist management and the Board in deriving the fair value 
of the subsidiary undertakings; and 

•   Considered  significant  matters,  risk  areas,  and  areas  of  judgement  in  relation  to  the  Group’s 
financial statements taking into account the areas highlighted by the external auditors in their 
presentations to the Committee, and challenged where necessary. 

The Committee is satisfied with the integrity of the financial statements of the Company in all material 
aspects,  including  the  application  of  significant  accounting  policies,  the  methods  used  to  account  for 
significant transactions, use of judgements and estimates made by management, including those made in 
deriving the fair value of the subsidiary undertakings, and the quality and completeness of the disclosures 
in the financial statements of the Company.   

82 

 
MANAGEMENT AND GOVERNANCE  

The Committee is satisfied that this Annual Report as a whole is fair, balanced and understandable, and 
provides the information necessary for a reasonable shareholder to assess the Company’s position and 
performance, business model and strategy.  

Internal controls and risk management systems 

•   Reviewed the principal elements of the Company’s  risk management  framework  as set out on 
pages 19 to 25 of this Annual Report.  The Committee gives consideration and provides guidance 
on enhancing the internal controls and risk management framework, as needed; 

•   Reviewed the established procedures, which provide a reasonable basis for the Board to make 
proper judgements on an ongoing basis as to the Financial Position, Prospects and Procedures 
(FPPP) of the Company following the adopted risk approach; and 

•   Reviewed  the  whistleblower  policy  that  was  established  and  approved  by  the  Board  in  2014, 
which has been communicated to employees.  The Audit Committee is satisfied that the policy 
has been designed to encourage staff to report suspected wrongdoing as soon as possible, provide 
staff with guidance on how to raise those concerns, and ensure staff that they should be able to 
raise genuine concerns without fear of reprisals, even if they turn out to be mistaken. 

Significant areas reported to the Board   

Fair value of financial assets and liabilities held under IFRS9 

Significant judgements are made in valuing the assets and liabilities and complex models are used to give 
a fair value, which present a high risk for the financial statements.  

Judgment on whether the Company has significant influence under IAS28 

There is a significant judgement in relation to whether the shares are accounted for as an investment in 
associate per IAS 28. This judgement includes, among others, an assessment of whether the Company has 
representation on the board of directors of the investee, whether the Company participates in the policy 
making processes of the investee, whether there is any interchange of managerial personnel, whether 
there  is any essential technical information provided to the investee and if there are any transactions 
between the Company and the investee. 

Accounting treatment of investments under IFRS10 

It has been determined that the Group no longer has control as defined in IFRS 10 but has maintained 
significant influence over some of its former subsidiaries and due to the fact that the Group holds a variety 
of  instruments  in  these  entities,  which  have  varying  risks  and  rights,  there  is  significant  judgement  in 
relation to the accounting for these instruments.  The valuation of these financial assets also includes a 
significant  level  of  judgement  and  external  valuation  specialists  are  utilised  in  this  process.    The 
Committee believes that the Group considered the pertinent terms and accurate accounting of each of 
the financial instruments (and sought external expertise as well). 

Viability 

The Committee reviewed the Company’s viability as further stated in the Overview on pages 32 to 33.  As 
previously  reported,  the  Company’s  strategic  objective  is  to  focus  exclusively  on  its  existing  portfolio 

83 

 
MANAGEMENT AND GOVERNANCE  

companies and to maximise  total returns to all shareholders  from monetisation of such portfolio.  The 
Board resolved, in March 2022, to undertake  a formal review of the Company's strategic options (the 
“Strategic Review”) including, but not limited to, a sale of the Company itself, which the Board intends to 
conduct  under  the  framework of  a  “Formal  Sale Process"  in  accordance  with Rules  2.4  and 2.6 of the 
Takeover Code, alternatively, to seek to distribute certain assets and any cash reserves directly back to 
shareholders  through  a  re-structure.  The  Strategic  Review  is  solely  aimed  at  creating  and/or  realising 
shareholder value. In line with this strategy, the Board anticipates delivering such returns within the next 
three  years.    After  careful  assessment  of  the  Company’s  cash  position  and  projections  through  such 
period, the Committee reasonably expect the Group to continue in operation and meet its liabilities as 
they fall due in order to execute on this strategy during such period. 

Impact of coronavirus pandemic and Going concern 

There is judgement  relating to whether the Group and Company have  sufficient  financial resources to 
continue as a going concern based on the Group and Company’s business model and other applicable 
factors that may impact such determination.  As previously noted, the impact of the coronavirus pandemic 
has the potential to negatively impact the Group’s and the Company’s financial position.  However, the 
Group continues to closely monitor the pandemic, its impact on its workforce, the global economy and its 
suppliers, customers  and partners  in order  to make decisions and take meaningful actions to mitigate 
against disruption to operations across the portfolio and the potential negative financial impact.  Taking 
all factors into consideration, management have assessed that the Group and Company continue to be a 
going concern and the Committee is satisfied with the assessment made.  

External audit 

•  Engaged in competitive process for determining the Group’s new independent auditor, including 

assessing and performing diligence on various independent audit firms. 

 •  Recommended the appointment of BDO LLP to the Board as the Group’s independent auditor for 

the financial year ending 31 December 2021.     

•   Reviewed and approved the scope of the procedures over the half-yearly report for the period 
ended 30 June 2021, and the Annual Report and Accounts for the year ended 31 December 2021; 

•   Discussed  with  management  and  agreed  upon  the  terms  of  the  engagement  of  the  external 
auditors  and  the  auditors’  remuneration  for  audit  and  non-audit  services.    In  assessing 
independence, the Audit Committee received the auditor’s presentation and confirmation that in 
its  professional  judgment,  BDO  LLP  (from  its  engagement  on  12  May  2021),  are  independent 
within the meaning of regulatory and professional requirements and the objectivity of the partner 
and audit staff is not impaired.  The Committee was satisfied that throughout the year that the 
objectivity and independence of BDO LLP, as applicable, was not in any way impaired by the non-
audit services they provided to the Group during the year, by the amounts of non-audit fees, or 
by any other factors; 

•   Assessed the independence, objectivity and qualifications of BDO LLP as the external auditor and 
evaluated  the  quality  and  effectiveness  of  the  audit  procedures.    In  doing  so,  the  Committee 
reviewed  the  audit  plan  and  monitored  performance  against  the  plan,  reviewed  the  periodic 
reports of BDO LLP to the Committee that highlighted key areas of focus during the audit and the 

84 

 
MANAGEMENT AND GOVERNANCE  

applied audit approach, and obtained feedback from the finance department in respect to quality 
and status of BDO LLP work in the course of the audit.  The Committee concluded that the audit 
process during the year was effective; and 

•   Reviewed and discussed the principal areas of financial reporting risk, as highlighted above, and 

reported to the Board. 

  In  2021,  the  Committee  reviewed  the  performance  of  the  independent  auditor  and  after  careful 
consideration and deliberation, the Committee determined that BDO LLP’s performance asindependent 
auditor was satisfactory and recommended to the Board that the retention of BDO LLP as independent 
auditors of  the  Company  remained  in the  best  interests  of  the  Company’s  shareholders.    Accordingly, 
upon recommendation by the Committee, which was free from influence by any third party, the Board 
approved  the  appointment  of  BDO  LLP  as  the  Company’s  auditor  for  the  financial  year  ending  31 
December  2021.    No  contractual  term  of  the  kind  under  the  Audit  Regulations  was  imposed  on  the 
Company.  The total fees to BDO LLP for the year ended 31 December 2021 were $526,000 USD (see note 
5 of the consolidated financial statements, which includes the breakdown of audit and non-audit related 
fees). Given the  appointment of BDO LLP in 2021, the next anticipated requirement to tender audit will 
be for the 2030 calendar year.  As such, the Company is complying with the Statutory Audit Services Order. 

Internal audit 

Given the size and composition of the Group, taking into account relevant significant matters, risk areas, 
areas of judgement in relation to the Group’s financial statements, and that all Group financial systems, 
transactions, and processes are conducted at the central office, the Board did not consider it necessary to 
have an internal audit function during the year.  The Board will keep this decision under annual review. 

Bruce Failing 
Chairman of the Audit Committee 
14 June 2022 

85 

 
 
 
Independent auditor’s report to the members of Allied Minds Plc 

Opinion on the financial statements 

In our opinion: 

• 

• 

• 

• 

the financial statements give a true and fair view of the state of the Group’s and of the 
Parent Company’s affairs as at 31 December 2021 and of the Group’s loss for the year 
then ended; 
the  Group  financial  statements  have  been  properly  prepared  in  accordance  with  UK 
adopted international accounting standards; 
the  Parent Company financial statements have been properly  prepared  in  accordance 
with UK adopted international accounting standards and as applied in accordance with 
the provisions of the Companies Act 2006; and 
the financial statements have been prepared in accordance with the requirements of the 
Companies Act 2006. 

We  have  audited  the  financial  statements  of  Allied  Minds  Plc  (the  ‘Parent  Company’)  and  its 
subsidiaries  (the  ‘Group’)  for  the  year  ended  31  December  2021,  which  comprise  the 
Consolidated  Statement  of  Comprehensive  (Loss),  the  Consolidated  Statement  of  Financial 
Position, the Consolidated Statement of Changes in Equity, the Consolidated Statement of Cash 
Flows, the Company Balance Sheet, the Company Statement of Changes in Equity, the Company 
Statement of Cash Flows and notes to the financial statements, including a summary of significant 
accounting policies. The financial reporting framework that has been applied in their preparation 
is applicable law and UK adopted international accounting standards, and as regards the Parent 
Company financial statements, as applied in accordance with the provisions of the Companies 
Act 2006. 

Basis for opinion 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) 
and  applicable  law.  Our  responsibilities  under  those  standards  are  further  described  in  the 
Auditor’s responsibilities for the audit of the financial statements section of our report. We believe 
that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our 
opinion. Our audit opinion is consistent with the additional report to the audit committee.  

Independence 

Following the recommendation of the audit committee, we were appointed by the Directors on 4 
August  2020  to  audit  the  financial  statements  for  the  year  ended  31  December  2020  and 
subsequent financial periods. The period of total uninterrupted engagement is 2 years, covering 
the years ended 31 December 2020 to 31 December 2021. We remain independent of the Group 
and  the  Parent  Company  in  accordance  with  the  ethical  requirements  that  are  relevant  to  our 
audit of the financial statements in the UK, including the FRC’s Ethical Standard as applied to 
listed public interest entities, and we have fulfilled our other ethical responsibilities in accordance 
with these requirements. The non-audit services prohibited by that standard were not provided to 
the Group or the Parent Company.  

Conclusions relating to going concern 

In  auditing  the  financial  statements,  we  have  concluded  that  the  Directors’  use  of  the  going 
concern  basis  of  accounting  in  the  preparation  of  the  financial  statements  is  appropriate.  Our 
evaluation  of  the  Directors’  assessment  of  the  Group  and  the  Parent  Company’s    ability  to 
continue to adopt the going concern basis of accounting included: 

  a detailed audit of forecasts prepared by the Directors for a period of at least 12 months 

from the date of approval of the financial statements; 

  a review of stressed forecasts, as prepared by the Directors, which detailed the changes 
of key assumptions which would lead to the business no longer being a going concern. 

 
 
 
 
 
 
 
 
 
 
 
As  part  of  this  we  reviewed  the  likelihood  of  these  changes  against  documentation 
provided by the Directors and from external sources;  

  We have assessed the accuracy of the Directors’  forecasts by confirming the accuracy 
of historic forecasts, corroborating the inputs to supporting documentation and agreeing 
expected changes from historic actuals; and 

  we carried out discussions with management and board members to challenge the future 
outlook (including the impact of recent board resignations) and cash commitments of the 
Group  and  how  these  had  been  included  within  the  forecasts  reviewed  and  further 
potential impacts on the forecasts. 

Further details of the Directors’ assessment of going concern is provided in note 1. 

Based on the work we have performed, we have not identified any material uncertainties relating 
to events or conditions that, individually or collectively, may cast significant doubt on the Group 
and the Parent Company’s ability to continue as a going concern for a period of at least twelve 
months from when the financial statements are authorised for issue.  

In relation to the Parent Company’s reporting on how it has applied the UK Corporate Governance 
Code, we have nothing material to add or draw attention to in relation to the Directors’ statement 
in  the  financial  statements  about  whether  the  Directors  considered  it  appropriate  to  adopt  the 
going concern basis of accounting. 

Our  responsibilities  and  the  responsibilities  of  the  Directors  with  respect  to  going  concern  are 
described in the relevant sections of this report. 

Overview 

Coverage1 

Key audit matters (‘KAM’) 

100% (2020: 100%) of Group profit before tax 
100% (2020: 100%) of Group revenue 
100% (2020: 99%) of Group total assets 

2021 

2020 

X 

X 

- 

X 

- 

X 

of 
and 
share 

of 
previously 

KAM 1 
Valuation 
investments 
preference 
liabilities 
KAM 2 
Deconsolidation 
entities 
consolidated 
KAM 3 
Consolidation 
and 
accounting 
judgement  of 
the 
Group  not  meeting 
for  an 
the  criteria 
investment 
entity 
(2020  only:  as  it  was 
adequately addressed in 
the  prior  year  audit  and 
there  have  been  no 
changes  expected  to  be 
made or actually made to 
management’s 
judgement in the year). 

Materiality 

Group financial statements as a whole 
$1.141m (2020: $1.1662m) based on 2% (2020: 2%) of net 
assets 

1 These are areas which have been subject to a full scope audit by the group engagement team 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
An overview of the scope of our audit 

Our Group audit was scoped by obtaining an understanding of the  Group and its environment, 
including the Group’s system of internal control, and assessing the risks of material misstatement 
in  the  financial  statements.    We  also  addressed  the  risk  of  management  override  of  internal 
controls, including assessing whether there was evidence of bias by the Directors that may have 
represented a risk of material misstatement. 

The Group comprises 4 components: one incorporated UK company, being a holding company 
and,  which  were  deemed  significant  components  and  3  significant  non-UK  (and  all  USA) 
components; the remaining entities were deemed non-significant.  

In  establishing  the  overall  approach  to  the  Group  audit,  we  assessed  the  audit  significance  of 
each component in the Group by reference to both its individual financial significance to the Group 
or other specific nature or circumstances. The four identified individually significant components, 
makes up 100% of Group loss before tax and also covers 100% of the total assets of the Group. 
Separate to the four significant components we carried out specified audit procedures on the one 
investment which is equity accounted for, to Group materiality. 

The  significant  components  were  located  in  the  UK  and  the  USA.  The  significant  component 
incorporated  in  the  UK  had  its  books  and  records  held  in  the  USA  alongside  the  entities  
incorporated in the USA and therefore, all the entites were subject to a full scope audit, with the 
support of our network member firm in the USA, with the oversight of the Group auditor. 

For components of the Group not considered to be significant components the component audtior 
performed specified audit procedures over areas considered to be significant risks to the Group 
audit.  Furthermore,  the  Group  auditor  has  been  responsible  for  directing  all  the  audit  work 
completed, the audit risks identified, the audit of the consolidation and the contents of the annual 
report  and  disclosures  accompanying  the  consolidated  and  Parent  Company  financial 
statements. 

Our involvement with component auditors 

For the work performed by component auditors, we determined the level of involvement needed 
in order to be able to conclude whether sufficient appropriate audit evidence has been obtained 
as a basis for our opinion on the Group financial statements as a whole. Our involvement with 
component auditors included the following: 

We  provided  instructions  to  the  component  auditor  setting  out  the  risks  and  procedures  to  be 
performed as part of their full scope audit, reporting to us on the significant components and equity 
investments accounted for in this territory, and determined appropriately scoped risks, procedures 
and agreed responses to those risks with the component audit team. 

We held planning meetings with the component team to discuss the component risk assessment 
including materiality, and overall reporting process that was then communicated formally in Group 
audit  instructions.  Our  instructions  required  a  number  of  reporting  deliverables  including  the 
component auditor opinion that was received and reviewed. We took an active part in reviewing 
the work performed; this was performed both on site and remotely with the component auditor in 
attendance or both methods.  

This,  together  with  the  additional  procedures  performed  at  Group  level  over  the  consolidation 
process gave us the evidence we needed for our opinion on the financial statements as a whole. 

 
 
 
 
 
 
 
 
Key audit matters 

Key audit matters are those matters that, in our professional judgement, were of most significance 
in  our  audit  of  the  financial  statements  of  the  current  period  and  include  the  most  significant 
assessed risks of material misstatement (whether or not due to fraud) that we identified, including 
those which had the greatest effect on: the overall audit strategy, the allocation of resources in 
the audit, and directing the efforts of the engagement team. These matters were addressed in the 
context of our audit of the financial statements as a whole, and in forming our opinion thereon, 
and we do not provide a separate opinion on these matters. 

Key audit matter  

1 

of 

Valuation 
investments 
and  preference 
share liabilities 
Note 
Financial 
instruments  and 
value 
Fair 
measurement 
policies,  Note  11 
and 16 

– 

financial 

The 
statements 
include significant investment 
assets  and  preference  share 
liabilities which are held at fair 
value under IFRS 9.  

to 

made 

the  number  of 
Due 
judgements  and 
significant 
estimates 
by 
management  in  valuing  the 
assets  and  liabilities,  as  well 
complexity of the models used 
to give a fair value, there is a 
high 
of  material 
misstatement.  

risk 

in 

the 

Due  to  the  complexity  of  the 
disclosure 
financial 
statements,  the  disclosures 
made are considered to be a 
significant  risk  of  material 
misstatement 

This  was 
identified  as  a 
significant  risk  as  part  of  the 
audit planning and a key audit 
matter  to  be  included  in  the 
audit report. 

How the scope of our audit addressed 
the key audit matter 
The work carried out on the risk identified 
was a follows: 
  Use of an auditor’s internal expert in 
valuations  prepared  under  IFRS9  to 
review the models used to value the 
investments  and  preference  share 
liability in order to determine whether 
they  were  aligned  with  recognised 
valuation models and that they were 
appropriate for valuing the underlying 
investment or liability. 

  A  re-performance  of  the  numerical 
and arithmetic accuracy of the model 
compared  with  the  inputs  used  to 
ensure  the  final  output  value  was 
accurately calculated. 

agreement 

  A review of the inputs into the models 
and 
supporting 
evidence  to  corroborate  whether  the 
inputs  were 
and 
appropriate. 

reasonable 

to 

information 

  Challenged  management  on  all 
judgemental  or estimated  inputs  into 
the models to determine whether they 
appear  reasonable 
in  respect  of 
from 
corroborating 
management and third party sources. 
  Carried  out  sensitivity  analysis  in 
respect  of  the  key  and  judgemental 
inputs into the models to understand 
potential impacts on  the valuation  of 
the underlying instruments. 
the  disclosure 

  Reviewed 

in 

the 
annual  report  to  understand  if  this 
the  underlying 
was  aligned  with 
calculation from the models used and 
that  all  information  of  importance  to 
the  users  of 
the  accounts  was 
adequately  disclosed  in  accordance 
with  the  accounting  standards.  We 
have  also  agreed  the  disclosure  is 
aligned  to  the  accounting  policy  as 
disclosed in the annual report. 

Key observations: 
Based  on 
consider 

that 

the  work  performed  we 
the 
investments  and 

 
 
 
 
 
 
 
Deconsolidation 
of  entities  no 
longer 
consolidated 

Note 11 

During the period the Group 
lost control and significant 
influence over one of the 
consolidated entities 
following a funding round, 
further to this the Group also 
disposed of and 
deconsolidated an entity 
following their share of the 
business being sold in a 
stock for stock exchange. 

There are a significant 
number of judgements and 
estimates made by 
management as part of the 
accounting treatment, 
including the value of the 
residual investment held, 
whether they maintain any 
significant influence in the 
entities, the value of assets 
and liabilities at the date of 
the deconsolidation.  

in 

the 

Due  to  the  complexity  of  the 
disclosure 
financial 
statements,  the  disclosures 
made are  considered to be a 
significant  risk  of  material 
misstatemetn 

This  was 
identified  as  a 
significant  risk  as  part  of  the 
audit planning and a key audit 
matter  to  be  included  in  the 
audit report.  

liability  have  been 
preference  share 
valued  appropriately  and  in  accordance 
with  the  Group’s  accounting  policy  for 
these financial statement areas.  

The work carried out on the risk identified 
was a follows: 

  Use of an auditor’s internal expert in 
valuations prepared under IFRS 9 to 
review the models used to value the 
residual investments held which have 
been  used  to  calculate  the  gain  on 
disposal  and  deconsolidation  of  the 
the 
entities.  By  determining 
that 
valuations  were 
aligned  with 
recognised valuation models and that 
they were appropriate for valuing the 
underlying 
the 
have 
date 
transaction 
reperformed  the  calculation  for  the 
fain on reconcolidation. 

investment  as  at 

we 

  Audit procedures on the fair value of 
the  assets and  liabilities disposed  of 
at  the  transaction  date  in  the  former 
subsidiary company. 

the 

required 

journal  entries 

  A reperformance and recalculation of 
the 
to 
correctly  recognise  the  transactions 
in 
financial 
consolidated 
statements  and  corroboration  of  all 
journals 
the 
consolidationfor  reasonableness  in 
line  with  the  understanding  of  the 
transactions obtained.. 

posted 

in 

  Agreed  that  the  transactions  are 
accurately  and  clearly  disclosed  in 
the financial statements. 

Key observations: 
Based  on 
the  work  performed  we 
consider  that  the  deconsolidation  of  the 
entities  bas  been  treated  correctly  and 
disclosed  correctly 
financial 
statements. 

the 

in 

Our application of materiality 

We apply the concept of materiality both in planning and performing our audit, and in evaluating 
the effect of misstatements.  We consider materiality to be the magnitude by which misstatements, 
including omissions, could influence the economic decisions of reasonable users that are taken 
on the basis of the financial statements.  

In order to reduce to an appropriately  low  level the  probability that  any misstatements exceed 
materiality, we use a lower materiality level, performance materiality, to determine the extent of 
testing needed. Importantly, misstatements below these levels will not necessarily be evaluated 
as immaterial as we also take account of the nature of identified misstatements, and the particular 

 
 
 
 
 
 
 
 
 
 
 
 
 
circumstances of their occurrence, when evaluating their effect on the financial statements as a 
whole.  

Based on our professional judgement, we determined materiality for the financial statements as 
a whole and performance materiality as follows: 

Materiality 
Basis for 
determining 
materiality 
Rationale for the 
benchmark 
applied 

Performance 
materiality 
Basis for 
determining 
performance 
materiality 

Group financial statements 

Parent company financial 
statements 

2021 
$’000 
1,118 
2% of net 
assets 

2020 
$’000 
1,166 

2021 
$’000 
31 

2% of net assets  2% of net assets 

2020 
$’000 
36 
2% of net 
assets 

The  Parent  Company  benchmark 
was  set  in  line  with  that  of  the 
Group  for  the  individual  Parent 
entity. 

risk  areas 

The  performance  of  the  Group  is 
measured  by  management  based 
on 
the 
the  performance  of 
underlying  investments.  Further, 
the 
as  noted  above,  one  of 
significant 
the 
is 
valuation  of 
investments  and 
preference  share  liabilities  in  the 
Group. These two balances make 
up the majority of the statement of 
financial  position,  indicating  net 
assets 
appropriate 
the 
as 
benchmark. 

671 

699 

19 

22 

Performance  materiality  was 
determined 
to  be  60%  of 
materiality  in  our  work.  This  level 
was  chosen  based  on  our 
understanding  on  the  business 
and  the  nature  of  the  underlying 
activity. Therefore, a a lower level 
of  performance  materiality  was 
used  to  ensure  sufficient  audit 
work 
to  ensure 
sufficient  and  appropraite  audit 
work was carried out on the Group. 

is  completed 

chosen 

basedon 

Performance  materiality  was 
determined 
to  be  60%  of 
materiality  in  our  work.  This  level 
our 
was 
understanding of the company and 
it’s activity, therefore a lower level 
of  performance  materiality  was 
used  to  ensure  sufficient  audit 
work  is  completed  on  the  Parent 
Company. 

Component materiality 

We set materiality for each significant component of the Group based on a percentage of between 
20%  and  90%  (2020:  20%  and  90%)  of  Group  materiality  dependent  on  the  size  and  our 
assessment  of  the  risk  of  material  misstatement  of  that  component.    Component  materiality 
ranged from $923k to $155k (2020: $1,166k to $233k). In the audit of each component, we further 
applied performance materiality levels of 60% (2020: 60%) of the component materiality to our 
testing  to  ensure  that  the  risk  of  errors  exceeding  component  materiality  was  appropriately 
mitigated. 

Reporting threshold   

We agreed with the Audit Committee that we would report to them all individual audit differences 
in excess of $34k (2020:$35k).  We also agreed to report differences below this threshold that, in 
our view, warranted reporting on qualitative grounds. 

 
 
 
 
 
 
 
 
 
 
 
Other information 

The  Directors  are  responsible  for  the  other  information.  The  other  information  comprises  the 
information included in the Annual Report and Accounts other than the financial statements and 
our  auditor’s  report  thereon.  Our  opinion  on  the  financial  statements  does  not  cover  the  other 
information and, except to the extent otherwise explicitly stated in our report, we do not express 
any form of assurance conclusion thereon. Our responsibility is to read the other information and, 
in  doing so, consider  whether the other  information is materially inconsistent  with the financial 
statements  or  our  knowledge  obtained  in  the  course  of  the  audit,  or  otherwise  appears  to  be 
materially  misstated.  If  we  identify  such  material  inconsistencies  or  apparent  material 
misstatements, we are required to determine whether this gives rise to a material misstatement 
in the financial statements themselves. If, based on the work we have performed, we conclude 
that there is a material misstatement of this other information, we are required to report that fact. 

We have nothing to report in this regard. 

Corporate governance statement 

The Listing Rules require us to review the Directors’ statement in relation to going concern, longer-
term  viability  and  that  part  of  the  Corporate  Governance  Statement  relating  to  the  Parent 
company’s compliance with the provisions of the UK Corporate Governance Code specified for 
our review.  

Based on the work undertaken as part of our audit, we have concluded that each of the following 
elements  of  the  Corporate  Governance  Statement  is  materially  consistent  with  the  financial 
statements or our knowledge obtained during the audit.  

Going 
concern  and 
longer-term 
viability 

Other  Code 
provisions  

  The  Directors'  statement  with  regards  to  the  appropriateness  of 
adopting  the  going  concern  basis  of  accounting  and  any  material 
uncertainties identified set out on page 45; and 

  The  Directors’  explanation  as  to  their  assessment  of  the  Group’s 
prospects, the period this assessment covers and why the period is 
appropriate set out on pages 32 and 83. 

  Directors' statement on fair, balanced and understandable set out on 

page 36;  

  Board’s confirmation that it has carried out a robust assessment of the 

emerging and principal risks set out on page 44;  

  The  section  of  the  annual  report  that  describes  the  review  of 
effectiveness of risk management and internal control systems set out 
on page 83; and 

  The section describing the work of the audit committee set out on page 

81. 

Other Companies Act 2006 reporting 

Based on the responsibilities described below and our work performed during the course of the 
audit, we are required by the Companies Act 2006 and ISAs (UK) to report on certain opinions 
and matters as described below.   

Strategic 
report 
Directors’ 
report  

and 

In our opinion, based on the work undertaken in the course of the audit: 

 

 

the information given in the Strategic report and the Directors’ report for 
the  financial  year  for  which  the  financial  statements  are  prepared  is 
consistent with the financial statements; and 
the  Strategic  report  and  the  Directors’  report  have  been  prepared  in 
accordance with applicable legal requirements. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In  the  light  of  the  knowledge  and  understanding  of  the  Group  and  Parent 
Company and its environment obtained in the course of the audit, we have not 
identified material misstatements in the strategic report or the Directors’ report. 

Directors’ 
remuneration 

In our opinion, the part of the Directors’ remuneration report to be audited has 
been properly prepared in accordance with the Companies Act 2006. 

Matters 
on 
which  we  are 
to 
required 
report 
by 
exception 

We have nothing to report in respect of the following matters in relation to 
which the Companies Act 2006 requires us to report to you if, in our opinion: 

 

  adequate  accounting  records  have  not  been  kept  by  the  Parent 
Company, or returns adequate for our audit have not been received 
from branches not visited by us; or 
the Parent Company financial statements and the part of the Directors’ 
remuneration  report  to  be  audited  are  not  in  agreement  with  the 
accounting records and returns; or 
certain disclosures of Directors’ remuneration specified by law are not 
made; or 

 

  we have not received all the information and explanations we require 

for our audit. 

Responsibilities of Directors 

As explained more fully in the Directors’ responsibilities statement, the Directors are responsible 
for the preparation of the financial statements and for being satisfied that they give a true and fair 
view,  and  for  such  internal  control  as  the  Directors  determine  is  necessary  to  enable  the 
preparation of financial statements that are free from material misstatement, whether due to fraud 
or error. 

In preparing the financial statements, the Directors are responsible for assessing the Group’s and 
the Parent Company’s ability to continue as a going concern, disclosing, as applicable, matters 
related to going concern and using the going concern basis of accounting unless the  Directors 
either intend to liquidate the Group or the Parent Company or to cease operations, or have no 
realistic alternative but to do so. 

Auditor’s responsibilities for the audit of the financial statements 

Our objectives are to obtain reasonable assurance about whether the financial statements as a 
whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s 
report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a 
guarantee that  an  audit conducted in  accordance  with ISAs (UK)  will always  detect a material 
misstatement  when  it  exists.  Misstatements  can  arise  from  fraud  or  error  and  are  considered 
material if, individually or in the aggregate, they could reasonably be expected to influence the 
economic decisions of users taken on the basis of these financial statements. 

Extent to which the audit was capable of detecting irregularities, including fraud 

Irregularities,  including  fraud,  are  instances  of  non-compliance  with  laws  and  regulations.  We 
design  procedures  in  line  with  our  responsibilities,  outlined  above,  to  detect  material 
misstatements in respect of irregularities, including fraud. The extent to which our procedures are 
capable of detecting irregularities, including fraud is detailed below: 

  We identify and assess the risks of material misstatement of the financial statements, whether 
due to fraud or error, and then design and perform audit procedures responsive to those risks, 
including obtaining audit evidence that is sufficient and appropriate to provide a basis for our 
opinion. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  We have identified and assessed the potential risks related to irregularities, including fraud, 

by considering the following: 

o  Enquiries of management regarding: the compliance with laws and regulations; the 
detection and response to the risk of fraud and any knowledge of actual, suspected 
or alleged fraud; and the controls in place to mitigate risks related to fraud or non-
compliance with laws and regulations;  

o  We communicated relevant identified laws and regulations and potential fraud risks 
to all engagement team members and the component auditor, who were all deemed 
to have appropriate competence and capabilities, to remain alert to any indications 
of fraud or non-compliance with laws and regulations throughout the audit; and 
o  Obtaining an understanding of the legal and regulatory framework in which the Group 
operates.  The  key  laws  considered  are  accounting  standards,  the  Companies  Act 
2006 and tax legislation. 

  We have responded to risks identified by performing procedures including the following: 

o  Enquiry of management and review of legal correspondence concerning actual and 

potential litigation and claims; 

o  Performing analytical procedures to identify any unusual or unexpected relationships 

which may indicate risks of misstatement due to fraud;  

o  Reading the minutes of meetings of those charged with governance; and 
o  Review of financial statements disclosures and testing to supporting documentation. 

  We have also considered the risk of fraud through management override of controls by: 

o  Testing  on  a  sample  basis  the  appropriateness  of  journal  entries  and  other 

adjustments; and 

o  Assessing  whether  the  judgements  made  in  making  accounting  estimates  are 

indicative of potential bias. 

Our audit procedures were designed to respond to risks of material misstatement in the financial 
statements,  recognising  that  the  risk  of  not  detecting  a  material  misstatement  due  to  fraud  is 
higher  than  the  risk  of  not  detecting  one  resulting  from  error,  as  fraud  may  involve  deliberate 
concealment by, for example, forgery, misrepresentations or through collusion. There are inherent 
limitations in the audit procedures performed and the further removed non-compliance with laws 
and regulations is from the events and transactions reflected in the financial statements, the less 
likely we are to become aware of it. 

A  further  description  of  our  responsibilities  is  available  on  the  Financial  Reporting  Council’s 
website  at:  www.frc.org.uk/auditorsresponsibilities.  This  description  forms  part  of  our  auditor’s 
report. 

Use of our report 

This  report  is  made  solely  to  the  Parent  Company’s  members,  as  a  body,  in  accordance  with 
Chapter 3 of Part 16 of the Companies Act 2006.  Our audit work has been undertaken so that 
we might state to the Parent Company’s members those matters we are required to state to them 
in an auditor’s report and for no other purpose.  To the fullest extent permitted by law, we do not 
accept  or  assume  responsibility  to  anyone  other  than  the  Parent  Company  and  the  Parent 
Company’s members as a body, for our audit work, for this report, or for the opinions we have 
formed. 

Iain Henderson (Senior Statutory Auditor) 
For and on behalf of BDO LLP, Statutory Auditor 
London, UK 
14 June 2022 

BDO LLP is a limited liability partnership registered in England and Wales (with registered number 
OC305127). 

 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS 

For the year ended 31 December 

Note 

Revenue 

Operating expenses: 
Cost of revenue 
Selling, general and administrative expenses 

  Research and development expenses 
  Operating loss 

Other income: 

       Gain on deconsolidation of subsidiary 

Loss on investments held at fair value (net) 

  Other income 

  Other income /(expense) 

Finance income 
Finance cost 
Finance cost from IFRS9/ fair value accounting  

Finance loss, net  

3 

4,5 
4,5 
4,5 

11 
11 
18 

7 
7 
7 

Share of net loss of associates accounted for using the equity method         11 

Taxation 

Loss before taxation 

Loss for the period 

Other comprehensive loss: 
Items that may be reclassified subsequently to profit or loss: 

Foreign currency translation differences 

  Other comprehensive loss, net of taxation 
Total comprehensive loss for the period 

Loss attributable to: 

Equity holders of the parent 

  Non-controlling interests 

Total comprehensive loss attributable to: 

Equity holders of the parent 

  Non-controlling interests 

Loss per share 

Basic 
  Diluted 

98 

23 

15 

15 

8 

8 

2021 
$ '000 

2020 
$ '000 

1,544 

480    

 (443) 
 (10,569) 
 (2,650) 

(12,118) 

 14,213  
(13,894)  
 705  

1,024 
 45  
 (255) 
 (2,578) 

(2,788) 
(2,362) 
(16,244) 
— 

(16,244) 

(41) 

(41) 

(16,285) 

 (15,534) 
 (710) 

(16,244) 

(15,575) 
(710) 

(16,285) 

$ 
(0.06) 

(0.06) 

(210)   
(10,497)   
(4,712)   

(14,939)   

— 
(31,934)   
— 
(31,934)   
291    
(314)   
(1,763)   

(1,786)   
(6,845)   
(55,504) 
— 

(55,504) 

(116)   

(116)   

(55,620) 

(53,025) 
(2,479)  

(55,504) 

(53,141) 
(2,479)  

(55,620) 

$ 
(0.22)   

(0.22)   

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

CONSOLIDATED STATEMENT OF FINANCIAL POSITION 
As of 31 December 

  Note 

2021 
$ '000 

2020 
$ '000 

Non-current assets 

Property and equipment  
Investment at fair value 

    Right-of-use assets 

Other financial assets 
Total non-current assets 
Current assets 

Cash and cash equivalents  
    Trade and other receivables  

Other financial assets 

Total current assets 
Total assets 

Equity 

Share capital 
Treasury shares 
Translation reserve 
Accumulated profit 

Equity attributable to owners of the Company 

Non-controlling interests 

Total equity 
Non-current liabilities 
Lease liabilities  
Loans 

Total non-current liabilities 
Current liabilities 

Trade and other payables 
Deferred revenue 
Loans 

    Preferred shares 
    Lease liabilities  
Total current liabilities 
Total liabilities 
Total equity and liabilities 

9  
11,20 
       19 
20  

12  
13  
20  

14 
14 
14 
14 

14,15 

19 
17,18  

17  
3  
18 
16  
19 

787 
33,984 
414 
44 
35,229 

9,710 
5,912 
5,050 

20,672 
55,901 

3,767 
(738) 
1,302 
40,156 
44,487 
168 
44,655 

213 
— 
213 

1,061 
4,948 
3,109 
1,255 
660 
11,033 
11,246 
55,901 

1,596 
41,588 
651 
581 
44,416 

24,489 
5,816 
                         2,279 

32,585 
77,000 

3,767 
— 
1,343 
55,440 
60,550 
(2,264) 
58,286 

806 
1,440 
2,246 

2,101 
3,697 
3,149 
6,497 
1,024 

16,468 
18,714 
77,000 

Allied Minds Plc 
Registered number: 08998697 
The financial statements on pages 98 to 159 were approved by the Board of Directors and authorised 
for issue on 14 June 2022 and signed on its behalf by: 

Harry Rein 
Non-Executive Chairman 

99 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
 
 
 
l

a
t
o
T

y
t
i
u
q
e

0
0
0

'

$

-
n
o
N

0
0
0

'

$

s
t
s
e
r
e
t
n

i

g
n

i
l
l

o
r
t
n
o
c

y
t
i
u
q
e

0
0
0

'

$

t
n
e
r
a
p

l

a
t
o
T

0
0
0

'

$

/
)
t
i
c
i
f
e
D

(

i

s
g
n
n
r
a
E

l

d
e
t
a
u
m
u
c
c
A

0
0
0

'

$

e
v
r
e
s
e
r

n
o
i
t
a
l
s
n
a
r
T

s
e
r
a
h
s
y
r
u
s
a
e
r
T

l

a
t
i
p
a
c
e
r
a
h
S

e
t
o
N

Y
T
I
U
Q
E
N

I
S
E
G
N
A
H
C
F
O
T
N
E
M
E
T
A
T
S
D
E
T
A
D
I
L
O
S
N
O
C

1
2
0
2
r
e
b
m
e
c
e
D
1
3
d
e
d
n
e
r
a
e
y
e
h
t

r
o
F

S
T
N
E
M
E
T
A
T
S
L
A
I
C
N
A
N
I
F

1
7
5

,

2
5
1

5
1
1

8

)
6
1
1
(

)
4
0
5

,

5
5
(

)
0
2
6

,

5
5
(

)
8
1
(

2
5
0
1

,

6
8
2

,

8
5

)
7
0
7

,

9
3
(

)
6
9
(

)
1
4
(

)
4
4
2

,

6
1
(

)
5
8
2

,

6
1
(

)
8
3
7
(

7
0
2
3

,

1
8
2

5
5
6

,

4
4

—

)
9
7
4
2
(

,

—

)
9
7
4
2
(

,

)
8
1
(

—

8
1
1

)
4
6
2
2
(

,

—

)
0
1
7
(

)
6
9
(

)
0
1
7
(

—

7
0
2
3

,

1
3

8
6
1

8

—

6
5
4

,

2
5
1

)
6
1
1
(

)
5
2
0

,

3
5
(

)
1
4
1

,

3
5
(

4
3
9

0
5
5

,

0
6

)
7
0
7

,

9
3
(

—

)
1
4
(

)
4
3
5

,

5
1
(

)
5
7
5

,

5
1
(

—

0
5
2

)
8
3
7
(

7
8
4

,

4
4

—

—

8
3
2

,

7
4
1

—

)
5
2
0

,

3
5
(

)
5
2
0

,

3
5
(

4
3
9

0
4
4

,

5
5

)
7
0
7

,

9
3
(

—

)
4
3
5

,

5
1
(

)
4
3
5

,

5
1
(

—

—

—

0
5
2

6
5
1

,

0
4

9
5
4
1

,

—

)
6
1
1
(

)
6
1
1
(

—

—

—

—

3
4
3
1

,

—

)
1
4
(

)
1
4
(

—

—

—

—

2
0
3
1

,

—

—

—

—

—

—

—

—

—

—

—

—

—

)
8
3
7
(

)
8
3
7
(

0
0
1

t
n
u
o
m
A

0
0
0

'

$

s
e
r
a
h
S

)
8
3
5
2
(

,

7
6
7
3

,

5
8
9
7
8
1

,

,

2
4
2

—

—

—

—

—

—

—

—

—

—

—

—

—

—

)
8
3
5
2
(

,

9
5
7
3

,

t
n
u
o
m
A

0
0
0

'

$

3
2
1
3
6
5

,

,

1
4
2

s
e
r
a
h
S

—

—

8

—

—

—

—

—

—

—

—

2
6
8

,

4
2
6

7
6
7
3

,

5
8
9
7
8
1

,

,

2
4
2

—

—

—

—

—

—

—

—

—

—

—

—

—

—

4
1

5
1

4
1

6

6

5
1

5
1

5
1

,

4
1

r
a
e
y
e
h
t

r
o
f

s
s
o

l

e
v
i
s
n
e
h
e
r
p
m
o
c

l

a
t
o
T

9
1
0
2
r
e
b
m
e
c
e
D
1
3
t
a
e
c
n
a
a
B

l

r
a
e
y
e
h
t

r
o
f

s
s
o

l

e
v
i
s
n
e
h
e
r
p
m
o
c

l

a
t
o
T

-
n
o
n
n

i

e
g
n
a
h
c
m
o
r
f
g
n
i
s
i
r
a
s
s
o
L

i

s
e
r
a
h
s
y
r
a
n
d
r
o
f
o
e
c
n
a
u
s
s
I

s
n
o
i
t
a
r
e
p
o
g
n
u
n
i
t
n
o
c
m
o
r
f

i

s
s
o
L

n
o
i
t
a
l
s
n
a
r
t

y
c
n
e
r
r
u
c
n
g
e
r
o
F

i

d
o
i
r
e
p
e
h
t

r
o
f

s
s
o

l

e
v
i
s
n
e
h
e
r
p
m
o
c

l

a
t
o
T

s
t
n
e
m
y
a
p
d
e
s
a
b
e
r
a
h
s
d
e
l
t
t
e
s
-
y
t
i
u
q
E

0
2
0
2
r
e
b
m
e
c
e
D
1
3
t
a
e
c
n
a
a
B

l

s
n
o
i
t
a
r
e
p
o
g
n
u
n
i
t
n
o
c
m
o
r
f

i

s
s
o
L

n
o
i
t
a
l
s
n
a
r
t

y
c
n
e
r
r
u
c
n
g
e
r
o
F

i

d
o
i
r
e
p
e
h
t

r
o
f

s
s
o

l

e
v
i
s
n
e
h
e
r
p
m
o
c

l

a
t
o
T

-
n
o
n
n

i

e
g
n
a
h
c
m
o
r
f
g
n
i
s
i
r
a
s
s
o
L

t
n
e
m
y
a
p
d
n
e
d
i
v
i
D

t
s
e
r
e
t
n

i

g
n

i
l
l

o
r
t
n
o
c

s
t
n
e
m
y
a
p
d
e
s
a
b
e
r
a
h
s
d
e
l
t
t
e
s
-
y
t
i
u
q
E

1
2
0
2
r
e
b
m
e
c
e
D
1
3
t
a
e
c
n
a
a
B

l

i

s
e
r
a
h
s
y
r
a
n
d
r
o
f
o
e
s
a
h
c
r
u
p
e
R

i

y
r
a
d
i
s
b
u
s

f
o
n
o
i
t
a
d

i
l

o
s
n
o
c
e
D

t
s
e
r
e
t
n

i

g
n

i
l
l

o
r
t
n
o
c

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

CONSOLIDATED STATEMENT OF CASH FLOWS 

For the year ended 31 December 

Cash flows from operating activities: 

Loss for the year 

  Adjustments to reconcile net loss to net cash 

used in operating activities: 
  Depreciation 
  Amortisation 

Impairment losses on property and equipment 
Share-based compensation expense 
Forgiveness of Paycheck Protection Program (PPP) loan 
Loss on investments held at fair value 
  Gain on deconsolidation of subsidiary 

Share of net loss of associate 

  Other income 

Changes in working capital: 

Increase in trade and other receivables 

  Decrease/(increase) in other assets 
  Decrease in trade payables 
  Decrease in accrued expenses 
Increase in deferred revenue 
Increase/(decrease) in other liabilities 
  Unrealised gain on foreign currency transactions 
  Other finance expense 
Net cash used in operating activities 
Cash flows from investing activities: 

Purchases of property and equipment, net of disposals 

  Purchase of investments at fair value 
  Receipt of payment for finance sub-lease 
  Cash derecognised upon loss of control over subsidiary 
Net cash used in investing activities 
Cash flows from financing activities: 

Proceeds from issuance of convertible notes 
Receipt of PPP loan 
Payment of lease liability 

  Dividend payment 

Payments to repurchase ordinary shares 
  Proceeds from issuance of share capital 
  Proceeds from issuance of preferred shares in subsidiaries 
Net cash provided by /(used in) financing activities 
Net decrease in cash and cash equivalents, and restricted cash 
Cash and cash equivalents, beginning of the period 
Cash and cash equivalents, end of the period 

101 

Note 

2021 
$ '000 

2020  
$ '000 

(16,244) 

(55,504) 

9,19 
10 
9 
5,6 
18 
11,20 
11 
11 
9 

13 

17 
17 
3 

7 

9 
11 
19 
11 

18 
18 
19 
14 
14 
6,14 
16 

839 
— 
458 
281 
(443) 
13,894 
(14,213) 
2,362 
(262) 

(96) 
693 
(78) 
(691) 
1,386 
517 
(41) 
2,578 

(9,060) 

(185) 
(5,283) 
45 
(13,326) 

(18,749) 

— 
259 
(1,100) 
— 
(738) 
— 
14,609 

13,030 
(14,779) 
24,489 
9,710 

819 
197 
—     
1,052 
—     
31,934 
—     
6,845 
—     

(114) 
(874) 
(876) 
(1,643)  
240 
(780) 
(116) 
1,763 

(17,057) 

(564)   
(10,855)   
78  
—     

(11,341)   

2,981    
184    
(1,150)   
(39,707)   
—     
8 
—     

(37,684)   
(66,082)   
90,571    
24,489    

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 

For the year ended 31 December 2021 

(1)  Accounting Policies 

Basis of Preparation 

Allied Minds Plc (“Allied Minds” or the “Company”) is a company incorporated and domiciled in the UK. 
The Annual Report and Accounts of Allied Minds and its subsidiaries (together referred to as the “Group”) 
are presented for the year ended 31 December 2021. The Group financial statements have been prepared 
and approved by the directors in accordance with UK adopted international accounting standards (“IFRS”) 
for  the  year  ended  31  December  2021.  The  accounting  policies  set  out  below  have,  unless  otherwise 
stated, been applied consistently to all periods presented in these consolidated financial statements. 

Basis of Measurement 

The consolidated financial statements have been prepared on the historical cost  basis  except that the 
following assets and liabilities are stated at their fair value: investments held at fair value and financial 
instruments classified as fair value through the profit or loss. 

Use of Judgments and Estimates 

In preparing these consolidated financial statements, management has made judgments, estimates and 
assumptions that affect the application of the Group’s accounting policies and the reported amounts of 
assets, liabilities,  income  and expenses. Actual results may  differ from these  estimates. Estimates  and 
underlying  assumptions  are  reviewed  on  an  on-going  basis.  Revisions  to  estimates  are  recognised 
prospectively. The effects on the amounts recognised in the consolidated financial statements, or on other 
alternative performance measures, is included in the following notes: 

Significant estimates made include: 

  Note 11 and 16 – Valuation of financial instruments measured at fair value through profit/loss: 
There is uncertainty in estimating the fair value of subsidiary note payables, subsidiary preferred 
shares, and convertible note assets and investments carried at fair value through profit and loss 
(FVTPL)  according  to  IFRS  9  at  initial  recognition  and  upon  subsequent  measurement.  This 
includes  determining  the  appropriate  valuation  methodology  and  making  certain  estimates 
including future earnings potential of the subsidiary businesses, appropriate discount rate and 
earnings  multiple  to  be  applied,  marketability,  the  probability  weighting  of  the  scenarios  and 
other industry and company specific risk factors.  

Significant judgements made include:  

  Note 11 – there is judgement in considering whether the power to control the subsidiary exists or 
retaining significant influence as it is dependent on certain factors including the voting power the 
entity exercises over the company, the proportion of seats the company controls on the board 
and the investees dependence on the investor for funding, knowledge and its operations. Further 
to the above the group has considered its position under IFRS10 in respect of whether it is an 

102 

 
 
FINANCIAL STATEMENTS  

investment entity for the purposes of this standard. Management have reviewed the operations 
of  the  group  in  line  with  the  standard,  and  whilst  there  are characteristics which  indicate  the 
group could be considered an investment company, the underlying measurement of success for 
the  consolidated  portfolio  investments  is  progress  in  relation  to  key  strategic  milestones  in 
bringing  their  products  to  market  and  not  the  fair  value  of  the  business.  Based  on  this 
management  have  judged  the  business  to  not  be  an  investment  entity  and  consolidate  its 
subsidiaries under IFRS10. 

  Note 11  –  as the  entities  in the group progress they require further external funding which in 
some scenarios reduces the Group’s shareholding to an extent that it loses control under IFRS 10 
which results in them no longer being able to consolidate the entity. There is a further significant 
judgement in relation to whether the shares are accounted for as an investment in associate per 
IAS 28 or as a financial asset per IFRS 9 and therefore held at fair value, i.e. whether the Group 
maintain  significant  influence  over  the  Company.  This  judgement  includes,  among  others,  an 
assessment of whether the Company has representation on the board of directors of the investee, 
whether the Company participates in the policy making processes of the investee, whether there 
is any interchange of managerial personnel, whether there is any essential technical information 
provided to the investee and if there are any transactions between the Company and the investee. 

  Note 16 and 20 – financial instrument liability classification: when determining the classification 
of financial instruments in terms of liability or equity. These judgements include an assessment 
whether  the  financial  instrument  include  any  embedded  derivative  features,  whether  they 
include a contractual obligations upon the Group to deliver cash or other financial assets or to 
exchange financial assets or financial liabilities with another party, and whether that obligation 
will be settled by the Company’s exchanging a fixed amount of cash or other financial assets for a 
fixed number of its own equity instruments. Further information about these critical judgments is 
included below under Financial Instruments. 

  Note 3 – revenue recognition: in determining the correct amount of revenue to be recognised, 
the Directors make estimates of the fair values of each component of a contract to be able to 
allocate the overall consideration to each component based on the relative fair value method or 
make estimates of future costs when applying the inputs method. 

  Note  3  –  timing  of  revenue  recognition:  making  certain  judgements  when  determining  the 
appropriate  accounting  treatment  of  key  customer  contract  terms  in  accordance  with  the 
applicable accounting standards and in determining whether revenue should be recognised at a 
point in time or over a period of time. 

Other estimates and judgments: 

  Note 19 – discount rate used in lease treatment: in determining the appropriate discount rate to 
calculate the present value of lease payments. These judgements include an assessment of what  
Group’s  incremental  borrowing  rate  is  where  there  is  no  rate  implicit  within  the  lease.  The 
incremental borrowing rate will take into account the credit standing of the lessee, the length of 
the  lease,  the  nature  and  quality  of  the  collateral  provided  and  the economic environment  in 
which the transaction occurs. 

103 

 
 
FINANCIAL STATEMENTS  

Going Concern 

The Directors have taken proactive cost management measures that include reduction in expenses of the 
management function of the head office at the parent level.  They have also decided to focus exclusively 
on supporting the six existing portfolio companies , albeit do not make or have and enforceable financial 
or  working  capital  commitments,  and  maximising  monetisation  opportunities  for  portfolio  company 
interests,  and  not  to  deploy  any capital  into  any  new  portfolio companies.   In  the  event  of  successful 
monetisation events from the sale of portfolio companies or portfolio company interests, the Directors 
anticipate distributing the net proceeds to shareholders, after due consideration of potential follow-on 
investment opportunities within the existing portfolio and working capital requirements. The Directors 
expect  this  strategy  to  take  at  least  two  years  to  be  fully  implemented,  and  as  a  matter  of  good 
governance, will continue to keep this strategy under review at appropriate intervals.  They have prepared 
trading and cash flow forecasts for the parent through 2025. Reflecting this revised strategy, although the 
Group is currently loss making and is likely to continue to be so, at least in the short term, after making 
enquiries and considering the impact of risks and opportunities on expected cash flows, and given the fact 
that  the  Group  has  $9.7  million  of  available  funds  in  the  form  of  cash  and  cash  equivalents  as  at  31 
December  2021,  and  added  to  this  with  the  sale  if  the  holding  in  TouchBistro  post  year  end  for 
consideration of $3.9 million, the Directors have a reasonable expectation that the Group has adequate 
cash to continue in operational existence for a period of not less than 12 months from the date of approval 
of the financial statements. Furthermore, the directors have considered the timeline of when it plans to 
dispose  of,  divest  or  reinvest  in  its  portfolio  companies  and  there  is  no  intention  to  cease  trading  or 
liquidate the business for the period under the going concern review. 

Though the majority of the Company’s operations are in the United States and the functional currency of 
the group  is the U.S. dollar, Allied Minds is based in the United Kingdom and therefore  susceptible to 
various international risks such as economic headwinds, including inflationary pressure, interest rates and 
component price increases, as well as changes in political and regulatory requirements.  These risks are 
continuously monitored and reviewed by management.  The  Group cannot  predict  all future events or 
conditions, however, the directors have concluded that there are no material uncertainties that could cast 
significant doubt over the ability of the Group to continue as a going concern for at least the going concern 
period as assessed above and the Company’s existing measures are sufficient to mitigate the inherent 
risks to its business model. 

The Directors have also put in measures to mitigate against the risks to the business due to the continued 
impact of COVID-19.  Any continued impact from COVID-19 or the situation in Ukraine will not affect Allied 
Minds from a going concern perspective.  In fact, it is expected that the impact of COVID-19 will continue 
to  add  cost  savings  during  2022  as  a  result  of  suspension  of most  travel  for  board  meetings,  investor 
meetings and the 2022 Annual General Meeting. These savings have a positive impact on Allied Minds as 
a going concern. 

The Directors are conscious of the recent board changes and the need to appoint additional directors to 
the board of the Company. The Directors are working closely with the Company’s largest shareholders to 
identify and recruit new directors to the board of the Company.  

The directors’ judgement concludes there is no material uncertainty in relation to going concern. For this 
reason, they have adopted the going concern basis in preparing the financial statements. 

104 

 
 
FINANCIAL STATEMENTS  

Basis of Consolidation 
Allied Minds Plc was formed on 15 April 2014 and the consolidated financial statements for each of the 
years ended 31 December 2021 and 2020 comprises the financial statements of Allied Minds Plc and its 
subsidiaries. 

Subsidiaries 

The  financial  information  of  the  subsidiaries  is  prepared  for  the  same  reporting  period  as  the  parent 
Company,  using  consistent  accounting  policies.  Subsidiaries  are  entities  controlled  by  the  Group.  The 
Group controls an entity when it is exposed to, or has rights to, variable returns from its involvement with 
the  entity  and  has  the  ability  to  affect  those  returns  through  its  power  over  the  entity.  The  financial 
statements of subsidiaries are included in the consolidated financial statements from the date that control 
commences  until  the  date  that  control  ceases.  Losses  applicable  to  the  non-controlling  interests  in  a 
subsidiary  are  allocated  to  the  non-controlling  interests  even  if  doing  so  causes  the  non-controlling 
interests to have a deficit balance. 

Changes in the Group’s interest in a subsidiary that do not result in a loss of control are accounted for as 
equity  transactions.  Where  the  Group  loses  control  of  a  subsidiary,  the  assets  and  liabilities  are 
derecognised along with any related NCI and other components of equity. Any resulting gain or loss is 
recognised in profit or loss. Any interest retained in the former subsidiary is measured at fair value under 
IFRS 9 when control is lost and it will be assessed whether significant influence remains. Where this is the 
case  the  ongoing  accounting  will  be  under  IAS  28,  if  significant  influence  is  also  lost,  the  remaining 
investment is accounted for under IFRS 9. 

Associates 

Associates  are  those  entities  in  which  the  Group  has  significant  influence,  but  not  control,  over  the 
financial and operating policies. Significant influence is presumed to exist when the Group holds between 
20  and  50  percent  of  the  voting  power  of  another  entity.  It  is  also  evidenced  in  one  or  more  of  the 
following ways: 

representation on the board of directors or equivalent governing body of the investee; 

 
  participation in policy-making processes, including participation in decisions about dividends or 

other distributions; 

  material transactions between the entity and its investee; 
 
interchange of managerial personnel; or 
  provision of essential technical information. 

Associates  are  accounted  for  using  the  equity  method  (equity  accounted  investees)  and  are  initially 
recognised  at  cost.  The  Group’s  investment  includes  goodwill  identified  on  acquisition,  net  of  any 
accumulated impairment losses. The consolidated financial statements include the Group’s share of the 
total comprehensive income and equity movements of equity accounted investees, from the date that 
significant influence commences until the date that significant influence ceases. When the Group’s share 
of losses exceeds its interest in an equity accounted investee, the Group’s carrying amount is reduced to 
$nil or up to additional losses are provided for, and a liability is recognised, to the extent that the entity 
has incurred legal or constructive obligations or made payments on behalf of the associate. Recognition 

105 

 
 
 
 
FINANCIAL STATEMENTS  

of further losses is discontinued except to the extent that the Group has incurred legal or constructive 
obligations  or  made  payments  on  behalf  of  an  investee.  To  the  extent  the  Group  holds  interests  in 
associates that are not providing access to returns underlying ownership interests and are more akin to 
debt like securities, the instrument held by Allied Minds is accounted for in accordance with IFRS 9. 

Transactions eliminated on consolidation 

Intra-group balances and transactions, and any unrealised income and expenses arising from intra- group 
transactions, are eliminated. Unrealised gains arising from transactions with equity-accounted investees 
are eliminated against the investment to the extent of the Group’s interest in the investee. Unrealised 
losses are eliminated in the same way as unrealised gains, but only to the extent that there is no evidence 
of impairment. 

Changes of non-controlling interests 

Non-controlling interests (‘‘NCI’’) are measured at their proportionate share of the acquiree’s identifiable 
net assets at the acquisition date. Changes in the Group’s interest in a subsidiary that do not result in a 
loss of control are accounted for as equity transactions. 

Changes  of  non-controlling  interests  that  do  not  result  in  a  change  of  control  are  accounted  for  as 
transactions with owners in their capacity as owners and therefore no goodwill is recognised as a result 
of such transactions. The adjustments to non-controlling interests are based on a proportionate amount 
of the net assets of the subsidiary. Any difference between the price paid or received and the amount by 
which non-controlling interests are adjusted is recognised directly in equity and attributed to the owners 
of the parent. 

Functional and Presentation Currency 

These consolidated financial statements are presented in US dollars, which is the functional currency of 
most of the entities in the Group. The parent has a functional currency of GBP. All amounts have been 
rounded to the nearest thousand unless otherwise indicated. 

Foreign Currency 

Transactions in foreign currencies are translated to the respective functional currencies of Group entities 
at  the  foreign  exchange  rate  ruling  at  the  date  of  the  transaction.  Monetary  assets  and  liabilities 
denominated in foreign currencies at the balance sheet date are retranslated to the functional currency 
at the foreign exchange rate ruling at that date. Foreign exchange differences arising on translation are 
recognised in the consolidated statement of comprehensive loss. Non-monetary assets and liabilities that 
are measured in terms of historical cost in a foreign currency are translated using the exchange rate at 
the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that 
are stated at fair value are retranslated to the functional currency at foreign exchange rates ruling at the 
dates the fair value was determined. 

The assets and liabilities of foreign operations, including fair value adjustments arising on consolidation, 
are translated to the Group’s presentational currency (US dollar) at foreign exchange rates ruling at the 
balance sheet date. The revenues and expenses of foreign operations are translated at an average rate 
for  the  year  where  this  rate  approximates  to  the  foreign  exchange  rates  ruling  at  the  dates  of  the 
transactions. Exchange differences arising from this translation of foreign operations are reported as an 

106 

 
 
FINANCIAL STATEMENTS  

item  of  other  comprehensive  income  and  accumulated  in  the  translation  reserve  or  non-  controlling 
interest, as the case may be. When a foreign operation is disposed of, such that control, joint control or 
significant influence (as the case may be) is lost, the entire accumulated amount in the translation reserve, 
net of amounts previously attributed to non-controlling interests, is reclassified to profit or loss as part of 
the  gain  or  loss  on  disposal.  When  the  Group  disposes  of only  part  of  its  interest  in  a  subsidiary  that 
includes  a  foreign  operation  while  still  retaining  control,  the  relevant  proportion  of  the  accumulated 
amount  is  reattributed  to  non-controlling  interests.  When  the  Group  disposes  of  only  part  of  its 
investment in a subsidiary or an associate that includes a foreign operation while still retaining significant 
influence or joint control, the relevant proportion of the cumulative amount is reclassified to profit or 
loss. 

Cash and Cash Equivalents 

Cash and cash equivalents include all highly liquid instruments with original maturities of three months or 
less. 

Financial Instruments 

Classification – Financial Assets  

IFRS 9 contains a classification and measurement approach for financial assets that reflects the business 
model, in which assets are managed, and their cash flow characteristics. IFRS 9 contains three principal 
classification  categories  for  financial  assets:  measured  at  amortised  cost,  fair  value  through  other 
comprehensive income (“FVOCI”) and fair value through profit or loss (“FVTPL”). Under IFRS 9, derivatives 
embedded  in  contracts  where  the  host  is  a  financial  asset  in  the  scope  of  the  standard  are  never 
bifurcated. Instead, the hybrid as a whole is assessed for classification. 

Under IFRS 9 all fair value changes of assets designated as at fair value through profit or loss are generally 
presented in profit or loss. 

Cash and cash equivalents: Represent basic cash balances in banks used to fund operations. These are 
classified as assets at amortised cost under IFRS 9.  

Trade Receivables: Under IFRS 9 trade receivables that do not have a significant financing component have 
to be initially recognised at their transaction price rather than at fair value. The Group initially recognises 
receivables and deposits on the date that they are originated at their transaction price, which is the same 
as their fair value. As such, Trade and other receivables are classified as assets at amortised cost under 
IFRS 9.  

Short-term notes: The short-term note from an associate, since its contractual terms do not consist solely 
of  cash  flow  payments  of  principal  and  interest  on  the  principal  amount  outstanding,  is  initially  and 
subsequently measured at fair value, with changes in fair value recognized through profit or loss under 
IFRS 9. The Group designates the SAFE note assets at FVTPL under IFRS 9. Hence, any gains and losses on 
the these notes are recognised in profit or loss and are measured in the same way as investments as fair 
value above. 

Security and other deposits: These generally represent security deposits paid by the Group to landlords as 
part of operating lease commitments. As the Company’s objective is that those deposits will be collected 
back, they are classified as assets at amortised cost under IFRS 9.  

107 

 
 
FINANCIAL STATEMENTS  

Investments at fair value: Reflect investments made by the Group in non-derivative instruments of the 
investees that are designated in this category or not classified in any other category. These financial assets 
are initially measured at fair value and subsequently re-measured at fair value at each reporting date, and 
on derecognition. The Company elects if the gain or loss will be recognised in the Consolidated Statements 
of Comprehensive Income/ (Loss) in Other Comprehensive Income/(Loss) or through the profit and loss 
on  an  instrument  by  instrument  basis.  Investments  at  fair  value  are  presented  in  the  Consolidated 
Statements of Financial Position as non-current assets, unless the Group intends to dispose of them within 
12 months after the end of the reporting period. If the investments at fair value continue to be held for 
the same long-term strategic purposes, per the application of IFRS 9, the Group may elect then to classify 
them as FVOCI or FVTPL. The Group classifies them as FVTPL. In this case, all fair value gains and losses 
would  be  recognised  in  profit  or  loss  as  they  arise,  increasing  volatility  in  the  Group’s  profits.  These 
financial assets do not have exposure to credit risk and are not considered credit-impaired. As a result, 
there  are  no  adjustments  considered  for  movement  in  credit  risk  as  this  is  not  applicable  within  the 
specific valuation  frameworks  utilised  for  the  fair  values  of  the  Group’s  preferred  stock  assets. To  the 
extent  the  Group  holds  interests  in  associates  that  are  not  providing  access  to  returns  underlying 
ownership  interests  and  are  more  akin  to  debt  like  securities,  the  instrument  held  by  Allied  Minds  is 
accounted for in accordance with IFRS 9. 

Classification – Financial Liabilities  

Under  IFRS  9  all  fair  value  changes  of  liabilities  designated  as  at  fair  value  through  profit  or  loss  are 
generally presented in profit or loss.  

The Group designates the subsidiary preferred shares liability at FVTPL under IFRS 9. Hence, any gains and 
losses on the preferred shares liability are recognised in profit or loss, unless they relate to changes in the 
entity’s own credit risk for financial liability designated as at fair value through profit or loss. The effect of 
changes in the entity’s own credit risk in the fair value of the financial liabilities are presented in other 
comprehensive  income.  For  the  underlying  financial  instruments  no  adjustments  are  considered  for 
movement in credit risk as this is not applicable within the specific valuation frameworks utilized for the 
fair values of the Group’s preferred share liability.  

Trade and other payables and loans are designated at amortised cost under IFRS 9.  

Impairment 

IFRS  9  includes  a  ‘forward  looking  expected  credit  loss’  (“ECL”)  model.  The  impairment  methodology 
applied depends on whether there has been a significant increase in credit risk. For trade receivables, the 
group applies the simplified approach permitted by IFRS 9, which requires expected lifetime losses to be 
recognised from initial recognition of the receivables. 

Financial Instruments Issued by the Group 

Under IAS 32, financial instruments issued by the Group are treated as equity only to the extent that they 
meet the following two conditions: 

 

they include no contractual obligations upon the Group to deliver cash or other financial assets 
or to exchange financial assets or financial liabilities with another party under conditions that are 
potentially unfavourable to the Group; and 

108 

 
 
FINANCIAL STATEMENTS  

  where the instrument will or may be settled in the Company’s own equity instruments, it is either 
a non-derivative that includes no obligation to deliver a variable number of the Company’s own 
equity  instruments  or  is  a derivative  that will  be  settled  by the  Company’s  exchanging  a  fixed 
amount of cash or other financial assets for a fixed number of its own equity instruments. 

To the extent that this definition is not met, the financial instrument is classified as a financial liability. 
Where  the  instrument  so  classified  takes  the  legal  form  of  the  Company’s  own  shares,  the  amounts 
presented in the financial information for share capital and merger reserve account exclude amounts in 
relation to those shares.  

Where a financial instrument that contains both equity and financial liability components exists, these 
components are separated and accounted for individually under the above policy. 

Paycheck Protection Program (PPP) loan 

The US CARES Act created the Paycheck Protection Program (PPP) to provide qualifying small businesses 
with necessary funds to support their operations during the COVID-19 pandemic. Entities have to meet 
certain eligibility requirements to receive PPP loans, and they must maintain  specified levels of payroll 
and employment to have the loans forgiven. The conditions are subject to audit by the US government, 
but entities that borrow less than $2 million will be deemed to have met the initial eligibility requirements. 

Under IAS 20, Accounting for Government Grants and Disclosure of Government Assistance, the initial 
receipt of PPP loans is recognized as a liability. This liability can be derecognized when there is “reasonable 
assurance”  that  the  loan  conditions  will  be  met  and  forgiveness  will  be  granted.  Once  forgiven,  the 
company records the amount as other income. 

Share Capital 

Ordinary shares are classified as equity. The Group considers its capital to comprise share capital, share 
premium, merger reserve, translation reserve, and accumulated deficit.  

Property and Equipment 

Property and equipment is stated at cost less accumulated depreciation and any accumulated impairment 
losses. Cost includes expenditure that is directly attributable to the acquisition of the asset. Assets under 
construction represent machinery and equipment to be used in operations, R&D activities, or to be leased 
to customers once completed. 

When parts of an item of property and equipment have different useful lives, they are accounted for as 
separate  items  (major  components)  of  property  and  equipment.  Depreciation  is  calculated  using  the 
straight-line method over the estimated useful lives of the related assets: 

Computers and electronics 
3 years  
Furniture and fixtures 
5 years 
Machinery and equipment 
5 -20 years 
Under construction 
Not depreciated until transferred into use 
Shorter of the lease term or estimated useful life of the asset 
Leasehold improvements 
Right-of-Use Assets                                     Shorter of the lease term or estimated useful life of the asset  

109 

 
 
 
 
FINANCIAL STATEMENTS  

Depreciation  methods,  useful  lives  and  residual  values  are  reviewed  at  least  annually  and  adjusted  if 
appropriate. 

The Directors have considered the value of fixed assets without revaluing them.  

The Directors are satisfied that the aggregate value of those assets at the time in question is or was not 
less than aggregate amount at which they are or were for the time being stated in the company's accounts. 

Intangible Assets 

Software 

Software intangible assets that are acquired by the Group and have finite useful lives are measured at 
cost less accumulated amortisation and any accumulated impairment losses. 

Finite-lived intangible assets are amortised on a straight-line basis over their estimated useful lives, from 
the date that they are available for use. Intangible assets which are not yet available for use (and therefore 
not amortised) are tested for impairment at least annually. 

Amortisation 

Amortisation is charged to the consolidated statement of comprehensive loss on a straight-line basis over 
the estimated useful lives of intangible assets unless such lives are indefinite. Intangible assets with an 
indefinite useful life and goodwill are systematically tested for impairment at each balance sheet date. 
Other intangible assets are amortised from the date they are available for use. Amortisation methods, 
useful lives and residual values are reviewed at least annually and adjusted if appropriate. 

The estimated useful lives of the Group’s intangible assets are as follows: 

Software 

Leases 

2 years 

IFRS  16  is  a  single,  on-balance  sheet  lease  accounting  model  for  lessees  and  requires  leases  to  be 
accounted for using a right-of-use model, which recognises that, at the date of commencement, a lessee 
has a financial obligation to make lease payments to the lessor for the right to use the underlying asset 
during the lease term. The lessee recognises a corresponding right-of-use asset related to this right. 

Upon adoption, the Group applied the following practical expedients:  
  excluding initial direct costs from the right-of-use assets;  
  use hindsight when assessing the lease term;  
  not reassessing whether a contract is or contains a lease; and  
  not separating the lease components from the non-lease components in lease contracts.  

The Group accounts for lease payments as an expense on a straight-line basis over the life of the lease 
for:  
 
 

Leases with a term of 12 months or less and containing no purchase options; and  
Leases where the underlying asset has a value of less than $5,000.  

110 

 
 
 
 
 
FINANCIAL STATEMENTS  

The  lease  liability  is  initially  measured  at  the  present  value  of  the  remaining  lease  payments  at  the 
transition date or date of entering the lease, discounted by using the rate implicit in the lease. If this rate 
cannot be readily determined, the Group used its incremental borrowing rate. The right-of-use asset is 
depreciated on a straight-line basis and the lease liability will give rise to an interest charge. 

Finance leases will continue to be treated as finance leases. In November 2020 the Company relocated its 
corporate  headquarters  as  part  of  management’s  initiative  to  minimise  headquarters  expenses.  As  a 
result, starting November 2020, the Company entered into a sublease for the remaining period of the 
head lease.  

Under IFRS 16, this sublease led to the de-recognition of the right of use asset and the recognition of an 
investment receivable in respect of this sublease. The lease liability remains in respect of the head lease 
as a lease liability on the balance sheet. 

The Group recognised lease liabilities of $0.9 million and $0.4 million in lease assets at 31 December 2021. 
Those rights and obligations are primarily related to operating leases for office and laboratory space. 

BridgeComm entered into a new lease in 2021. Further information regarding the right of use asset and 
lease liability can be found in Note 19. 

Taxation 

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognised in the income 
statement except to the extent that it relates to items recognised directly in equity, in which case it is 
recognised in equity. 

Current Income Tax 

Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax 
rates enacted or substantially enacted at the reporting date, and any adjustment to tax payable in respect 
of previous years. 

Deferred Income Tax 

Deferred tax is recognised in respect of temporary differences between the carrying amounts of assets 
and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax 
assets are recognised for unused tax losses, unused tax credits and deductible temporary differences to 
the extent that it is probable that future taxable profits will be available against which they can be used. 
Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer 
probable that the related tax benefit will be realised. 

Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when 
they reverse, using tax rates enacted or substantively enacted at the reporting date. 

Deferred  tax  assets  and  liabilities  are  offset  if  there  is  a  legally enforceable  right  to  offset current tax 
liabilities and assets, and they relate to taxes levied by the same tax authority on the same taxable entity, 
or on different tax entities where the Group intends to settle current tax liabilities and assets on a net 
basis or their tax assets and liabilities will be realised simultaneously. 

111 

 
 
 
 
FINANCIAL STATEMENTS  

Deferred taxes are  recognised in profit or loss except  to the extent that it relates to items recognised 
directly in equity or in other comprehensive income. 

Impairment 

Impairment of Non-Financial Assets 

Non-financial assets consist of property and equipment and intangible assets with finite lives and such 
intangible assets which are not yet available for use. 

The Group reviews the carrying amounts of its property and equipment and finite-lived intangibles at each 
reporting date to determine whether there is any indication of impairment. If any such indication exists, 
then the asset’s recoverable amount is estimated. Intangible assets which are not yet available for use are 
tested annually for impairment. 

For impairment testing, assets are grouped together into the smallest group of assets that generates cash 
inflows  from  continuing  use  that  are  largely  independent  of  the  cash  inflows  of  other  assets  or  cash-
generating units (‘‘CGUs’’). 

The recoverable amount of an asset or CGU is the greater of its value in use and its fair value less costs to 
sell. Value in use is based on the estimated future cash flows, discounted to their present value using a 
pre-tax discount rate that reflects current market assessments of the time value of money and the risks 
specific to the asset or CGU. 

An impairment loss is recognised in profit and loss if the carrying amount of an asset or CGU exceeds its 
recoverable amount. Impairment losses are allocated to reduce the carrying amounts of assets in a CGU 
on a pro rata basis. 

Impairment of Financial Assets 

The company recognises loss allowances for expected credit losses (ECLs) on financial assets measured at 
amortised cost. 

The  company  measures  loss  allowances  at  an  amount  equal  to  lifetime  ECL,  except  for  other  debt 
securities and bank balances for which credit risk (i.e. the risk of default occurring over the expected life 
of the financial instrument) has not increased significantly since initial recognition, which are measured 
as 12-month ECL. 

Loss allowances for trade receivables and contract assets are always measured at an amount equal to 
lifetime ECL. 

When  determining  whether  the  credit  risk  of  a  financial  asset  has  increased  significantly  since  initial 
recognition and when estimating ECL, the company considers reasonable and supportable information 
that is relevant and available without undue cost or effort. This includes both quantitative and qualitative 
information and analysis, based on the company’s historical experience and informed credit assessment 
and including forward-looking information.  

Share-based Payments 

Share-based payment arrangements in which the Parent receive goods or services as consideration for 
their  own  equity  instruments  are  accounted  for  as  equity-settled  share-based  payment  transactions, 

112 

 
 
FINANCIAL STATEMENTS  

regardless of how the equity instruments are obtained by the Group or its subsidiaries. Grants of equity 
instruments under the subsidiary stock option incentive plans are accounted for as equity-settled in the 
consolidated accounts of the parent and are reflected in equity as a credit to Non-Controlling Interest. 

The  grant  date  fair  value  of  share-based  payment  awards  granted  to  employees  is  recognised  as  an 
employee expense, with a corresponding increase in equity, over the period that the employees become 
unconditionally entitled to the awards. The fair value of the options granted is measured using an option 
pricing  valuation  model,  taking  into  account  the  terms  and  conditions  upon  which  the  options  were 
granted. The amount recognised as an expense is adjusted to reflect the actual number of awards for 
which  the  related  service  and  non-market  vesting  conditions  are  expected  to  be  met,  such  that  the 
amount ultimately recognised as an expense is based on the number of awards that do meet the related 
service  and non-market performance conditions at the vesting date. For share-based payment  awards 
with market or non-vesting conditions, the grant date fair value of the share-based payment is measured 
to reflect such conditions and there is no true-up for differences between expected and actual outcomes. 

Employee Benefits 

Short-term Employee Benefits 

Short-term employee benefit obligations are measured on an undiscounted basis and are expensed as the 
related service is provided. A liability is recognised for the amount expected to be paid if the Group has a 
present  legal or constructive obligation to pay this amount as a  result of past service  provided by the 
employee, and the obligation can be estimated reliably. 

Defined Contribution Plans 

A  defined  contribution  plan  is  a  post-employment  benefit  plan  under  which  an  entity  pays  fixed 
contributions into a separate entity and has no legal or constructive obligation to pay further amounts. 
Obligations  for  contributions  to  defined  contribution  plans  are  recognised  as  an  employee  benefit 
expense in the periods during which related services are rendered by employees. Prepaid contributions 
are recognised as an asset to the extent that a cash refund or a reduction in future payments is available. 

Phantom Plan 

The Phantom Plan is a cash settled bonus plan. Expense is accrued when it is determined that it is probable 
that a payment will be made and when the amount can be reasonably estimated. 

Provisions 

A  provision  is  recognised  in  the  balance  sheet  when  the  Group  has  a  present  legal  or  constructive 
obligation as a result of a past event, that can be reliably measured and it is probable that an outflow of 
economic benefits will be required to settle the obligation. Provisions are determined by discounting the 
expected future cash flows at a pre-tax rate that reflects risks specific to the liability. 

Revenue Recognition 

The Group recognises revenue to depict the transfer of promised goods to customers in an amount that 
reflects  the  consideration  to  which  it  expects  to  be  entitled  in  exchange  for  those  goods.  In  order  to 
achieve this, the Group uses the five step model outlined in IFRS 15: 1) to identify the contract with the 
customer; 2) identify the performance obligation(s) in the contract; 3) determine the transaction price; 4) 

113 

 
 
FINANCIAL STATEMENTS  

allocate the transaction price to the performance obligation(s); and 5) recognise revenue when (or as) we 
satisfy the performance obligation(s). 

IFRS  15  implements  a  uniform  method  of  recognising  revenue  based  on  the  actual  contract  and 
performance obligation. Under IFRS 15, revenue is recognised when the Company satisfies a performance 
obligation by transferring a promised good or service to its customer. As such, the amount of revenue 
recognised is the amount allocated to the satisfied performance obligation. A performance obligation may 
be satisfied at a point in time (typically for promises to transfer goods to a customer) or over time (typically 
for promises to transfer services to a customer).  

Determining the timing of the transfer of control – at a point in time or over time – requires judgement. 
Based on Group’s assessment, it was concluded that the majority of the Company’s projects that: 

  Render a service is performed on a time and materials basis and revenue is recognised as services 
are  provided  based  on  actual  hours  worked  for  a  set  period.  The  performance  obligations 
identified within these projects are distinct and meet the criteria resulting in transfer of control 
over time.  

  Sell  goods,  revenue  is  recognised  when  the  control  of  the  products  were  transferred  to  the 
customer. The performance obligations identified within these projects are distinct and meet the 
criteria resulting in transfer of control at a point in time.  

Refer to Note 3, "Revenue Recognition," for additional information related to the revenue recognised in 
the consolidated statements of operations. 

Finance Income and Finance Costs 

Finance income mainly comprises interest income on funds invested and foreign exchange gains. Finance 
costs  mainly  comprise  fair  value  movements  on  preferred  share  liabilities,  loan  interest  expense  and 
foreign exchange losses. Interest income and interest payable are recognised as they accrue in profit or 
loss, using the effective interest method. 

Fair Value Measurements 

A number of the Group’s accounting policies and disclosures require the measurement of fair values, for 
both financial and non-financial assets and liabilities. 

When measuring the fair value of an asset or a liability, the Group uses market observable data as far as 
possible. Fair values are categorised into different levels in a fair value hierarchy based on the inputs used 
in the valuation techniques as follows: 

  Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities. 

  Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, 

either directly (i.e. as prices) or indirectly (i.e. derived from prices). 

  Level 3: inputs for the asset or liability that are not based on observable market data (unobservable 

inputs). 

If the inputs used to measure the fair value of an asset or a liability might be categorised in different levels 
of the fair value hierarchy, then the fair value measurement is categorised in its entirety in the same level 
of the fair value hierarchy as the lowest level input that is significant to the entire measurement. 

114 

 
 
FINANCIAL STATEMENTS  

The  Group  recognises  transfers  between  levels of  the  fair  value  hierarchy  at  the  end  of the  reporting 
period during which the change has occurred. 

The  carrying  amount  of  cash  and  cash  equivalents,  accounts  receivable,  deposits,  accounts  payable, 
accrued expenses and other current liabilities in the Group’s Consolidated Statements of Financial Position 
approximates their fair value because of the short maturities of these instruments. 

Operating Segments 

Allied  Minds  determines  and  presents  operating  segments  based  on the  information  that  internally  is 
provided  to  the  executive  management team,  the  body  which  is considered  to  be  Allied  Minds’  Chief 
Operating Decision Maker (‘‘CODM’’). 

An operating segment is a component of Allied Minds that engages in business activities from which it 
may earn revenues and incur expenses, including revenues and expenses that relate to transactions with 
any  of  the  Allied  Minds’  other  components.  The  operating  segment’s  operating  results  are  reviewed 
regularly by the CODM to make decisions about resources to be allocated to the segment, to assess its 
performance, and for which discrete financial information is available. 

Newly adopted standards 

New standards and interpretations adopted in the current year that did not have a material impact on the 
Company’s financial statements were as follows: 

Effective date  

1 January 2021  

New standards or amendments  

Amendments to References to Conceptual Framework in IFRS 
Standards 

Definition of a Business (Amendments to IFRS 3) 

Definition of Material (Amendments to IAS 1 and IAS 8) 

Amendments  to  IFRS  9,  IAS  39  and  IFRS  17:  Interest 
Benchmark reform 

(2)  New Standards and Interpretations not yet effective 

There are a number of new standards, amendments to standard, and interpretations which have been 
issued by the IASB that are effective in future periods that the group has decided not to adopt early.  

The following amendments are effective for the period beginning 1 January 2022: 

Effective date  

1 January 2022  

New standards or amendments  

Onerous  contracts  –  Cost  of  Fulfilling  a  Contract 
(Amendments to IAS 37) 

115 

 
 
 
FINANCIAL STATEMENTS  

References to Conceptual Framework (Amendments to IFRS 3) 

Property, Plant and Equipment: Proceeds before Intended Use 
(amendments to IAS16 

Improvements 

Annual 
(Amendments to IFRS 1, IFRS 9, IFRS 16 and IAS 41) 

IFRS  Standards  2018-2020 

to 

1 January 2023 

IFRS 17 Insurance Contracts 

The  Group  does  not  expect  any  other  standard  issued  by  the  IASB,  but  not  yet  endorsed  by  the  UK 
Endorsement Board (“UKEB”), to have a material impact on the group. 

(3)  Revenue 

Revenue recorded in the Statement of Comprehensive Loss consists of the following: 

For the year ended 31 December: 

Service revenue (and transferred over time) 
Total revenue in Consolidated Statement of Loss 

Contract Balances  

2021 
$'000 

2020 
$'000 

1,544 
1,544 

480 
480    

Contract  liabilities represent  the Group’s obligation to transfer products or services to a customer for 
which consideration has been received. When applicable, contract assets and liabilities are reported on a 
net basis at the contract level, depending on the contracts position at the end of each reporting period. 
Contract  liabilities  are  included  within  deferred  revenue  on  the  Consolidated  Statement  of  Financial 
Position. At the point of inception all contracts were expected to be completed within 12 months and 
therefore, no discounting of the contract liabilities has been accounted for. 

As of 31 December: 

Deferred revenue, current 

2021 
$'000 
(4,948) 

2020 
$'000 
(3,697) 

116 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(4)  Operating Segments  

Basis for Segmentation 

For management  purposes,  the  Group’s  principal operations  are currently  organised  in  three  types  of 
activities: 

(i) 

(ii) 

Early  stage  companies  –  subsidiary  businesses  that  are  in  the  early  stage  of  their  lifecycle 
characterised by incubation, research and development activities; 

Later  stage  companies  –  subsidiary  businesses  that  have  substantially  advanced  with  or 
lifecycle  to 
completed  their  research  and  development  activities,  are  closer 
commercialisation, and/or have a potential of realising material return on investment through a 
future liquidity event; 

in  their 

(iii)  Minority  holdings  companies  –  reflects  the  activity  related  to  portfolio  companies  other  than 
consolidated subsidiary businesses where the Group has made a minority investment and does 
not control or exercise joint control over the financial and operating policies of those entities. This 
segment will only include the results of entities which were deconsolidated during the accounting 
period.  As  of  31  December  2021, this  operating  segment  includes  OcuTerra  Therapeutics,  Inc. 
profit and loss for the period up to deconsolidation on 27 April 2021 as well as Spark Insights, Inc. 
profit and loss for the period up to its disposal on 29 October 2021. 

Minority holdings: During the period there was one deconsolidation and one disposal. The results of the 
two companies up to the point of deconsolidation and disposal, respectively, is included in the Minority 
Holdings segment below and included the following:  

  OcuTerra Therapeutics, Inc., one of the company’s subsidiaries that was deconsolidated during 

the first half of 2021 as a result of financing events at the company. 

  Concirrus LTD (Spark Insights, Inc.) a company in which Allied Minds holds a minority stake. Spark 
was disposed of during the second half of 2021 as a result of the sale of the subsidiary to Concirrus. 
The Group’s CODM reviews internal management reports on these segments at least quarterly in order 
to make decisions about resources to be allocated to the segment and to assess its performance. 

Other operations include the management function of the head office at the parent level of Allied Minds. 

Information about Reportable Segments 

The following provides detailed information of the Group’s reportable segments as of and for the years 
ended 31 December 2021 and 2020, respectively: 

Statement of Comprehensive Loss 

Revenue 
Cost of revenue 
Selling, general and administrative 
expenses 

Later 
Stage 

1,544 
(443) 
 (3,089) 

  Minority 
Holdings 

Other 

  Operation

Consolidate
d 

― 
― 
(1,875) 

s 

― 
― 
(5,605) 

1,544 
(443) 
 (10,569) 

117 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Research and development expenses 

  Other expense 

Finance cost, net  
Share of net loss of associates accounted 
for using the equity method   
Loss for the period 

  Other comprehensive loss 

Total comprehensive loss 

 (2,026) 
520  
15,889 

― 
12,395 
― 

12,395 

 (624) 
 14,398  
(8,089) 

― 
3,810 
― 

3,810 

― 
(13,894) 
(10,588) 

(2,362) 
(32,449) 
(41) 

(32,490) 

 (2,650) 
 1,024  
 (2,788) 

(2,362) 
(16,244) 
(41) 

(16,285) 

Total comprehensive loss attributable to: 

Equity holders of the parent 
Non-controlling interests 

 12,209  
 186  

 4,706  
 (896) 

(32,449) 
― 

 (15,534) 
 (710) 

Total comprehensive loss 

12,395 

3,810 

(32,449) 

(16,244) 

Statement of Financial Position 
  Non-current assets 
Current assets 

Total assets 

  Non-current liabilities 
Current liabilities 

Total liabilities 
Net assets/(liabilities) 

820 
6,262 
7,082 
(75) 
(12,820) 
(12,895) 
(5,813) 

― 
― 
― 
― 
― 
― 
― 

34,409 
14,410 
48,819 
(138) 
1,787 
1,649 
50,468 

35,229 
20,672 
55,901 
(213) 
(11,033) 
(11,246) 
44,655 

Statement of Comprehensive Loss 

Revenue 
Cost of revenue 
Selling, general and administrative 
Research and development expenses 
expenses 
  Other expense 

Finance cost, net  
Share of net loss of associates accounted 
for using the equity method   

Loss for the period 

  Other comprehensive loss 

Total comprehensive loss 

Early Stage 

― 
― 
 (526) 
 (1,420) 
― 
(20) 

― 
(1,966) 
― 

(1,966) 

Later 
Stage 

480 
(210) 
 (2,788) 
 (3,292) 
― 
(5,241) 

― 
(11,051) 
― 

(11,051) 

Total comprehensive loss attributable to: 

Equity holders of the parent 
Non-controlling interests 

 58  
 (2,024) 

(10,596) 
 (455) 

Total comprehensive loss 

 (1,966) 

(11,051) 

Statement of Financial Position 
  Non-current assets 
Current assets 

Total assets 

  Non-current liabilities 
Current liabilities 

Total liabilities 
Net assets/(liabilities) 

 320  
 502  
 822  
(105) 
(3,756) 
 (3,861) 
 (3,039) 

1,288 
7,105 
8,393 
(1,380) 
(27,707) 
(29,087) 
(20,694) 

118 

2020 
$'000 
  Minority 
  Holdings 

Other 

  Operation

Consolidate
d 

― 
― 
― 
― 
― 
― 

― 
― 
― 

― 

― 
― 

― 

― 
― 
― 
― 
― 
― 
― 

s 

― 
― 
(7,183) 
― 
(31,934) 
 3,475  

 (6,845) 
(42,487) 
(116) 

(42,603) 

480 
(210) 
 (10,497) 
 (4,712) 
(31,934) 
(1,786) 

(6,845) 
(55,504) 
(116) 

(55,620) 

(42,487) 
― 

(53,025) 
 (2,479) 

(42,487) 

(55,504) 

42,808 
24,977 
67,785 
(761) 
14,995 
14,234 
82,019 

44,416 
32,584 
77,000 
(2,246) 
(16,468) 
(18,714) 
58,286 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Early Stage companies comprise those that receive an array of business support resources and services 
from  Allied  Minds  in  order  to  successfully  develop  early  stage  technologies.  In  addition,  all  closed  or 
dissolved subsidiaries were presented in the Early Stage segment up to the time at which they were all 
dissolved.  

Later  Stage  companies  comprise  those  that  have  graduated  from  Early  Stage  by  way  of  further 
advancements in their development as described above. This currently includes BridgeComm Inc.  

The results of the management function of the head office at the parent level of Allied Minds are reported 
separately as Other Operations. As the investment in associate is a parent activity, the share of loss, gain 
on  deconsolidation,  remeasurement  of  the  investments  to  fair  value  and  investment  in  associate  are 
disclosed in the Other Operations segment. 

Summarised information related to the Company’s operating revenues by reporting segment for the years 
ended 31 December 2021 and 2020 is as follows: 

Early Stage 
Later Stage 
Minority 
 Total revenue  

2021 

2020 

Service 
revenue 
- 
1,544 
- 
1,544 

Software 
revenue 
- 
- 
- 
- 

Total 
- 
1,544 
- 
1,544 

Service 
revenue 
- 
480 
- 
480 

Software 
revenue 
- 
- 
- 
- 

Total 
- 
480 
- 
480 

In  2021,  Cost  of  revenue  and  Selling,  general  and  administrative  expenses  of Early  Stage,  Later  Stage, 
Minority  Holdings and  Other  Operations segments  included  depreciation  and  amortisation expense  of 
$nil,  $374,240,  $9,239,  and  $166,626,  respectively  (2020:  $10,100,  $460,880,  $0,  and  $179,637, 
respectively). 

The  proportion  of  net  assets  shown  above  that  is  attributable  to  non-controlling  interest  is  disclosed 
further in notes 11 and 15. 

Geographic Information 

The  Group  revenues  and  net  operating  losses  for  the  years  ended  31  December  2021  and  2020  are 
considered  to  be  entirely  derived  from  its  operations  within  the  United  States  and  accordingly  no 
additional geographical disclosures are provided. 

(5)  Operating Expenses 

The average number of persons employed by the Group (including Directors) during the year, analysed by 
category, was as follows: 

For the year ended 31 December: 

2021 

2020 

Selling, general and administrative 
Research and development 

16      
14      

28    
46    

119 

 
 
 
 
  
  
  
  
  
  
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Total 

30 

74    

The aggregate payroll costs of these persons were as follows: 

For the year ended 31 December: 

Selling, general and administrative 
Research and development 

Total 

Total operating expenses were as follows: 

For the year ended 31 December: 

Salaries and wages 
Payroll taxes 
Healthcare benefit 
Other payroll cost 
Share-based payments 
Total 

Cost of revenue 
Other SG&A expenses 
Other R&D expenses 
Total operating expenses 

Auditor's remuneration 
Audit of these financial statements 
Audit-related assurance services 

2021 
$'000 

4,959 
1,378 

6,337 

2021 
$'000 

4,669 
333 
1,020 
34 
281 
6,337 

443 
5,610 
1,272 
13,662 

2021 
$'000 

430 
96 
526 

2020 
$'000 

5,873    
2,619    

8,492    

2020 
$'000 

5,903    
158    
1,338    
41    
1,052    
8,492   

210    
4,624    
2,093    
15,419   

2020 
$'000 

419    
96    
515    

The Group recorded an impairment charge on property and equipment of $0.4 million (2020: $ nil million). 

See  note  6  for  further  disclosures  related  to  share-based  payments  and  note  22  for  management’s 
remuneration disclosures. 

(6)  Share-Based Payments 

UK Long Term Incentive Plan 

120 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Under the UK Long Term Incentive Plan (“LTIP”), awards of Ordinary Shares may be made to employees, 
officers  and  directors,  and  other  individuals  providing  services  to  the  Company  and  its  subsidiaries. 
Awards may be granted in the form of share options, share appreciation rights, restricted or unrestricted 
share awards, performance share awards, restricted share units, phantom-share awards and other share-
based awards. Vesting is subject to the achievement of certain performance conditions and continued 
services of the participant.  

Awards have been granted under the LTIP based on the following vesting criteria: 

  awards subject to performance conditions based on the Company’s total shareholder return (“TSR”) 

performance or relative total shareholder return (rTSR) performance over a defined of time; 

  awards subject to performance conditions based on a basket of shareholder value metrics (“SVM”). 

Performance is assessed on these measures on a scorecard basis over a defined period of time; 

  awards that vest 100 per cent after a period of time subject to continued service condition only. 

On 10 June 2019, the Board determined to retire the long term incentive plan (LTIP) scheme and therefore 
no future awards will be made to executive directors, management and other employees. Historic awards 
remained outstanding and eligible to vest in accordance with their terms.  A significant majority of the 
outstanding awards are subject to relative total shareholder return (TSR) performance; however, at the 
current share price, the performance criteria of these awards will not be met and therefore, no shares are 
expected to be issued under such awards. 

No shares were issued in respect of historic awards under the LTIP during 2021 (2020: 387,000 Ordinary 
shares). A summary of stock option activity under the UK LTIP for the years ended 31 December 2021 and 
2020, respectively, is shown below: 

For the year ended 31 
December: 

Number of shares granted 
at maximum (‘000) 
Weighted average fair value ($) 
Fair value measurement basis 

rTSR 

—     
—     
Monte 
Carlo 

2021 
SVM 

—     
—     
  Market 
value of 
ordinary 
share 

Time 

rTSR 

—     
—     
  Monte 
Carlo 

—     
—     
Market 
value of 
ordinary 
share 

2020 

SVM 

—     
—     
Market 
value of 
ordinary 
share 

Time 

387 
0.36 
Market 
value of 
ordinary 
share 

The  share  grants  that  vest  upon  the  occurrence  of  a  market  condition  (i.e.  the  TSR  performance)  and 
service condition were adjusted to current market price at the date of the grant to reflect the effect of 
the  market  condition  on  the  non-vested  shares’  value.  The  Company  used  a  Monte  Carlo  simulation 
analysis utilising a Geometric Brownian Motion process with 50,000 simulations to value those shares. 
The model takes into account share price volatilities, risk-free rate and other covariance of comparable 
UK public companies and other market data to predict distribution of relative share performance. This is 
applied to the reward criteria to arrive at expected value of the TSR awards. 

The share grants that vest only upon the occurrence of a non-market performance condition (i.e. the SVM 
grants) and service condition or upon passage of time were valued at the fair value of the shares on the 

121 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

date of the grants the vesting conditions are taken into account. The number of instruments included in 
the measurement of the transaction amount is subsequently adjusted so that, ultimately, the amount of 
recognised share-based expense is based on the number of instruments that eventually vest. None of the 
outstanding awards under the LTIP as of 31 December 2021 are subject to SVM vesting.  

The accounting charge does not necessarily represent the intended value of share-based payments made 
to recipients, which are determined by the Remuneration Committee according to established criteria. 
The share-based payment charge for the fiscal year ended 31 December 2021 related to the UK LTIP was 
$0.3 million (2020: $0.9 million). 

U.S. Stock Option/Stock Issuance Plan 

The U.S. Stock Option/Stock Issuance Plan (the “U.S. Stock Plan”) was originally adopted by Allied Minds, 
Inc. (now Allied Minds, LLC) in 2008. The U.S. Stock Plan provides for the grant of share option awards, 
restricted  share  awards,  and  other  awards  to  acquire  common  stock  of  Allied  Minds,  Inc.  (now  Allied 
Minds, LLC). All stock options granted to employees under this plan are equity settled, for a ten-year term. 
Pursuant to the Company’s IPO in 2014, Allied Minds Plc adopted and assumed the rights and obligations 
of Allied Minds, Inc. (now Allied Minds, LLC) under this plan except that the obligation to issue Common 
Stock is replaced with an obligation to issue ordinary shares to satisfy awards granted under the U.S. Stock 
Plan.  As  of  19  June  2014,  the  maximum  number  of  options  reserved  under  the  plan  were  issued  and 
outstanding and as a result of the Company’s IPO in 2014, all issued and outstanding options vested on 
19 June 2014. The Company does not intend to make any further grants under the U.S. Stock Plan. 

No new stock option grants were awarded in 2021 and 2020 under the Allied Minds 2008 Plan. A summary 
of stock option activity in the U.S. Stock Plan is presented in the following table: 

For the twelve months ended: 

31 December 2021 

Number of 
 options 

Weighted 
average 
exercise 
price 

— 
— 
— 
—     
—     

$ nil 

— 
— 
— 
—      
—      

Outstanding as of 1 January 
Exercised during the period 
Forfeited during the period 
Outstanding as of period end 
Exercisable at period end 
Intrinsic value of exercisable 

31 December 2020 
Number of 
 options 

Weighted 
average 
exercise 
price 

230,000    
—     
(230,000)    
—     
—     

$ nil 

$ 2.49 

—     

$ 2.49 

—     
—     

As of 31 December 2021 no options were exercised (2020: nil) resulting in $nil (2020: $ nil) additional 
share premium for the period. 

Allied Minds Phantom Plan 

In  2007,  Allied  Minds  established  a  cash  settled  plan  for  Allied  Minds  employees,  also  known  as  its 
Phantom Plan. In 2012, the Board of Directors adopted the Amended and Restated 2007 Phantom Plan. 
Under the terms of the Amended and Restated Plan, upon a liquidity event Allied Minds will allocate 10% 
of the value (after deduction of the amount invested by Allied Minds and accrued interest at a rate not 

122 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

exceeding 5% per annum) of the invested capital owned by Allied Minds of each operating company to 
the plan account. Upon a liquidity event, plan participants holding units will receive their proportionate 
share of the plan account. The allocated shares at all times remain the sole and exclusive property of Allied 
Minds and holders of units have no rights or interests in Allied Minds.  

Allied Minds has not accrued any expense relating to the Phantom Plan as of 31 December 2021 and 2020. 
Management records an expense relating to this plan when it is probable that a subsidiary will be sold 
and the amount of the payout is reasonably estimable or will be paid out in accordance with the plan. 
Given the current valuation of the investments and the thresholds required for payments to be made, 
management has judged that is unlikely there will be any future payouts in respect of this plan based on 
the position at 31 December 2021. 

Share-based Payment Expense 

The  Group  recorded  share-based  payment charge/ credit  related  to  stock  options  of  approximately 
$281,471 and $1,052,000 for the years ended 31 December 2021 and 2020, respectively. There was no 
income tax benefit recognised for share- based payment arrangements for the years ended 31 December 
2021 and 2020, respectively, due to operating losses.  

The following table provides the classification of the Group’s consolidated share-based payment expense/ 
income as reflected in the Consolidated Statement of Loss: 

 For the year ended 31 December: 

Selling, general and administrative 
Research and development 

Total 

(7)  Finance Cost, Net 

2021 
$'000 

270 
11 

281 

2020 
$'000 

991 
61 

1,052 

The following table shows the breakdown of finance income and cost: 

For the year ended 31 December: 

Interest income on:   
 – Bank deposits   
Foreign exchange gain 
  Finance income 
Interest expense on: 
 – Financial liabilities at amortised cost 
Foreign exchange loss   

 Finance cost contractual   
Loss on fair value measurement of 
subsidiary preferred shares  
  Finance cost 
Total finance cost, net 

2021 
$'000 

2020 
$'000 

45 
— 
45 

(250) 
(5) 
(255) 

(2,578) 
(2,833) 
(2,788) 

292    
(1)   
291    

(313)   
(1)   
(314)   

(1,763)   
(2,077)   
(1,786)   

See note 16 for further disclosure related to subsidiary preferred shares. 

123 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(8)  Loss Per Share 

The  calculation  of  basic  and  diluted  loss  per  share  as  of  31  December  2021  was  based  on  the  loss 
attributable  to  ordinary  shareholders  of  $15.5  million  (2020:  $53.0  million)  and  a  weighted  average 
number of ordinary shares outstanding of 242,187,985 (2020: 241,901,871), calculated as follows: 

Loss attributable to ordinary shareholders: 

2021 
$'000 

2020 
$'000 

Basic 

Diluted 

Basic 

Diluted 

Loss for the year attributed to 
the owners of the Company 
Loss for the year attributed to 
the ordinary shareholders 

(15,534)   

(15,534)   

(53,025)   

(53,025)   

(15,534)   

(15,534)   

(53,025)   

(53,025)   

Weighted average number of ordinary shares: 

2021 

2020 

Basic 

Diluted 

Basic 

Diluted 

Issued ordinary shares on 1 January 

242,187,985 

242,187,985 

 241,563,123  

 241,563,123  

Effect of RSUs issued 

Effect of dilutive shares 

― 

― 

― 

― 

338,748 

338,748 

― 

― 

Weighted average ordinary shares 

242,187,985 

242,187,985 

241,901,871 

241,901,871 

 Loss per share: 

Loss per share 

(9)  Property and Equipment 

2021 
$ 

2020 
$ 

Basic 

(0.06) 

Diluted 

(0.06) 

Basic 

(0.22) 

   Diluted 

(0.22) 

Information regarding the cost and accumulated depreciation of property and equipment, net, consists 
of the following: 

Cost 

in $'000 

Balance as of 31 December 2019 

Additions 
Transfers 

Machinery 
and 
Equipment 

1,049 
64    
(454)   

Furniture 
and 
Fixtures 

71 
— 
— 

Leasehold 
Improvements 
871 
— 
— 

Computers and 
Electronics 

355 
353 
— 

Under 
Construction 
208 
147 
454 

Tota
l 
554 
564 
0 

124 

 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Balance as of 31 December 2020 

Additions 

Disposals 
Impairment 
Deconsolidation of 
subsidiaries 

Balance as of 31 December 2021 

Accumulated Depreciation 
and Impairment loss 

in $'000 

Balance as of 31 December 2019 

Depreciation 
Impairment loss 
Disposals 

Balance as of 31 December 2020 

Depreciation 
Disposals 
Deconsolidation of 
subsidiaries  

Balance as of 31 December 2021 

Property and equipment, net 

in $'000 

Balance as of 31 December 2020 
Balance as of 31 December 2021 

659 
309 

(347) 
— 

— 

621 

71 
— 

— 
— 

— 

71 

871 
— 

— 
— 

— 

871 

708 
15 

— 

809 
— 

(139)  

3,11
8 
324 
(486
) 

— 

(458) 

(458) 

(34) 

689 

— 

212 

(34) 
2,46
4 

Machinery 
and 
Equipment 

Furniture 
and 
Fixtures 

Leasehold 
Improvements 

Computers and 
Electronics 

Under 
Construction 

(300) 

(175) 
― 
― 

(475) 

(221) 
347 

— 

(349) 

(3) 

(14)   
― 
― 

(17) 

(14) 
— 

— 

(31) 

(493) 

(143) 
― 
― 

(636) 

(143) 
— 

— 

(779) 

(273) 

(121) 
― 
― 

(394) 

(144) 
— 

21 

(518) 

― 

― 
― 
― 

— 

— 

— 

—     

Machinery 
and 
Equipment 

Furniture 
and 
Fixtures 

184 

272 

54 

40 

Leasehold 
Improvements 
235 

92 

Computers and 
Electronics 

314 

171 

Under 
Construction 
809 

212 

Tota
l 
(1,0
69) 
(453
) 
― 
― 
(1,5
22) 
(523
) 
347 

21 
(1,6
77) 

Tota
l 
1,59
6 
787 

Impairment of property and equipment of $0.5 million and $ nil for the years ended 31 December 2021 
and 2020, respectively, is mainly attributed to the closing of subsidiary companies, which resulted in the 
associated assets being impaired. Impairment of property and equipment is included in selling, general 
and administrative expenses in the consolidated statement of comprehensive income. 

Property and equipment under constructions represents assets that are in the process of being built and 
not placed in service as of the reporting date.  

(10) 

Intangible Assets 

Information regarding the cost and accumulated amortisation of intangible assets is as follows: 

Cost 
in $'000 

Balance as of 31 December 2019 
  Additions - Acquired separately 
  Disposals 

Software 
926 
— 
— 

Total 

926 
— 
— 

125 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Balance as of 31 December 2020 
  Additions - Acquired separately 
  Disposals 
Balance as of 31 December 2021 

Accumulated amortisation 
and Impairment loss 
in $'000 
lance as of 31 December 2019 
  Amortisation 
Balance as of 31 December 2020 
  Amortisation 

Impairment loss 

Balance as of 31 December 2021 

926 
— 

—   

926 

Software 
(729) 
(197) 
(926) 
— 
— 
(926) 

926 
— 
— 
926 

Total 
(729) 
(197) 
(926) 
— 
— 
(926) 

Intangible assets, net 
in $'000 

Software 
— 
Balance as of 31 December 2020 
— 
Balance as of 31 December 2021 
Amortisation  expense  is  included  in  selling,  general  and  administrative  expenses  in  the  consolidated 
statement of comprehensive loss. Amortisation expense, recorded using the straight-line method, was 
approximately $nil and $197,000 for the years ended 31 December 2021 and 2020, respectively. This is 
mainly attributed to software assets being fully amortized.  

Total 
— 
— 

Impairment of intangible assets was $nil for the years ended 31 December 2021 and 2020. Impairment 
expense  is  included  in  selling,  general  and  administrative  expenses  in  the  Consolidated  Statement  of 
Comprehensive Loss. 

At  each  reporting  period,  management  considers  qualitative  and  quantitative  factors  that  define  the 
future  prospects  of  the  respective  investment  and  assesses  whether  it  supports  the  value  of  the 
underlying intangible. 

(11) 

Investments  

Group Subsidiaries, associates and investments 

As of 31 December 2021, Allied Minds has six portfolio companies, including subsidiaries, associates and 
investments  and two holding companies. As at  the  31 December 2021 the  investments in each of the 
companies and the accounting treatment is summarized below: 

Portfolio company 

Financial instruments held 

Allied Minds LLC 

Ordinary shares 

Accounting treatment of financial 
instruments 
Consolidated by the group in line 
with IFRS 10 and following 
management assessment of 
significant control. 

126 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Allied Minds Securities Corp.  Ordinary shares 

BridgeComm, Inc. 

Ordinary share capital and 
preferred shares 

Concirrus, 
Insights, Inc.) 

LTD 

(Spark 

Preferred shares 

OcuTerra Therapeutics, Inc. 

Ordinary share capital and 
preferred shares 

Federated Wireless, Inc. 

Ordinary share capital and 
preferred shares 

127 

Consolidated by the group in line 
with IFRS 10 and following 
management assessment of 
significant control. 

Consolidated by the group in line 
with IFRS 10 and following 
management assessment of 
significant control. 
Preferred shares are eliminated on 
consolidation between group 
companies, preferred shares held by 
third parties are fair valued through 
profit and loss under IFRS 9. 

The Group has a minority stake in 
the investment and does not have 
significant influence over the 
company. The investment in 
preferred shares is accounted for at 
fair value through the profit and loss 
under IFRS 9. 

The Group has consolidated the 
company up to the point it lost 
control in OcuTerra due to its latest 
financing event and was no longer a 
majority owner. As a result, the 
company was deconsolidated and it 
retained a minority stake in the 
investment. As of the year end, the 
Group does not have significant 
influence over the company. 
Therefore, the investment in 
ordinary shares is accounted for at 
fair value through the profit and loss 
under IFRS 9. Preferred share 
holdings are accounted for at fair 
value through profit and loss as 
investments held by the Group 
under IFRS 9. 

The ordinary share capital ownership 
means that the group has significant 
influence but not control over the 
entity. Therefore, the investment in 
ordinary shares is accounted for by 
the equity method of accounting 

 
 
 
 
 
 
FINANCIAL STATEMENTS  

Orbital sidekick, Inc. 

Preferred shares 

TouchBistro, Inc. 

Ordinary shares 

under IAS 28. 
Preferred share holdings are 
accounted for at fair value through 
profit and loss as investments held 
by the Group under IFRS 9. 

No ordinary shares are owned by 
Allied Minds and the directors have 
judged, at the year end, that the 
group does not have significant 
influence over the entity through its 
preferred share holding. 
Preferred share holdings are 
accounted for at fair value through 
profit and loss as investments held 
by the Group under IFRS 9. 
The group has a minority stake in the 
investment and does not have 
significant influence over the 
company. Therefore, the investment 
in ordinary shares is accounted for at 
fair value through the profit and loss 
under IFRS 9. 

The following outlines the formation of each subsidiary and evolution of Allied Minds’ ownership interest 
over the two year period ended 31 December 2021: 

Inception 
Date 

Location (2) 

Issued and Outstanding 
Ownership percentage 
at 31 December (1)  
2020 
2021 

Active subsidiaries 
Holding companies 
  Allied Minds, LLC  
  Allied Minds Securities Corp.  
Later stage company 
  BridgeComm, Inc. (3) 

  Number of active subsidiaries at 31 December: 

Associates  
  Federated Wireless, Inc. (3) 
  Spin Memory, Inc. 

  Other investments 
  TouchBistro, Inc (4) 
  Orbital Sidekick, Inc. (3) 
  OcuTerra Therapeutics, Inc. (3)(4) 
  Concirrus, LTD. (Spark Insights, Inc.) (3) 

19/06/14 
21/12/15 

09/02/15 

08/08/12 
03/12/07 

08/05/20 
02/08/16 
14/12/10 
10/29/21 

Boston, MA 
Boston, MA 

Denver, CO 

 100.00% 
 100.00% 

  81.15% 
3 

100.00% 
100.00% 

81.15% 
3 

Arlington, VA 
Fremont, CA 

  42.72% 
N/A 

43.11% 
43.01% 

Boston, MA 
San Francisco, CA 
Cambridge, MA 
London, UK 

1.40% 
  26.29% 
  17.06% 
0.98% 

1.52% 
33.23% 
62.67% 
70.59% 

128 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Notes: 

(1)  Represents ownership percentage held by Allied Minds Plc based on the equity interest owned in ordinary shares plus 
potential equity interest owned in convertible preference shares. The current percentage ownership of each company 
ordinary share capital is as follows: Allied Minds LLC 100%, Allied Minds Securities Corp. 100%, BridgeComm, Inc. 
98.47%, OcuTerra Therapeutics, Inc. 75.26%, Federated Wireless 91.71%, TouchBistro 1.40%, Orbital Sidekick 0%;  
(2)  Allied Minds LLC, BridgeComm, Inc., OcuTerra Therapeutics, Inc., Federated Wireless, Inc. and Federated Wireless 

Government Solutions, Inc. have a registered office address at CT Corporation System, Corporation Trust Center, and 
1209 Orange Street, Wilmington, DE 19801, United States. Allied Minds Securities Corp. has a registered office 
address at CT Corporation System, 155 Federal Street, Suite 700, Boston, MA 02110, United States. TableUp Inc. have 
a registered office address at 1209 Orange Street, Wilmington, DE 19801. Orbital Sidekick Inc. has a registered office 
at Corporation Service Company, 251 Little Falls Drive, Wilmington, DE 19808. Concirrus, LTD. has a registred office 
address at New City Court, 20 St. Thomas Street, London SE1 9RS. 

(3)  The preferred shares that Allied Minds has in these companies are accounted for under IFRS 9. 
(4)  The common shares that Allied Minds has in these companies are accounted for under IFRS 9. 

The following tables summarise the financial information related to the Group’s subsidiaries with material 
non-controlling interests, aggregated for interests in similar entities, and before intra-group eliminations. 

As of and for the year ended 31 December: 

Statement of Comprehensive Loss 

  Revenue 

Income for the year 

  Other comprehensive income 

  Total comprehensive income 

  Comprehensive (loss)/ income attributed 

to NCI 

Statement of Financial Position 

  Non-current assets 
  Current assets 

  Total assets 
  Non-current liabilities 
  Current liabilities 

  Total liabilities 
  Net liabilities 

  Carrying amount of NCI 

Statement of Cash Flows 

  Cash flows from operating activities 
  Cash flows from investing activities 
  Cash flows from financing activities 

Early Stage 

2021 
$'000 
Later Stage 

Minority 
Holdings 

-      
-      
-      
-      

-      

-      
-      
-      
-      
-      
-      
-      

- 

-      
-      
-      
-      

1,544 
12,395 

-      

12,395 

186 

-    

3,810 

-    

3,810 

(896) 

 820  
 6,262  
7,082 
 (75) 
 (12,820) 
(12,895) 
(5,813) 

168 

 (2,089) 
 (184)  
 1,387  
(886) 

-    
-    
-    
-    
-    
-    
-    

-    

 13,916  
 -    

 (1,186) 
12,730 

129 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Statement of Comprehensive Loss 

  Revenue 

Loss for the year 

  Other comprehensive loss 

  Total comprehensive loss 

  Comprehensive loss attributed to NCI 

Statement of Financial Position 

  Non-current assets 
  Current assets 

  Total assets 
  Non-current liabilities 
  Current liabilities 

  Total liabilities 
  Net liabilities 

  Carrying amount of NCI 

Statement of Cash Flows 

  Cash flows from operating activities 
  Cash flows from investing activities 
  Cash flows from financing activities 

Investment in Associates 

Early stage 

2020 
$'000 
Later stage 

Minority 
holdings 

-      

             (1,966) 

480 
(11,051) 

-      

-      

             (1,966) 

(2,024) 

 320  
 502  
822 
 (105) 
 (3,756) 
 (3,861) 
 (3,039) 

(3,441)      

 (1,953) 
 (20) 
 184  
(1,789) 

(11,051) 

(455) 

 1,288  
 7,105  
8,393 
 (1,380) 
 (27,707) 
 (29,087) 
 (20,694) 

1,180 

 (6,621) 
 (538) 
 4,707  
(2,452) 

-    
-    
-    
-    

-    

-    

-    
-    
-    

-    
-    
-    
-    

At 31 December 2021, the Group has one associate, Federated Wireless, which is material to the Group 
and is equity accounted. During the year, the group held Spin Memory as an equity accounted for 
associate. Its operations were ceased in the period as the board made the decision to liquidate this 
company. 

Spin Memory: : As of 31 December 2020, Allied Minds’ ownership percentage went from 42.69% to 43.01% 
as a result of the entity’s latest financing round in July 2020. In accordance with IAS 28, once the share of 
losses  of  an  associate  equals  or  exceeds  its  "interest  in  the  associate",  the  investor  discontinues 
recognising its share of further losses. Once Allied Minds’ interest in Spin Memory was reduced to zero 
no further adjustments were made to the investment balance at 31 December 2020. As of 31 December 
2021, Allied Minds’ ownership percentage remained at 43.01%.  

On 23 June 2021, the Board of Spin Memory has taken the decision to liquidate the company. Allied Minds 
first  invested  $1.5  million  in  Spin  Memory  in  November  2007  and  continued  to  provide  funding  in 
subsequent  fundraising  rounds.  Allied  Minds'  total  investment  in  Spin  Memory  is  $50.5  million.  As 
indicated at the full year results in March, and due to the fact the company was not able to secure further 
investment  from  third  parties,  despite  shareholders  providing  operational  and  financial  support,  Spin 
Memory  faced  significant  liquidity  issues.  These  were  due  to  challenges  in  securing  new  customers, 
alongside the impact of COVID-19 which significantly delayed the required testing of its development chip 
with ARM. In light of these challenges and the significant quantum of capital committed to Spin Memory 
to  date,  the  Board  of  Allied  Minds  has  concluded  that  it  is  no  longer  prepared  to  make  any  further 
investment  into  Spin  Memory.  As  of  31  December  2021,  the  liquidation  process  is  pending  final 

130 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

environmental issues and is expected to be completed in Q2 2022.  Based on the Assignments For The 
Benefit Of Creditors (ABC) proceedings Allied Minds expects to get no payment from the process. 

Spin Memory, Inc. 

Group’s interest in net assets of investee, beginning of period 
Share of loss from continuing operations 
Carrying amount for equity accounted investees 
Unrecognised share of losses in associate 
Total outstanding 

  Ownership percentage 

31 December 
2021 

31 December 
2020 

43.01% 

43.01% 

Location 

Fremont, 
CA 

31 December 
2021 
$'000 

31 December 
2020 
$'000 

― 
― 
― 
(37,393) 
(37,393) 

― 
― 
― 
(37,393) 
(37,393) 

Federated Wireless: As of 31 December 2020, Allied Minds’ ownership percentage went from 42.57% to 
43.11%  and  the  investment  in  Federated  Wireless  continues  to  be  subject  to  the  equity  method 
accounting. In accordance with IAS 28, the Company’s investment was adjusted by the share of profits 
and losses generated by Federated Wireless subsequent to the date of deconsolidation. As a result, Allied 
Minds recorded a share of loss of $6.8 million in the Consolidated Statements of Comprehensive Loss for 
the year ended 31 December 2020, that reduced the investment in Federated to a zero balance.  

As of 31 December 2021, Allied Minds’ ownership percentage went from 43.11% to 42.72% and continues 
to be subject to the equity method accounting. No further adjustments were made to the investment 
balance  at  31  December  2021.  If  Federated  Wireless  subsequently  reports  profits,  Allied  Minds  will 
resume recognising its share of those profits only after its share of the profits equals the share of losses 
not recognised. 

  Ownership percentage 

Location 

31 December 2021 

31 December 2020 

Federated Wireless, Inc. 

Arlington, 
VA 

42.72% 

43.11% 

Group’s interest in net assets of investee, beginning of 
period 
Addition in the year 
Share of loss from continuing operations 
Carrying amount for equity accounted investees 
Unrecognised share of losses in associate 
Total outstanding 

131 

31 December 2021 

31 December 2020 

$'000 

$'000 

― 
― 
― 
― 
(53,169) 
(53,169) 

6,845 
― 
(6,845) 
― 
(19,432) 
(19,432) 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

The  following  is  summarised  financial  information  for  Federated  Wireless,  based  on  their  perspective 
consolidated financial statements prepared in accordance with IFRS: 

Federated Wireless 
$'000 

2021 

2020 

11,021 

(36,788) 

10,067 

24,209 

34,276 

(4,516) 

(86,607) 
(56,847) 

2,882 

(28,073) 

17,948 

30,597 

48,545 

(5,804) 

(133,917) 
(91,176) 

Revenue 

        Loss for the period 

Total non-current assets 

Total current assets 

        Total assets 

Total non-current liabilities 

Total current liabilities 
         Net assets 

Investments at fair value 

The Group’s investments at fair value represent securities of portfolio companies where Allied Minds 
holds preferred shares or a minority stake in those companies. These investments are initially measured 
at fair value through profit or loss and are subsequently re-measured at fair value at each reporting date 
and on derecognition. 

The fair value of these investments is derived using the option pricing model (“OPM”), the Probability-
Weighted Expected Return Method (“PWERM”) or a hybrid of the two.  

The key inputs into these valuation models include the equity value of the portfolio company, the term of 
the instrument, risk free rate and volatility.  

The valuation methodologies utilised for determining the equity value include market approach, income 
approach or cost approach or hybrid of these approaches. Other methodologies such as asset based and 
cash in are also utilised where deemed appropriate. It is noted that in the current year none of the equity 
values were determined using the income approach. 

Other valuation approaches 

In certain cases, the value of a portfolio company is determined using a market instead of income- based 
approach.  

Where there has been a third party funding round in the year this has been used as the implied value of 
the portfolio company or comparable guideline public companies or comparable transactions, adjusted 
for indexation where this is deemed to be appropriate. 

Whilst the Board considers the methodologies and assumptions adopted in the valuation are supportable, 
reasonable and  robust,  because  of the  inherent  uncertainty  of valuation,  those  estimated  values  may 
differ significantly from the values that would have been used had a ready market for the investment 
existed and the differences could be material. 

132 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

PWERM and OPM 

The principal methods the Group applies for allocation of value are the PWERM, the OPM as well as a 
hybrid of the two. These models take assumptions such as the equity values, term of the instruments, risk 
free rate and volatility to determine the fair value of each share class.  

The  PWERM  estimates  the  value  of  equity  securities  based  on  an  analysis  of  various  discrete  future 
outcomes, such as an IPO, merger or sale, dissolution, or continued operation as a private enterprise until 
a later exit date. The equity value today is based on the probability-weighted present values of expected 
future investment returns, considering each of the possible outcomes available to the enterprise, as well 
as the rights of each security class. The key judgement relates to probability weighting of the scenarios.  

The OPM treats common stock or derivatives thereof as call options on the enterprise’s value or overall 
equity value. The value of a security is based on the optionality over and above the value securities that 
are senior in the capital structure (e.g. preferred stock), considering the dilutive effects of subordinate 
securities. In the OPM, the exercise price is based on a comparison with the overall equity value rather 
than per-share value. 

Those investments are presented in the below table: 

31 December 
2021 
$'000 
 14,154  
 -    
 8,528  
4,330 

6,276 
 696  

33,984  

Disposals 
$'000 
― 
― 
― 
― 

― 
― 

― 

Finance 
(income)/cost 
from IFRS 9 fair 
value accounting 
$'000 
(14,378) 
(4,821) 
564 
1,559 

2,965 
― 

(14,111)  

Additions* 
$'000 
― 
― 
2,500 
― 

3,311 
696 

6,507 

31 December 
2020 
$'000 
28,532 
4,821 
5,464 
2,771 

― 
― 

41,588 

Federated Wireless, Inc. 
Spin Memory, Inc. 
Orbital Sidekick, Inc. 
TouchBistro, Inc.  
OcuTerra Therapeutics, 
Inc. 
Concirrus, LTD 
Total investments at 
fair value 

* Of the total amount presented in the additions column, $1.0 million was cash used in investing 
activities.  related to Orbital Sidekick’s latest financing. As such, on the cash flow statement, the 
total cash used for purchase of investments consists of that $1.0 million and the $4.3 million noted 
below related to Federated Wireless SAFE. 

Federated  Wireless:  The  Company’s  investment  at  fair  value  in  Federated  Wireless  has  changed  from 
$28.5 million, as reported at 31 December 2020, to $14.2 million at 31 December 2021. The decrease in 
investment balance primarily relates to the IFRS 9 fair value accounting during the period. 

In November 2021, Allied Minds invested $4,283,000 in the form of SAFEs (simple agreements for equity) 
in  Federated  Wireless,  which  will  convert  into shares  of  preferred  stock  in  the company’s  next  equity 
financing  round.  The  entire  instrument  is  measured  at  fair  value  through  profit  or  loss.  The  SAFE  is 
classified  as  a  current  receivable on  Allied Minds’  financial  position.  At 31  December  2021, the  entire 
instrument was adjusted by a fair market gain of $0.2 million. 

133 

 
 
 
 
 
FINANCIAL STATEMENTS  

Spin Memory: The company’s investment at fair value in Spin Memory has changed from $4.8 million, as 
reported at 31 December 2020, to $nil at 31 December 2021. The change was due to the Board’s decision 
to liquidate the company.  

Orbital  Sidekick:  On  6  April  2018,  Allied  Minds  made  an  investment  in  Orbital  Sidekick,  a  company 
developing capabilities in aerial and space-based hyperspectral imaging and analytics, initially for the oil 
and gas industry. Allied Minds has significant influence over financial and operating policies of the investee 
by virtue of its large, albeit minority, stake in the company and its representation on the entity’s board of 
directors. Allied Minds only held shares of preferred stock in Orbital Sidekick. The preferred shares held 
by Allied Minds are not equity-like and therefore these fall under the guidance of IFRS 9 and will be treated 
as  a  financial  asset  held  at  fair  value  where  all  movements  to  the  value  of  Allied  Minds’  share  in  the 
preferred stock will be recorded through the Consolidated Statements of Comprehensive Loss. 

On 13 April 2021, Orbital Sidekick, Inc. ("OSK") completed the closing of its $16 million Series A funding 
round  led  by  Temasek,  an  investment  company  headquartered  in Singapore,  with  participation  from 
Energy Innovation Capital, Syndicate 708, and existing investors Allied Minds and 11.2 Capital. Out of the 
total financing capital raised, Allied Minds invested $2.5 million (including the conversion of its SAFE of 
$1.5 million). As of 31 December 2021, Allied Minds' ownership of Orbital Sidekick's issued share capital 
is 26.29% compared to 33.23% at 31 December 2020. As of 31 December 2021, Allied Minds investment 
held at fair value related to its Preferred Shares in Orbital Sidekick was valued at $8.5 million (31 December 
2020: $5.5 million).  

TouchBistro: On 6 April 2018, Allied Minds made an investment in TableUp, a software provider enabling 
end-to-end  transparency  through  the  restaurant  supply  chain  to  enable  more  effective  inventory  and 
operations management. On 5 August 2020, TableUp was acquired by TouchBistro, Inc. (“TouchBistro”). 
The acquisition was structured as a stock-for-stock transaction in which TouchBistro acquired 100% of the 
shares of TableUp in exchange  for the  issuance of TouchBistro common shares to the  shareholders of 
TableUp. As such, Allied Minds’s investment in preferred stock, along with the convertible note, was fully 
converted into common shares in TouchBistro. A total of 2,542,662 common shares of TouchBistro was 
paid to Allied Minds valued at $5.99 million at the time of the transaction. As a result of the acquisition, 
Allied  Minds’  ownership  percentage  was  1.52%  at  31  December  2020.  Allied  Minds  does  not  have 
significant influence over the investee as it does not hold 20% or more of the voting power of the investee 
as well as it does not have any board representation. As such, the investment does not meet the definition 
of an associate under IAS 28 Equity Accounting (“IAS 28”) and therefore, the common shares are classified 
as an investment at fair value, under IFRS 9 Financial Instruments (“IFRS 9”). As of 31 December 2021, 
Allied Minds' ownership of TouchBistro's issued share capital is 1.40% compared to 1.52% at 31 December 
2020. At 31 December 2021, the fair value of Allied Minds’ investment in TouchBistro was measured at 
$4.3 million (31 December 2020: $2.8 million). 

OcuTerra Therapeutics: As of April 2021, OcuTerra Therapeutics was deconsolidated from the Group’s 
financial statements as a result of the first closing of its Series B Preferred Stock financing round. On that 
date Allied Minds’ issued and outstanding ownership percentage dropped from 62.67% to 27.58%. 

Consequently, since the Company no longer held a majority of the voting rights in OcuTerra Therapeutics 
and did not hold a majority on its board of directors, Allied Minds did not exercise effective control over 
OcuTerra Therapeutics. However, even after the transaction, Allied Minds was able to exercise significant 
influence over the entity by virtue of its large, albeit minority, stake in the company and its representation 

134 

 
 
FINANCIAL STATEMENTS  

on  the  OcuTerra  Therapeutics’s  board  of  directors.  As  such,  only  the  profits  and  losses  generated  by 
OcuTerra  Therapeutics  through  April  2021  were  included  in  the  Group’s  Consolidated  Statements  of 
Comprehensive  Loss.  Upon  the  date  of  deconsolidation,  Allied  Minds  recognised  an  investment  in 
OcuTerra Therapeutics related to its common shares of $2.4 million. Series A Preferred Stock and Series 
B Preferred Stock (collectively the “OcuTerra Therapeutics Preferred Stock”) held by Allied Minds are not 
equity-like and therefore these fall under the guidance of IFRS 9 and will be treated as a financial asset 
held at fair value where all movements to the value of Allied Minds’ share in the preferred stock will be 
recorded through the Consolidated Statements of Comprehensive Loss. At the date of deconsolidation 
these were classified as an investment at fair value of $3.3 million.  The fair value of the investment in 
associate at the  date  of deconsolidation was  based on the value  implied from the third party funding 
round  which  lead  to the  loss  of  control. This  is  a  market  based  valuation  approach.  As  a  result  of  the 
deconsolidation, Allied Minds recorded an unrealised gain of $14.2 million in the Consolidated Statements 
of Comprehensive Loss. The gain was calculated by taking the difference between the fair value of the 
interest retained in the former subsidiary at the date control is lost less the carrying amount of net assets 
adjusted for the non-controlling interests of the former subsidiary.  

On 21 June 2021, OcuTerra completed the third closing of the same Series B financing and as a result, 
Allied Minds’ ownership dropped to 18.98% of the issued and outstanding shares. In addition, Allied Minds 
has  only  1  out  7  Board  of  Directors  representation  and  therefore  it  is  limited  in  its  participation  in 
operating and capital. Based on these factors management have judged that Allied Minds cannot alone 
impact the policy making processes of the company and there are no other material transaction between 
the  investor  and  investee.  It  has  therefore  been  determined,  Allied  Minds  no  longer  has  significant 
influence over the investee and the investment does not meet the definition of an associate under IAS 28 
at this date. As such, Allied Minds’ share of common stock is accounted as an investment at fair value in 
accordance with IFRS 9 for the period beyond 21 June 2021. 

Allied Minds’ investment in common shares was adjusted by the share of loss of $2.4 million generated 
by OcuTerra Therapeutics for the period 27 April through 21 June 2021. This reduced the investment in 
OcuTerra to a zero balance. At 21 June 2021, the investment in OcuTerra’s common shares was accounted 
as an investment at fair value in accordance with IFRS 9. The investment in OcuTerra’s common shares 
was subsequently measured at $2.6 million from $nil at 21 June 2021. This resulted in a gain through profit 
and loss in relation to the fair value of this amount.  

Allied  Minds  recognised  $2.4  million  as  its  share  of  loss  from  OcuTerra  Therapeutics  through  the 
Consolidated Statements of Comprehensive Loss as follows: 

  Ownership percentage 

Location 

31 December 2021   

31 December 
2020 

OcuTerra Therapeutics, Inc. 

Cambridge
, MA 

17.06% 

62.67% 

31 December 2021 

$'000 

31 December 
2020 
$'000 

135 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Group’s interest in net assets of investee, beginning 
of period 
Addition in the year 
Share of loss from continuing operations 
Carrying amount for equity accounted investees 
Unrecognised share of losses in associate 
Total outstanding 

― 
2,362 
(2,362) 
― 
(1,406) 
(1,406) 

― 
― 
― 
― 
― 
― 

Spark Insights: On 29 October 2021, Allied Minds Plc has disposed of its portfolio company, Spark Insights, 
Inc. to Concirrus, a private UK-based insurance technology company. The acquisition was structured as a 
stock-for-stock transaction in which Concirrus acquired 100% of the shares of Spark in exchange for the 
issuance of Concirrus’ Series A1 preferred shares. As such, Allied Minds’s investment in preferred stock, 
along with the promissory notes, was fully converted into preferred shares in Concirrus. A total of 61,252 
Series A1 preferred shares of Concirrus was paid to Allied Minds, valued at $700,000. As at 29 October 
2021,  Allied  Minds'  issued  and  outstanding  ownership  of  Spark  Insights  was  70.44%  and  fully-diluted 
ownership was 60.00%. As a result of the acquisition, Allied Minds’ ownership percentage in Concirrus is 
0.98%. Allied Minds has not retained any board representation as it waived that with the disposal of Spark 
Insights.  As  such,  the  company  does  not  exercise  effective  control  over  Spark  and  as  a  result  was 
deconsolidated from the Group’s financial statements.  

Allocation Model Inputs  

Allied Minds holds shares of preferred stock in Federated Wireless and Orbital sidekick and has significant 
influence over financial and operating policies of the investee by virtue of its stake in the companies and 
representation on the entity’s board of directors. Allied Minds holds a minority interest in the ordinary 
share capital of TouchBistro and a minority interest in the preferred share of Concirrus, where significant 
influence is not held. It also hold a minority interest in the ordinary share capital and preferred stock of 
OcuTerra Therapeutics. The preferred shares and ordinary share capital in the investments noted above 
fall  under  the  guidance  of  IFRS  9  and  will  be  treated  as  a  financial  asset  held  at  fair  value  and  all 
movements to the value of Allied Minds’ share of these assets will be recorded through the Consolidated 
Statements of Comprehensive Income/(Loss). The following presents the quantitative information about 
the significant unobservable inputs used in the fair value measurement of the Group’s financial assets: 

As of 31 December: 
Volatility 
Time to Liquidity (years) 
Risk-Free Rate 
IPO/M&A/Sale Probability 

Sensitivity Analysis 

2021 
51.8%-81.2% 
0.75 - 2.75 
0.29% - 0.89% 
0%/ 100%/ n/a  

2020 
38.8%-73.5% 
1.50 - 3.27 
0.10% - 0.2% 
0%/ 100%/ n/a  

The following summarises the sensitivity from the assumptions made by the Company in respect to the 
unobservable inputs used in the fair value measurement of the Group’s financial assets. The sensitivities 
provided reflect reasonably possible changes to the key assumptions: 

As of 31 December: 

2021 
$'000 

2020 
$'000 

136 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Input 

Enterprise Value 

Volatility 

Time to Liquidity 

Risk-Free Rate (1) 

Sensitivity range  

Financial assets increase/(decrease) 

-2% 
+2% 
-10% 
+10% 
-6 months 
+6 months 
-0.23%/-0.09% 
0.18% /0.02% 

 (780) 
 677  
 171  
 (79) 
 534  
 (1,756) 
 809 
 (465) 

 (451) 
 613  
 602  
 (290) 
 445  
 (198) 
 445  
 (198) 

(1)  Risk-free rate is a function of the time to liquidity input assumption. 

(12) 

Cash and Cash Equivalents 

As of 31 December: 

Bank balances 

Total cash and cash equivalents 

(13) 

Trade and Other Receivables 

As of 31 December: 

Trade receivables  
Prepayments and other current assets 
Total trade and other receivables 

(14) 

Equity 

2021 
$'000 

2020 
$'000 

9,710 
9,710 

24,489    
24,489    

2021 
$'000 

2020 
$'000 

434    
5,478    
5,912    

394   
5,422   
5,816   

ALM's Board of Directors (the "Board") approved a new programme to buy back up to $3.0 million of the 
Group's  shares  ("Buyback  Programme")  during  2021.  Share  purchases  took  place  in  open  market 
transactions  and  were  made  from  time  to  time  depending  on  market  conditions,  share  price,  trading 
volume and other factors. The Buyback Programme ran from the date of the announcement to 6 October 
2021.  The  Buyback  Programme  was  in  accordance  with  Allied  Minds'  general  authority  to  purchase  a 
maximum of 24,218,799 Ordinary Shares, granted by its shareholders at the Annual General Meeting held 
on  12  May  2021  and  the  purpose  was  to  reduce  share  capital.  Shares  purchased  under  the  Buyback 
Programme will be cancelled. As of 31 December 2021, the company has repurchased 2,537,712 of its 
own shares for a total value of $737,678. 

During 2021 and 2020, there were no options exercised under the U.S. Stock Plan. Additionally, no shares 
(2020: 624,862 shares) were issued to existing and former employees of the Group during the year as 
result of vesting of RSUs under the LTIP.   

137 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

As  of  31  December  2021,  11,551,496  ordinary  shares  were  reserved  under  the  U.S.  Stock  Plan  and 
24,781,174 were reserved under the LTIP, see note 6 for further discussion of the share-based payment 
plans.  

The table below explains the composition of equity: 

As of 31 December: 

2021 
$'000 

2020 
$'000 

Equity 
Share capital, $0.01 par value, issued and fully paid 
242,187,985 and 242,187,985, respectively 
Treasury shares 
Translation reserve 
Accumulated profit 

Equity attributable to owners of the Company 

Non-controlling interests 

Total equity 

3,767 

(738) 
1,302 
40,156 
44,487 
168 

44,655 

3,767  

― 
1,343  
55,440 
60,550 
(2,264) 
58,286 

Holders of Ordinary Shares are entitled to vote, on all matters submitted to shareholders for a vote. Each 
Ordinary Share is entitled to one vote. Each ordinary share is entitled to receive dividends when and if 
declared by the Company’s Board of Directors. The Company has not declared any dividends prior to 2020. 
In February 2020, Allied Minds made a special cash dividend payment to shareholders of $39.7 million as 
a result of the sale of Allied Minds’ share in HawkEye in the second half of 2019.    

Translation reserve comprises all foreign exchange differences arising from the translation of the financial 
statements of foreign operations. 

(15) 

Changes in Non-Controlling Interest (“NCI”) 

The following summarises the changes in the non-controlling ownership interest in subsidiaries by 
reportable segment, calculated on the basis of percentage ownership of non-controlling interest in 
voting stock on an as converted basis, excluding liability classified preferred shares: 

Early Stage 
$'000 

Later Stage 
$'000 

Consolidated 
$'000 

Non-controlling interest as of 31 
December 2019 
Share of comprehensive loss 
Effect of change in Company’s 
ownership interest 
Equity-settled share based payments 
Non-controlling interest as of 31 
December 2020 
Share of comprehensive loss 
Effect of change in Company’s 
ownership interest 
Equity-settled share based payments 
Deconsolidation of subsidiaries  

1,533    
(455)   

(18)   
117    

1,177 
(3,424) 

(38) 
32 
2,421 

115    
(2,479)   

(18)   
118    

(2,264) 
(710) 

(96) 
31  
3,207 

(1,418)   
(2,024)   

—       
1    

(3,441) 
2,714  

(58) 
(1) 
786 

138 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Non-controlling interest as of 31 
December 2021 

(16) 

Preferred Shares 

—       

168  

168 

Certain of  the  Group’s  subsidiaries  have  outstanding preferred  shares  which  have  been  classified  as a 
subsidiary  preferred  shares  in  current  liabilities  in  accordance  with  IFRS  9  as  the  subsidiaries  have  a 
contractual obligation to deliver cash or other assets to the holders under certain future liquidity events, 
and/or a requirement to deliver an uncertain number of common shares upon conversion. The preferred 
shares do not contain mandatory dividend rights. The preferred shares are convertible into common stock 
of  the  subsidiary  at  the  option  of  the  holder  and  mandatorily  convertible  into  common  stock  of  the 
subsidiary upon a qualified public offering at or above certain value and gross proceeds specified in the 
agreements or upon the vote of the holders of a majority of the subsidiary preferred shares. Under certain 
scenarios  the  number  of  common  stock  shares  receivable  on  conversion  will  change.  The  Group  has 
elected not to bifurcate the variable conversion feature as a derivative liability, but account for the entire 
instrument at fair value through the income statement.   

The preferred shares are entitled to a vote with holders of common stock on an as converted basis. The 
holders  of  the  preferred  shares  are  entitled  to  a  liquidation  preference  amount  in  the  event  of  a 
liquidation  or  a  deemed  liquidation  event  of  the  respective  subsidiary.    The  Group  recognises  the 
subsidiary preferred shares balance upon the receipt of cash financing, and records the change in its fair 
value for the respective reporting period through profit and loss. Preferred shares are not allocated shares 
of the subsidiary losses. 

As of April 2021, OcuTerra Therapeutics was deconsolidated from the Group’s financial statements as a 
result  of  the  first  closing  of  its  Series  B  Preferred  Stock  financing  round  and  Allied  Minds’  issued  and 
outstanding ownership percentage dropped from 62.67% to 27.58%. On that date, OcuTerra has issued 
$14.1 million in Series B Preferred Shares to its third party investors. In addition, as a result of the round 
OcuTerra’s Series A Preferred Shares and Special Stock went up in value by $7.7 million. 

The following summarises the subsidiary preferred shares balance: 

As of 31 December: 

BridgeComm 
OcuTerra Therapeutics 

Total subsidiary preferred 
shares 

Fair value 
gain or loss 
under IFRS 9 
$'000 

  Disposals 

$'000 

Additions  
$'000 

(5,242) 
7,704 

― 
(21,841) 

― 
14,137 

2020 
$'000 

6,497 
― 

2,462 

(21,841) 

14,137 

6,497 

2021 
$'000 

1,255 
― 

1,255 

The redemption is conditional on occurrence of uncertain future events beyond the control of the 
Group. The amount that would be payable in case of such events is as follows: 

139 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

As of 31 December: 

BridgeComm 

Total liquidation preference 

2021 
$'000 

1,260 

1,260 

2020 
$’000 

6,500 

6,500 

The  fair  value  is  derived  using  the  option  pricing  model  (“OPM”),  the  Probability-Weighted  Expected 
Return Method (“PWERM”) or a hybrid of the two.  

The key inputs into these valuation models include the equity value of the subsidiary, the term of the 
instrument, risk free rate and volatility.  

The  valuation  methodologies  utilised  for  determining  the  equity  value  include  the  market  approach, 
income  approach or cost  approach or hybrid of these  approaches. Other methodologies such as asset 
based are also utilised where deemed appropriate. It is noted that in the current year none of the equity 
values were determined using the income approach.  

Where there has been a third party funding round in the year this has been used as the implied value of 
the portfolio company or comparable guideline public companies or comparable transactions, adjusted 
for indexation where this is deemed to be appropriate. 

Whilst the Board considers the methodologies and assumptions adopted in the valuation are supportable, 
reasonable and  robust,  because  of the  inherent  uncertainty  of valuation,  those  estimated  values  may 
differ significantly from the values that would have been used had a ready market for the investment 
existed and the differences could be significant. 

PWERM and OPM 
The principal methods the Group applies for allocation of value are the PWERM, the OPM as well as a 
hybrid of the two. These models take assumptions such as the equity values, term of the instruments, risk 
free rate and volatility to determine the fair value of each share class.  

The  PWERM  estimates  the  value  of  equity  securities  based  on  an  analysis  of  various  discrete  future 
outcomes, such as an IPO, merger or sale, dissolution, or continued operation as a private enterprise until 
a later exit date. The equity value today is based on the probability-weighted present values of expected 
future investment returns, considering each of the possible outcomes available to the enterprise, as well 
as the rights of each security class. The key judgement relates to probability weighting of the scenarios.  

The OPM treats common stock or derivatives thereof as call options on the enterprise’s value or overall 
equity value. The value of a security is based on the optionality over and above the value securities that 
are senior in the capital structure (e.g. preferred stock), considering the dilutive effects of subordinate 
securities. In the OPM, the exercise price is based on a comparison with the overall equity value rather 
than per-share value. 

140 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Allocation Model Inputs  

The following presents the quantitative information about the significant unobservable inputs used in the 
fair value measurement of the Group’s subsidiary preferred shares liability: 

As of 31 December: 
Volatility 
Time to Liquidity (years) 
Risk-Free Rate 
Probability M&A 

Sensitivity Analysis 

2021 
77.7% 
2.00 
0.73% 
n/a 

2020 
53.6% 
2.00 
0.10% 
100% 

The following summarises the sensitivity from the assumptions made by the Company in respect to the 
unobservable  inputs  used  in  the  fair  value  measurement  of  the  Group’s  subsidiary  preferred  shares 
liability. Option Pricing Model and Probability Weighted Expected Return Method Inputs for Investments 
Held at Fair Value at 31 December 2021 and 2020 respectively: 

OPM Measurement Date 

As of: 

Input 

Sensitivity range 

Enterprise Value 

Volatility 

-2% 

+2% 

-10% 

+10% 

Time to Liquidity 

-6 months 

+6 months 

Risk-Free Rate 

-0.17/-0.02 

0.12/ 0.02 

2021 

$'000 

 (3) 

 35  

 35  

 (3) 

 35  

 (3) 

 35  

 (3) 

2020 

$'000 

(112) 

114 

266 

(264) 

117 

(112) 

117 

(112) 

(1) Risk-free rate is a function of the time to liquidity input assumption. 

The subsidiary preferred shares are measured at fair value through profit/loss (FVTPL) according to IFRS 
9 at initial recognition and upon subsequent measurement. Hence, any gains and losses on the preferred 
shares liability are recognised in profit or loss, unless they relate to changes in the entity’s own credit risk 
for financial liability designated as at fair value through profit or loss. The effect of changes in the entity’s 
own credit risk in the fair value of the financial liabilities are presented in other comprehensive income. 
There were no adjustments considered for movement in credit risk  as this is not applicable within the 
specific  valuation  frameworks  utilized  for  the  fair  values  of  the  Group’s  preferred  share  liability.   The 
subsidiary  preferred  shares  values  and  movement  in  credit  risk,  if  applicable,  are  being  constantly 
monitored as new information becomes available. For the year ended 31 December 2021, the change in 

141 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

fair value of the subsidiary preferred shares is recorded in Finance cost, net in the consolidated statement 
of comprehensive loss. 

(17) 

Trade and Other Payables 

As of 31 December: 

Trade payables 
Accrued expenses 
Other current liabilities 
Trade and other payables, current 

(18) 

Loans 

As of 31 December: 

Current liabilities - Loans: 
Unsecured loans 
Paycheck Protection Program (PPP) 
loans* 
Non- Current liabilities - Loans: 
Unsecured loans 
Total loans 

2021 
$'000 

210 
525 
326 
1,061 

2020 
$'000 

319    
1,457   
325    
2,101    

2021 
$'000 

2020 
$'000 

3,109 

― 

― 
3,109 

2,965 

184 

1,440 
4,589  

*Two subsidiaires of the Group during the year, Spark Insights and BridgeComm, have received PPP loans 
under the CARES Act in 2020 ($0.2 million) and 2021 ($0.2 million). At 31 December 2021, the full PPP 
balance decreased from $443 thousand to $nil due to PPP loan forgiveness in current period. 

The terms and conditions of outstanding loans are as follows: 

2021 
$'000 

2020 
$'000 

As of 31 December: 

Unsecured loan(1) 
Unsecured loan(2) 
Unsecured loan(3) 
Total interest bearing 
liabilities 

Currency 

Nominal 
interest 
rate 

Year of 
maturity 

Face value 

Carrying 
amount 

Face value 

Carrying 
amount 

USD 
USD 
USD 

5.0% 
12.0% 
8.0% 

2020-22 
2021-21 
2020-22 

2,500 
― 
― 

2,500 

3,109 
― 
― 

3,109 

2,500 
100 
1,325 

3,825 

2,862 
103 
1,440 

4,589 

BridgeComm convertible note (1) 
On 16 December 2020, BridgeComm secured $1.0 million of funding through the issuance of a convertible 
bridge note to Boeing HorizonX Ventures, LLC (“Boeing”). All principal and accrued interest shall be due 
and payable on 30 June 2022. In August 2021, as a result of achieving certain development milestones 
under  the  JDA  with  Boeing,  BridgeComm  secured the  remaining $1.5  million of  convertible  debt  from 

142 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
 
FINANCIAL STATEMENTS  

Boeing. The  $2.5 million  promissory  note  was  issued  at  a  5.0%  interest  rate  that will  be  compounded 
monthly and computed on the basis of a year of 365 days for the actual number of days elapsed and shall 
be  paid on the maturity date. The  loan balance  is due  to amortize  withinthe 12 months following the 
reporting date and will be classed as a current liability. The entire instrument is measured at fair value 
through profit or loss due to the conversion feature being an embedded derivative. At 31 December 2021, 
the entire instrument was adjusted upward by a fair market change of $0.1 million.   

OcuTerra Therapeutics promissory note (2) 
On 23 September 2020, OcuTerra Therapeutics secured $0.1 million of funding through the issuance of a 
promissory note to multiple investors at annual interest rate of 12.0% payable within one year from the 
date of issuance. The note was issued at an interest rate that will accrue on the unpaid Principal Amount 
at the rate of twelve (12%) per annum computed on the basis of a 365-day year. The note converted into 
preferred shares upon the closing of the Series B funding in April 2021. 

OcuTerra Therapeutics convertible note (3) 
On 5 November 2020, OcuTerra Therapeutics secured $0.95 million of funding through the issuance of a 
convertible  bridge  note  to  multiple  investors  at  annual  interest  rate  of  8.0%.  On  10  January  2021, 
OcuTerra  Therapeutics  raised  an  additional  $0.4  million  in  the  second  closing  of  its  convertible  note 
financing. The note was issued at an interest rate that will accrue on the unpaid Principal Amount at the 
rate of eight (8%) per annum, payable at the maturity date (36 month anniversary of the closing date). All 
accrued interest shall be computed on the basis of a 360-day year consisting of twelve 30-day months, 
and  shall  be  payable  on  the  date  the  outstanding  principal  amount  shall  become  due  and  payable, 
whether on the Maturity Date or by acceleration or otherwise, or upon conversion. The entire instrument 
and the offsetting discount will be measured at fair value through profit or loss as the conversion feature 
fails the fixed for fixed equity classification. The convertible note of $1.5 million converted into preferred 
shares upon the closing of the Series B funding in April 2021. 

(19) 

Leases 

Office and laboratory space is rented under non-cancellable operating leases. These lease agreements 
contain various clauses for renewal at the Group’s option and, in certain cases, escalation clauses typically 
linked to rates of inflation. 

Right of use asset 

Balance at 1 January  

Additions 

Depreciation 

Deconsolidation 
Balance at 31 December 

2020 
$000s 
1,016 

-    

(365) 

-    

651 

2021 
$000s 
651 

192 

 (316) 

 (113) 
414 

143 

 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Lease liability 

Balance at 1 January 
Additions 
Cash paid  
Interest expense 
Deconsolidation 

Balance at  31 December 

2021 
$000s 
1,830 
 192  
 (1,100) 
 71  
 (120)  

873 

2020 
$000s 
2,854 
-    
(1,150) 
126 
-    

1,830 

The following details the short term and long-term portion of the lease liability as at 31 December 2021: 

Lease liability released in < 1 year 
Lease liability released in over 1 year 
Total Lease Liability 

Total lease liability 
$000s 
660 
213 
873 

During 2019, the Group relocated its corporate headquarters and as a result it sub-leased the office space 
that has been presented as part of a right-of-use asset. As the sub-lease is for all of the remaining useful 
economic life of the right-of-use asset, the sub-lease is classified as a finance lease. 

The  following  table  sets  out  a  maturity  analysis  of  lease  receivables,  showing  the  undiscounted  lease 
payments to be received after the reporting date. Under IAS 17, the Group did not have any finance leases 
as a lessor. 

In thousands of $ 
Less than 1 year 
Between 1 and 5 years 
More than 5 years 

Total undiscounted lease receivable 
Unearned finance income 
Net investment in the lease 

31 December 2021 
438 
-   
-   
438 

(24) 
414 

Additions  in  the  period  relate  to  site  leases  that  were  entered  into  by  Allied  Minds’  consolidated 
subsidiaries during 2021. Amounts were arrived at using the contractual minimal lease payments, present 
valued using the applicable incremental borrowing rate of 5.0%. 

Amounts recognised in profit or loss 

In thousands of $ 

2021 – Leases under IFRS 16 

Interest on lease liabilities 

Income from sub-leasing right-of-use assets presented in 
‘interest income’ 

31 December 2021 

71 

45 

144 

 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(20) 

Financial Instruments and Related Disclosures 

The following table shows the carrying amounts and fair values of financial assets and financial liabilities, 
including their levels in the fair value hierarchy: 

As of 31 December: 

Financial assets designated as fair 
value through profit or loss 
Investments at fair value 

Convertible note receivable 

Loans and receivables 

Cash and cash equivalents 
Trade and other receivables 
Security and other deposits 

Total 

Financial liabilities designated as fair 
value through profit or loss 
      Convertible notes 

Subsidiary preferred shares 
Financial liabilities measured at 
amortised cost 

Trade and other payables 
Lease liability 

Total 

As of 31 December: 

Financial assets designated as fair 
value through profit or loss 
Investments at fair value 

Convertible note receivable 

Loans and receivables 

Cash and cash equivalents 
Trade and other receivables 
Security and other deposits 

Total 

Financial liabilities designated as fair 
value through profit or loss 
      Convertible notes 

Subsidiary preferred shares 

2021 
$'000 
Fair value 

Level 1 

Level 2 

Level 3 

 Total 

— 

— 

— 

— 
— 

— 

— 

— 

— 
— 

33,984 

33,984 

4,500 

4,500 

38,484 

38,484 

3,109 
1,255 

3,109 
1,255 

— 

— 

4,364 

4,364 

2020 
$'000 
Fair value 

Level 1 

Level 2 

Level 3 

 Total 

— 

— 

— 

—  

41,588 

41,588 

1,500 

1,500   

— 

—  

43,088 

43,088 

Carrying 
Amount 

33,984 

4,500 

9,710 
5,912 
594 

54,700 

3,109 
1,255 

1,061 
873 
6,298 

Carrying 
Amount 

41,588 

1,500    

24,489  
5,816  
1,360   

74,753 

4,590    
6,497    

— 
— 

— 
— 

4,590 
6,497 

4,590    
6,497    

145 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Financial liabilities measured at 
amortised cost 

Trade and other payables 
Lease liability 

Total 

2,101    
1,830    
15,018   

— 

— 

11,087 

11,087  

Total other financials assets were as follows: 

For the year ended 31 December: 

Deposits 
Other long term assets 
Total 

Convertible note receivable 
Other current assets 
Total  

2021 
$'000 

44 
— 
44 

4,500 
550 
5,050 
5,094 

2020 
$'000 

81 
500 
581 

1,500 
779 
2,279 
2,860 

The fair value of financial instruments that are not traded is determined by using valuation techniques 
that maximise the use of observable market data where it is available and rely as little as possible on entity 
specific  estimates.  If  all  significant  inputs  required  to  fair  value  an  instrument  are  observable,  the 
instrument is included in Level 2. Where the inputs for determining the fair value of financial instruments 
are not based on observable market data, the instrument is included in Level 3. See the assumptions for 
the valuation of the Convertible note receivable as disclosed in note 11 of the financial statements. As 
such, for assumptions used in the fair value measurement of the Group’s convertible notes designated as 
Level 3, see note 18.  

For assumptions used in the fair value measurement of the Group’s subsidiary preferred shares liability 
designated as Level 3, see note 16. For assumptions used in the fair value measurement of Investments 
at fair value designated as Level 3, see note 11. 

Cash and cash equivalents, trade receivables, and trade payables are carried at cost, which approximates 
fair value because of their short-term nature. 

The movement in the convertible loan note assets are presented in the below table: 

31 December 
2021 
$'000 
 4,500 
 ― 

Disposals 
$'000 
― 
(2,500) 

Movement from 
IFRS 9 fair value 
accounting 
$'000 
217 
― 

Additions 
$'000 
4,283 
1,000 

31 December 
2020 
$'000 
― 
1,500 

 4,500 

(2,500) 

217  

5,283 

1,500 

Federated Wireless, Inc. 
Orbital Sidekick, Inc. 
Total convertible loan 
note assets at fair value 

146 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(21) 

Capital and Financial Risk Management 

The  Group’s  policy  is  to  maintain  a  strong  asset  base  so  as  to  maintain  investor,  creditor  and  market 
confidence and to sustain future development of the business. Management monitors the level of capital 
deployed and available for deployment in subsidiary projects. The Board of Directors seeks to maintain a 
balance between the higher returns that might be possible with higher levels of deployed capital and the 
advantages and security afforded by a sound capital position. 

The Group’s executive management and Board of Directors have overall responsibility for establishment 
and oversight of the Group’s risk management framework. The Group is exposed to certain risks through 
its normal course of operations. The Group’s main objective in using financial instruments is to promote 
the commercialisation of intellectual property through the raising and investing of funds for this purpose. 
The Group’s policies in calculating the nature, amount and timing of funding are determined by planned 
future investment activity. Due to the nature of activities and with the aim to maintain the investors’ funds 
secure and protected, the Group’s policy is to hold any excess funds in highly liquid and readily available 
financial instruments and reduce the exposure to other financial risks. 

The Group has exposure to the following risks arising from financial instruments: 

Credit Risk 

Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument 
fails  to  meet  its  contractual  obligations.  Financial  instruments  that  potentially  subject  the  Group  to 
concentrations  of  credit  risk  consist  principally  of  cash  and  cash  equivalents,  investments  held  at  fair 
value, and trade and other receivables. 

The Group held following balances: 

As of 31 December: 

2021 
$'000 

2020 
$'000 

Cash and cash equivalents 
Investments held at fair value 
Trade and other receivables 

9,710 
33,984 
5,912 
49,606 

24,489 
41,588 
5,816 
71,893 

Risk control assesses the credit  quality of the customer, taking into account  its financial position, past 
experience and other factors. Individual risk limits are set based on ratings in accordance with limits set 
by the Board. The utilisation of credit limits is regularly monitored. The credit quality of financial assets 
that are neither past due nor impaired can be assessed by reference to credit ratings (if available) or to 
historical information about counterparty default rates. 

Group policy is to maintain its funds in highly liquid deposit accounts with reputable financial institutions.  

The Group’s investments in preferred stock are accounted for at fair value through profit or loss (FVTPL) 
in accordance with IFRS 9. This measurement is appropriate as these financial assets are not held with the 
objective to collect contractual cash flows which are solely payments of principal and interest (SPPI) on 

147 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

the principal amount outstanding.  The entity is primarily focused on fair value information and uses that 
information to assess the asset’s performance and to make  decisions. The subsidiary preferred shares 
values and movement in credit risk are being constantly monitored as new information becomes available. 

The Group has a concentration of credit risk in respect of its financial assets held at fair value through the 
profit or loss which relate to ordinary and preferred share investments with movements in fair value of 
$14.1 million. Of this balance $14.4 million in losses relates specifically to the preferred shares held in 
Federate Wireless for the period. These investments are reviewed in detail in note 11. The Group assesses 
the credit quality of customers, taking into account their current financial position. 

The aging of trade receivables that were not impaired was as follows: 

As of 31 December: 

2021 
$'000 

2020 
$'000 

Neither past due nor impaired 
Past due 30-90 days 
Past due over 90 days 
Reserve for bad debt 

434 
―  
―  
―  
434 

135    
259    
―  
―  
394    

An analysis of the credit quality of trade receivables that are neither past due nor impaired is as follows: 

As of 31 December: 

Customers with less than three years of 
trading history with the Group 

Liquidity Risk 

2021 
$'000 

2020 
$'000 

434 
434 

394  
394  

Liquidity risk is the risk that the Group will encounter difficulty in meeting the obligations associated with 
its financial liabilities that are settled by delivering cash or another financial asset. The Group’s approach 
to managing liquidity is to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities 
when they are due, under both normal and stressed conditions, without incurring unacceptable losses or 
risking damage to the Group’s reputation. 

The Group seeks to manage liquidity risk, ensuring that sufficient liquidity is available to meet foreseeable 
requirements. 

The following are the remaining contractual maturities of financial liabilities at the reporting date. The 
amounts are gross and undiscounted, and include estimated interest payments and exclude the impact 
of netting agreements.  

As of 31 December 2021: 

$'000 

Carrying 
amount 

Total 

Contractual cash flows 
Less than 
1 year  

2-5 years 

  More than 
5 years 

Trade and other payables 

1,061 

1,061 

1,061 

—     

—     

148 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Convertible loan notes 
Subsidiary preferred shares 
Lease liability  

3,109 
1,255 
873 
6,298 

3,109 
1,255 
873 
6,298 

3,109 
1,255 
660 
6,085 

—     
—     
213 
213 

—     
—     
—     
—     

As of 31 December 2020: 

$'000 

Trade and other payables 
Convertible loan notes 
Subsidiary preferred shares 
Lease liability  

Carrying 
amount 

Total 

Contractual cash flows 
Less than 
1 year  

2-5 years 

  More than 
5 years 

2,101 
4,590 
6,497     
1,830 
15,018 

2,101 
4,590 
6,497     
1,830 
15,018 

2,101 
3,150 
6,497     
1,830 
13,578 

—     
1,440 
—     
—     
1,440 

—     
—     
—     
—     
—     

It is not expected that the cash flows included in the maturity analysis could occur significantly earlier, or 
at significantly different amounts. 

Market Risk 

Market risk is the risk that changes in market prices – such as foreign exchange rates, interest rates and 
equity prices – will affect the Group’s income or the value of its holdings of financial instruments. The 
objective of market risk management is to manage and control market risk exposures within acceptable 
parameters,  while  optimising  the  return.  The  Group  maintains  the  exposure  to  market  risk  from  such 
financial instruments to insignificant levels. The Group exposure to changes in interest rates is determined 
to be insignificant. 

Capital Risk Management 

The Group is funded by equity finance and long term borrowings. Total capital is calculated as ‘total equity’ 
as shown in the consolidated statement of financial position. 

The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going 
concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain 
an  optimal  capital  structure  to  reduce  the  cost  of  capital.  In  order  to  maintain  or  adjust  the  capital 
structure, the Group may issue new shares or borrow new debt. The Group has some external debt in the 
form of preferred shares and no material externally imposed capital requirements. The Group’s share 
capital is set out in note 16. 

149 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(22) 

Related Parties 

Transactions with Key Management Personnel 

Key Management Personnel Compensation 

Key management personnel compensation received comprised the following: 

For the year ended 31 December: 

 Short-term employee benefits   
 Share-based payments   

Total 

2021 
$'000 
18 
—  
18 

2020 
$'000 
1,022 
   105 
1,127 

Short-term employee benefits of the Group’s key management personnel include salaries and bonuses, 
health care and other non-cash benefits. 

Share-based payments include the value of awards granted under the LTIP during the year. Share-based 
payments under the LTIP are subject to vesting terms over future periods. See further details of the two 
plans in note 6. 

Key Management Personnel Transactions 

Directors’ remuneration for the year comprised the following: 

For the year ended 31 December: 

Executive Directors’ fees 
Non-executive Directors' fees 

 Total 

2021 
$'000 
18  
345 
363 

2020 
$'000 
1,127  
359  
1,486 

Executive management and Directors of the Company control 0.6% of the voting shares of the Company 
as of 31 December 2021 (2020: 0.6 %). 

The Group has not engaged in any other transactions with key management personnel or other related 
parties. 

(23) 

Taxation 

Amounts recognised in profit or loss 

No current income tax expense was recorded for the years ended 31 December 2021 and 2020 due to 
accumulated losses.  

For the year ended 31 December: 

2021 
$'000 

2020 
$'000 

Net income/(loss) 

(15,534) 

(53,025) 

150 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Income taxes 
Net income/(loss) before taxes 

—  
(15,534) 

—  
(53,025) 

Reconciliation of Effective Tax Rate 

The Group is primarily subject to taxation in the US, therefore the reconciliation of the effective tax rate 
has been prepared using the US statutory tax rate. A reconciliation of the US statutory rate to the effective 
tax rate is as follows: 

US federal statutory rate 
Effect of state tax rate in US 
Research credits 
Share-based payment remeasurement 
Permanent differences from consolidation 
Other permanent differences 
Current year income/(losses) for which no deferred  
tax asset/(liability) is recognised 

2021 
% 

2020 
% 

21.0 
5.7 
1.4 
(0.5) 
52.7 
2.2 

(82.5) 
—  

21.0 
5.3 
0.7 
(0.4) 
1.2 
(0.7) 

(27.1) 
—  

Factors that may affect future tax expense 

The Group is subject to taxation in the US and UK. Additionally, the Group is exposed to state taxation in 
various jurisdictions throughout the US. Changes in corporate tax rates can change both the current tax 
expense (benefit) as well as the deferred tax expense (benefit). A UK corporation tax rate of 25% (effective 
1 April 2023) was substantively enacted on 23 May 2021, increasing the rate from 19% to 25% for future 
periods.  

Unrecognised Deferred Tax Assets 

Deferred tax assets have not been recognised in respect of the following items, due to history of operating 
losses and no convincing evidence that future taxable profit will be available against which the Group can 
use the benefits therefrom, as well as due to potential permanent restrictions under Internal Revenue 
Code Section 382 rules: 

As of 31 December: 

Tax loss carry forward  
Research credits  
Temporary differences  
Deferred tax assets 

Other temporary differences  
Deferred tax liabilities 

Deferred tax assets, net, not recognised 

2021 
$’000 

2020 
$'000 

74,282    

5,201    

24,291    

103,774    
— 
— 
103,774    

79,285 

7,022 

15,494 

101,801 
— 
— 
101,801 

151 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Deferred  tax  is  measured  at  the  rates  that  are  expected  to  apply  in  the  period  when  the  temporary 
differences are expected to reverse, based on tax rates and laws that have been enacted or substantially 
enacted by the statement of financial position date.  

As  of  31  December  2021  the  Company  had  United  States  federal  net  operating  losses  carry  forwards 
(“NOLs”) of approximately $277.6 million (2020: $292.7 million) available to offset future taxable income, 
if any.  These carryforwards start to expire in 2024 and are subject to review and possible adjustment by 
the  Internal  Revenue  Service.   The  Company  may  be  subject  to  limitations  under  Section  382  of  the 
Internal Revenue Code as a result of changes in ownership. The Company’s preliminary analysis on the 
impact from Section 382 limitations suggests that there is unlikely to be a material restriction on NOLs. A 
detailed exercise is ongoing.  Upon the completion of the study, there may or may not be limitations on 
the Company’s ability to utilise its current NOLs against future profits, although these are not expected to 
be material. 

(24) 

Subsequent Events 

On 28 March 2022, Allied Minds plc (LSE: ALM) has completed the disposal of its residual shareholding in 
TouchBistro for $5.5 million CAD ($4.4 million USD) in line with its strategy of monetising its investment 
portfolio. Of the sale proceeds, $5.0 million CAD has been received and $0.5 million CAD is to be held in 
escrow, with an initial release date in the third quarter of 2022, subject to any then outstanding claims.  

On 2 May 2022, Federated Wireless, Inc., ("Federated"), the industry leader in enterprise shared 
spectrum 5G private wireless, completed a $72.0 million in Series D funding at a pre new-money 
valuation of $230.0 million. Participants in Federated's latest financing round include an affiliate of 
Cerberus Capital Management, L.P. ("Cerberus"), a new investor, alongside existing investors GIC 
(Singapore's sovereign wealth fund) and Allied Minds.  

On 8 June 2022, Allied Minds and AE Industrial HorizonX Venture Fund I, LP (HorizonX), jointly 
contributed an aggregate of $0.8 million of convertible bridge financing to BridgeComm, each 
contributing $0.4 million. The bridge financing will be applied to support the business to the completion 
of a new financing round. 

COMPANY BALANCE SHEET 

As of 31 December 

Note 

2021 
$ '000 

2020 
$ '000 

Non-current assets 

Loan to subsidiary 
Total non-current assets 
Current assets 

Cash and cash equivalents  
Trade and other receivables  

53,271 
53,271 

1,682 
307 

92,648 
92,648 

1,756 
284 

3  

2  

152 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
  
 
 
FINANCIAL STATEMENTS  

Total current assets 
Total assets 
Equity 
Share capital 
Treasury shares 
Translation reserve 
Accumulated reserves 
Total equity 
Current liabilities 

Trade and other payables 

Total current liabilities 
Total liabilities 
Total equity and liabilities 

4  
4  
4  
4  
4  

1,989 
55,260 

3,767 
(738) 
(55,215) 
107,357 
55,171 

89 
89 
89 
55,260 

2,040 
94,688 

3,767 
— 
(59,394) 
150,080 
94,453 

235 
235 
235 
94,688 

As permitted by Section 408 of the Companies Act 2006, the Company’s profit and loss account has not 
been  included  in  these  financial  statements.  The  Company’s  loss  for the year was  $38,177,000  (2020: 
$55,917,000). 

Registered number:  

The financial statements on pages 98 to 159 were approved by the Board of Directors and authorised for 
issue on 14 June 2022 and signed on its behalf by: 

Harry Rein 
Non-Executive Chairman 

153 

 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

COMPANY STATEMENT OF CHANGES IN EQUITY 

For the year ended 31 
December 2021 

Balance at 31 December 
2019 

Total comprehensive loss for 
the year 

Loss for the year 
Foreign currency 
translation 

Total comprehensive loss for 
the year 

Issuance of ordinary 
shares 
Dividend payment 
Equity-settled share 
based payments 
Balance at 31 December 
2020 

Total comprehensive loss for 
the year 

Loss for the year 
Foreign currency 
translation 

Total comprehensive loss for 
the year 

Issuance of ordinary 
shares 
Repurchase of ordinary 
shares 
Equity-settled share 
based payments 
Balance at 31 December 
2021 

241,563,123 

— 

— 

624,862    
— 

— 

$'000 

3,759 

— 

— 

8    
— 

— 

242,187,985 

3,767    

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

Share capital 

Treasury shares 

Share 

Translation 

Accumulated 

Shares 

Amount 

Shares 

Amount 
$' 000 

premium 

$'000 

reserve 

$'000 

reserves 

$'000 

Total 

equity 

$'000 

— 

— 

— 
— 

— 

— 

— 

— 

— 

— 

— 

— 
— 

— 

— 

— 

— 

— 

 (2,538) 

 (738) 

— 

— 

— 

— 

— 

— 
— 

— 

— 

— 

— 

— 

— 

— 

— 

(54,612) 

239,876   

189,023    

—     

(55,917) 

(55,917) 

(4,782)   

(4,782)   

— 
— 

— 

4,894    

112 

(51,023) 

(55,805) 

— 
(39,707)   

934    

8    
(39,707)   

934    

94,453 

(59,394) 

150,080 

—     

4,179 

4,179 

— 

— 

— 

(38,177) 

(38,177) 

(4,796) 

(617) 

(42,973) 

(38,794) 

— 

— 

250 

— 

 (738) 

250 

(55,215)   

107,357   

55,171 

242,187,985 

3,767    

 (2,538) 

 (738) 

154 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

COMPANY STATEMENT OF CASH FLOWS 

For the year ended 31 December: 

Cash flows from operating activities: 
  Net operating loss for the year 
  Adjustments to reconcile net loss to net cash 

used in operating activities: 

Share-based compensation expense 
Impairment loss in loan to subsidiary 
Changes in working capital: 

Increase in trade and other receivables 
  Decrease in trade and other payables 

  Other finance income /(cost) 
Net cash used in operating activities 
Cash flows from investing activities: 

Proceeds from issuance of note receivable  
Repayments of note receivable from subsidiary 

Net cash provided by investing activities 
Cash flows from financing activities: 
     Payments to repurchase ordinary shares 
Proceeds from issuance of share capital 

  Dividend payment 
Net cash used in financing activities 

Net decrease in cash and cash equivalents 
Cash and cash equivalents at beginning of the period 
Cash and cash equivalents at end of the period 

Note 

2021 
$ '000 

2020 
$ '000 

(38,177) 

(55,917) 

3 

3 

4 
4 

250 
36,674 

(23) 
(147) 
19 
(1,404) 

1,070 
(3,138) 
2,068 

(738) 
— 
— 
(738) 

(74) 
1,756 
1,682 

934    
53,755    

(199)   
(340)   
(2,086)    
(3,853)   

1,910 
(45,133) 
43,223  

— 
8    
(39,705)   
(39,697)   

(328)   
2,082    
1,756    

155 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

NOTES TO THE FINANCIAL STATEMENTS 
For the year ended 31 December 2021 

(1) 

Accounting Policies 

Basis of Preparation and Measurement 

The financial statements of the parent company have been prepared under the historical cost convention, 
in accordance with international accounting standards as applied inaccordance with the provisions of the 
Companies Act 2006 and in accordance with UK Adopted International Accounting Standards (”IFRS”). A 
summary of the more important accounting policies which have been applied consistently throughout the 
year are set out below. 

Functional and Presentation Currency 

The functional currency of the parent company is British Pounds. The financial statements of the parent 
company are presented in US dollars to the nearest $’000s. 

Foreign Currency 

Transactions  in  foreign  currencies  are  translated  to  the  respective  functional  currencies  of  the  parent 
company at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities 
denominated in foreign currencies at the balance sheet date are retranslated to the functional currency 
at the foreign exchange rate ruling at that date. Foreign exchange differences arising on translation are 
recognised in the income statement. Non-monetary assets and liabilities that are measured in terms of 
historical cost in a foreign currency are translated using the exchange rate at the date of the transaction. 
Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are 
retranslated to the functional currency at foreign exchange rates ruling at the dates the fair value was 
determined. 

On translation of the Company financial statements from functional currency to presentational currency 
the  assets  and  liabilities  are  translated  at  the  closing  exchange  rates.  Profit  and  loss  accounts  are 
translated at the average rates of exchange during the year. Gains and losses arising on these translations 
are taken to reserves. Each reporting date, the retained earnings reserve, as measured in the functional 
currency,  is  translated  to  the  presentational  currency  using  the  closing  exchange  rate.  The  retained 
earnings  balance  represents  the  deemed  amount  in  US  Dollars,  measured  at  the  reporting  date, 
equivalent to the functional currency Great British Pounds available for distrubtion to the shareholders 
from  the  parent  company’s  distributable  reserves.  Any  differences  between  this  amount  and  the 
aggregate of the opening retained earnings measured at the opening rate and the profit in the period 
measured at the average rate are recognised in the Translation reserve. 

Intercompany Loans 

All intercompany loans are initially recognised at fair value and subsequently measured at amortised cost. 
Where intercompany loans are intended for use on a continuing basis in the  Company’s activities and 
there  is  no  intention  of  their  settlement  in the  foreseeable  future,  they  are  presented  as  non-current 
assets. 

Cash and Cash Equivalents 

Cash and cash equivalents include all highly liquid instruments with original maturities of three months or 

156 

 
 
FINANCIAL STATEMENTS  

less. 

Impairment 

If there is an indication that an asset might be impaired, the Company will perform an impairment review. 
An asset is impaired if the recoverable amount, being the higher of net realisable value and value in use, 
is less than its carrying amount. Value in use is measured based on future discounted cash flows (“DCF”) 
attributable  to  the  asset.  In  relation to the  investment  held  in  subsidiaries  and  intra  group  receivable 
balance the net realisable value is the fair value of the underlying subsidiaries.  In such cases, the carrying 
value of the asset is reduced to recoverable amount with a corresponding charge recognised in the profit 
and loss account.  The underlying assumptions in determining the fair value of the subsidiaries are key 
estimates and include the determination of the fair value as described in note 11 and 16 of the group 
financial statements.  

Financial Instruments 

Currently the Company does not enter into derivative financial instruments. Financial assets and financial 
liabilities are recognised and cease to be recognised on the basis of when the related titles pass to or from 
the Company. 

Share-based Payments 

Share-based payment arrangements in which the Company receives goods or services as consideration 
for  its own  equity  instruments  are  accounted  for  as equity-settled  share-based  payment  transactions, 
regardless of how  the equity instruments are obtained by the Company.  The Company’s share  based 
payment scheme, which awards shares in the parent entity, includes recipients who are not employees 
the company, but in its subsidiaries.  Where beneficiaries are employees in a subsidiary, their element of 
the share based payment charge would usually be capitalized to recognize the service received by the 
subsidiary.  To  the  extent  that  these  amounts  will  not  be  recovered  the  charge  has  continued  to  be 
expensed by the Company.   

The  grant  date  fair  value  of  share-based  payment  awards  granted  to  employees  is  recognised  as  an 
employee expense, with a corresponding increase in equity, over the period that the employees become 
unconditionally entitled to the awards. The fair value of the options granted is measured using an option 
valuation model, taking into account the terms and conditions upon which the options were granted. The 
amount recognised as an expense is adjusted to reflect the actual number of awards for which the related 
service  and  non-market  vesting  conditions  are  expected  to  be  met,  such  that  the  amount  ultimately 
recognised as an expense is based on the number of awards that do meet the related service and non-
market performance conditions at the vesting date. For share-based payment awards with non-vesting 
conditions, the grant date fair value of the share-based payment is measured to reflect such conditions 
and there is no true-up for differences between expected and actual outcomes. 

(2) 

Cash and Cash Equivalents 

As of 31 December: 

Bank balances 

Cash and cash equivalents 

2021 
$'000 

2020 
$'000 

1,682 
1,682 

1,756    
1,756    

157 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(3) 

Loan to Subsidiary 

Balance at 1 January 
  Additions 

Impairment 
  Repayments 

Effect from currency translation 

Balance at 31 December 

2021 
$'000 

2020 
$'000 

92,648 
1,070 
(36,674) 
(3,138) 
(635) 
53,271 

187,431 
1,910 
(53,755) 
(45,133) 
2,195 
92,648 

The Company has loaned its excess cash to its operating subsidiary Allied Minds, LLC (‘the subsidiary’) , as 
part  of  its  continuing  working  capital  investment  programme  in  the  wider  group,  and  to  be  further 
deployed by the subsidiary, to enable the group to deliver its strategic plans. The note bears an interest 
of 1.25% and in the foreseeable future, repayment is neither planned nor likely to occur.  

During 2021, the Directors reviewed the value of the underlying business and concluded an impairment 
charge of $36.7 million should be recorded.  The asset’s recoverable amount is determined to be based 
on the fair value of the company’s subsidiaries together with its associates, preferred shares held and the 
recoverable cash. This has been recorded against the loan to subsidiary balance (this note).  

(4) 

 Share Capital and Reserves 

Allied Minds Plc was incorporated with the Companies House under the Companies Act 2006 as a public 
company on 15 April 2014. Full detail of the share capital and reserves activity for the year can be found 
in note 16 to the consolidated financial statements. 

As of 31 December: 

2021 
$'000 

2020 
$'000 

Equity 
Share capital, $0.01 par value, issued and fully paid 
242,187,985 and 242,187,985, respectively 
Treasury Shares 
Translation reserve 
Accumulated deficit 

Total equity 

3,767 

(738) 
(55,215) 
107,357 

55,171 

3,767 

— 
(59,394) 
150,080 

94,453 

In December 2016, the Company issued 17,457,015 ordinary shares of one pence at 367 pence, which 
were admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading 
on the LSE’s Main Market for listed securities. This resulted in approximately $78.1 million of net proceeds 
from the equity placing (net of issue cost of $2.2 million). The amounts subscribed for share capital in 
excess of the nominal value in relation to this transaction are reflected in the merger reserve balance as 
of 31 December 2016.  

158 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

ALM's Board of Directors (the "Board") approved a new programme to buy back up to $3.0 million of the 
Group's  shares  ("Buyback  Programme")  during  2021.  Share  purchases  took  place  in  open  market 
transactions  and  were  made  from  time  to  time  depending  on  market  conditions,  share  price,  trading 
volume and other factors. The Buyback Programme ran from the date of the announcement to 6 October 
2021.  The  Buyback  Programme  was  in  accordance  with  Allied  Minds'  general  authority  to  purchase  a 
maximum of 24,218,799 Ordinary Shares, granted by its shareholders at the Annual General Meeting held 
on  12  May  2021  and  the  purpose  was  to  reduce  share  capital.  Shares  purchased  under  the  Buyback 
Programme will be cancelled. As of 31 December 2021, the company has repurchased 2,537,712 of its 
own shares for a total price of $737,678. 

Holders of Ordinary Shares are entitled to vote, on all matters submitted to shareholders for a vote. Each 
Ordinary Share is entitled to one vote. Each ordinary share is entitled to receive dividends when and if 
declared by the Company’s Board of Directors. 

The share-based payment credit for the fiscal year ended 31 December 2021 included in accumulated 
deficit was $0.3 million (2020 charge: $0.9 million). 

In the period, management have calculated that an amount of $4,796k foreign exchange on converting 
their  functional  currency  retained  earnings  to  the  presentation  currency  retained  earnings.  The 
cumulative, foreign exchange, amount recorded in retained earnings is $8,045k.   

(5) 

Profit and Loss Account 

As permitted by Section 408 of the Companies Act 2006, the Company’s profit and loss account has not 
been  included  in  these  financial  statements.  The  Company’s  loss  for the year was  $38,177,000  (2020: 
$55,917,000). 

(6) 

Directors’ Remuneration, Employee Information and Share-based Payments 

The remuneration of the Directors of the Company is disclosed in note 23 to the consolidated financial 
statements. Full details for their remuneration can be found in the Directors’ Remuneration Report on 
pages 56 to 59. Full detail of the share-based payment charge and related disclosures can be found in note 
6 to the consolidated financial statements. 

The Company had no employees during 2021 (2020: none). 

159 

 
 
 
 
 
 
Company Information 

Company Registration Number 08998697 

Registered Office  
Beaufort House 
51 New North Road 
Exeter EX4 4EP 
United Kingdom 

Website 
www.alliedminds.com  

Board of Directors  
Harry Rein 
(Non-Executive Chairman) 

Bruce Failing 
(Senior Independent Director) 

Company Secretary 
JTC (UK) Limited 
The Scalpel 
18th Floor 
52 Lime Street 
London 
EC3M 7AF 

Broker 
Numis Securities Limited 
The London Stock Exchange Building  
10 Paternoster Square 
London EC4M 7LT  
United Kingdom 
TEL: +44 207 260 1000 

Registrar 
Link Group 
The Registry 
Unit 10 
Central Square 
29 Wellington Street 
Leeds 
LS1 4DL 
TEL UK: 0871 664 0300 
TEL Overseas: +44 208 639 3399 

Solicitors 
DLA Piper UK LLP  
160 Aldersgate Street  
London EC1A 4HT  
United Kingdom 
TEL: +44 207 349 0296 

Independent Auditor 
BDO LLP 
55 Baker Street 
London  W1U 7EU 
United Kingdom 
TEL: 020 7486 5888 

Media Relations 
Instinctif Partners 
65 Gresham Street, 
London EC2V 7NQ 
United Kingdom 
TEL: +44 20 7457 2020 

160